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SUMMARY
A total of 9 differing experimental models of scrapie were surveyed
initially. This thesis has shown that there is at least one model, 87V in
p7
Sincf mice, in which changes in the host's humoral immune responsiveness 
have been consistently demonstrated. These changes were identified 
initially as a significant increase in the serum IgG concentrations, which 
is probably not produced as a specific response to scrapie agent as antigen 
nor to brain antigens. It is not the cause of disease, as judged by its 
late appearance during the incubation period, and its occurrence is 
independent of the route of infection. It appears to be directly linked to 
the persistence of agent in the spleen, which causes selective (i.e. IgGl 
subclass) but non-specific (i.e. polyclonal) changes. This polyclonal 
expansion of immunoglobulin-secreting lymphocytes has been confirmed by 
isoelectricfocusing studies of the increased IgG fraction, and also from 
its accelerated catabolism in serum. As a further consequence of the long­
term presence of 87V strain of scrapie in the spleen, a significant 
decrease of some T cell subsets, possibly T suppressor cells, was also 
noted.
It was also possible to identify an early immunological consequence 
of infection with the 87V strain of scrapie, which is independent of T cell 
involvement. There is an early and sustained increase in the activity of 
IgGl-secreting B cells, as demonstrated in studies with other IgGl- 
stimulating antigens (i.e. ovalbumin and KLH), and which parallels the 
concentration of agent in the spleen. This also suggests that T cells are 
not involved in the initial extraneural phase of scrapie (87V) 
pathogenesis.
Read not to contradict and confute,
nor to believe and take for granted, 
nor to find talk and discourse, 
but to weigh and discover.
Francis Bacon,(1561-1626)
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1.INTRODUCTION
1.1 SCRAPIE-LIKE DISEASES
Slow virus infections were defined by Sigurdsson (1954) in a series 
of lectures. His concept was of an initially mild clinical disease which 
progressed over a period of time (from weeks to months) leading to a chronic 
condition and, ultimately, death, and which was the result of an infection 
that had occurred years earlier. From the now considerable list of diseases, 
many of which have very little in common except that they fulfill 
Sigurdsson's criteria (Sigurdsson, 1954), a small subgroup can be identified 
based on histopathological and aetiological similarities. This group can 
best be described as infectious, chronic degenerative encephalopathies, and 
include kuru and Creutzfeldt-Jakob disease (CJD) in man, and scrapie and 
transmissible mink encephalopathy (TME) in animals.
These 4 scrapie-like diseases are caused by virus-like agents, which 
have not been identified or isolated, and which appear to show many unusual 
physico-chemical properties following treatments which would inactivate 
conventional viruses (Millson et al.,1976). These agents can be 
experimentally transmitted to hosts of some other species, resulting in 
clinical disease after long, but in many experimental situations, precise 
incubation periods. There is no evidence of inflammation or demyelination in 
the central nervous system, nor have any pathological changes been described 
elsewhere in the body. These 4 diseases show a degenerative pathology, and 
the only accompaniment of these lesions is a hypertrophy of astrocytes 
(Fraser, 1976). The degenerative lesions include vacuolation, which may 
appear within the nerve cell or can appear within the neuropil (Fraser,1976). 
One of the late lesions can be a mild neuronal degeneration, which can be 
concentrated in certain areas of the brain (Fraser, 1979).
There is considerable variation in the incidences of these
diseases; CJD, for example is rare, but it has a fairly uniform world-wide
incidence of 1 case per million per annum. There have been 14 reported 
outbreaks of TME which can result in up to 95% morbidity of animals. Some 
sheep breeds are reported to have between 10-20% scrapie deaths per year, 
but within a breed some flocks may have up to 50% morbidity.
1.2 NATURAL SCRAPIE IN SHEEP
Scrapie is an infectious disease which has been known in Europe for 
over 200 years, and has been reported from most areas of the world. Its 
incidence varies not only between breeds, but between flocks of the same 
breed. Most scrapie cases occur between the ages of 2 and 5 years 
(Dickinson 1976), but 10% of all cases occur in older animals. However, 
there have been few reported instances of scrapie in sheep of less than one 
year of age.
The major portion of the incubation period (i.e. from time of 
infection to the final clinical phase) is asymptomatic. The clinical phase 
of the disease is initially marked by changes in behaviour and proceeds 
through various, and often well defined, stages to eventual death after a 
time varying from a few weeks to several months. Following the changes in 
behaviour, the next phase is characterised by rubbing and nibbling of parts 
of the head, body and legs, and can result in extreme pruritus. 
Occasionally, fine tremblings of the limbs and head can be observed when 
the animals are stationary. Inco-ordination of gait and ataxia of the hind 
quarters mark the onset of the debilitating phase which progresses to 
wasting of the animal as-it becomes unable to feed or drink. The 
occurrence of the classical signs of scrapie, as described above, makes 
diagnosis relatively easy, but there is such considerable variation in the 
signs and in the course of the disease that confirmation is often needed 
and this can only come from histopathological examination of CNS tissue.
The most diagnostically useful lesion at the clinical phase is the presence 
of single or multiple vacuoles in neurones, especially in medulla, pons, 
mid-brain and spinal cord. There may also be some neuronal loss (Fraser, 
1976). However, in some cases even the pathological criteria can be 
inadequate.
Maternal transmission of infection to lambs can account for as much 
as 65% of cases in an outbreak (Kimberlin, 1979a). Since infectious agent 
is present in placentae from diseased ewes (Pattison et al, 1974) infection 
may occur pre-natally (Gordon, 1966, Dickinson*et al, 1966), or at 
parturition. However, other evidence suggests that infection may also 
occur later, during the period of close contact between ewe and lamb that 
occurs from birth to weaning (Hourrigan et al, 1979). There is also a 
significant amount of contagious spread of scrapie between adults (up to 
25%, Dickinson et al, 1974). There is strong evidence from Icelandic 
studies (Palsson, 1976) that contaminated pastures ( for example by infected 
placentae) may be a persistent source of infection. Studies of 
experimental scrapie have indicated that the most probable modes of 
infection to account for lateral spread of scrapie are oral ingestion of 
infected placentae (Pattison and Millson, 1961), scarification of skin 
(Stamp et al, 1959), and via the conjunctiva (Haralambiev et al, 1973).
Scrapie is caused by a virus-like agent, and there is considerable 
evidence that the development of many aspects of disease depends on genetic 
factors in the host (Dickinson, 1976). In experimental scrapie, one major 
gene SIP (Scrapie .Incubation Period) has been identified which controls 
susceptibility to infection with the SSBP/1 source of scrapie (Dickinson et 
al, 1968; Nussbaum et al, 1975). This gene has 2 alleles, and the allele 
conferring susceptibility to SSBP/1 is dominant. There is some evidence 
that similar genetic factors may be involved in natural infection 
(Dickinson, 1979; Kimberlin, 1979a), but there maybe additional host genes 
involved in the natural disease which control infection. There is also
evidence that the genetic control of experimental scrapie may vary with the 
strain of agent (Dickinson, 1976), but this is discussed later with 
reference to experimental mouse scrapie for which there is much more 
precise information.
1.3 EXPERIMENTAL SCRAPIE
Initially sheep and goats were used for studies on experimental 
scrapie (Wilson et al, 1950; Pattison, 1957), but the biological 
variability of these hosts and considerable cost of maintaining a 
relatively small number of animals made the search for a convienient 
laboratory animal a priority. However, when this was finally achieved in 
mice (Chandler, 1961, 1963; Zlotnik and Rennie, 1965; Dickinson and Smith, 
1966), it did not result in any real savings in time; for example strain 
22A inoculated into sheep and mice carrying specific analogous genes 
results in incubation periods of similar length (Dickinson, personal 
communication). With the possible exception of one hamster model 
(Kimberlin and Walker, 1977), transmission into laboratory animals has not 
achieved the anticipated reduction in the duration of experiments, but it 
has resulted in improved experimental control and allowed larger numbers of 
animals to be used at a reduced cost. A 'species barrier' (Dickinson, 
1976) operates on first passage of infected material to a different 
species, such that the incubation period is prolonged, compared with later 
passages. This may arise from some selection of strains by the recipient 
species (Kimberlin and Walker, 1978a), or because of some modification of 
pathogenesis at first pass compared to later ones (Kimberlin 1979a). 
However, the majority of work avoids this issue by using strains of agent, 
which have been serially passaged many times, usually by the intracerebral 
route, to give stable and reproducible incubation periods.
The clinical and histological features seen in experimental mouse 
scrapie cover broadly the same range as those seen in the natural disease,
but there is great variety between some of the models available, so it is 
possible to select individual models to emphasise specific features of the 
disease. As with the natural disease, there is no routine diagnostic test 
for the presence of scrapie agent; there appears to be no specific 
immunological response, as conventionally defined (see below), and so 
workers have to define the different strains of agent, not in terms of 
immunological differences, as would apply in conventional virology, but in 
terms of biological differences.
There are two main methods of identifying different strains of 
scrapie which depend on two biological features evident at the clinical end 
point. Firstly, on the type, distribution and severity of brain lesions, 
and parts of this have been developed into a quantitative system, called 
'lesion profiles1 (Fraser, 1976), which are extremely reproducible, and are 
independent of the dose of infectivity used. This point is stressed, 
because the other main parameter used in strain typing depends on the 
relative incubation period in three genotypes of mouse with respect to the 
gene Sine; absolute incubation periods are of limited use here as they are 
dose dependent. A third method of strain typing which is sometimes used is 
based on the degree of thermal stability of different strains. So far, 15 
individual strains have been identified. These methods of strain typing 
relate directly to the disease process, whereas conventional typing, based 
on antigenic differences, may have a less direct bearing on the biological 
variety for the disease in question.
1.4 IMMUNOLOGICAL ASPECTS OF SCRAPIE
Conventional immunological tests to detect neutralising antibodies 
in sheep with natural scrapie (Gordon, 1957) and in experimentally infected 
goats (Pattison et al, 1964) proved unsuccessful, as was the work to 
demonstrate a scrapie-specific antibody response in sheep (Chandler, 1959). 
There was some evidence that brain and spleen from sheep with natural
scrapie produced a better response in rabbits than the same tissues from
uninfected sheep (Gardiner, 1965). More recently, studies with Herdwick
sheep with either natural or experimental scrapie have demonstrated that a
high percentage of animals (which varies between lamb crops) show increases
in serum IgG concentrations at the clinical phase of the disease (Collis et
al, 1979, Collis and Kimberlin, 1983), and that there is a shift in the
percentage distribution of IgG isotypes (Collis and Kimberlin, 1983).
However the immunological specificity of these changes is not known and
would in any case be difficult to evaluate in sheep, which is why the work
has been developed in mice (see later).
Specific work on immunological aspects of murine scrapie
concentrated on using the 139A ('Chandler") and ME7 strains of scrapie in 
s7
Sine mice in the search for neutralising antibodies (Gardiner, 1965;
Clarke and Haig, 1966; Eklund et al, 1967; Gibbs, 1967) and antibodies
against double stranded nucleic acids (Cunnington et al,1976) but these
studies all provided negative results. Further work by Porter et al (1973 )
S7showed that the humoral responses in Sine mice infected with 139A were 
the same as for control animals. Scrapie-infected mice were shown to 
respond normally when challenged with various antigens (Clarke, 1968; 
Gardiner and Marucci, 1969), and with other viruses (Katz and Koprowski, 
1968; Worthington, 1972). However, there is some evidence that subtle 
immunological changes might be occuring during scrapie infection 
(Vettermann et a*l, 1981; Rutter et al, 1981), and recent work has shown 
that certain strains of scrapie are characterised by the production of 
cerebral amyloid plaques (Bruce, 1981). The exact chemical composition of 
this amyloid is at present unknown, but there is evidence that some types 
of systemic amyloid are formed from modified immunoglobulin light chains 
(Glenner and Terry, 1973).
Experiments to modify the pathogenesis of scrapie began using 
interferon when this was shown to be produced as an early, non-specific
antiviral agent. However, direct administration of interferon (Gresser and 
Pattison, 1968) and interferon-inducers (Field et al, 1969; Worthington, 
1972) had no effect on incubation period when given intraperitoneally. 
Allen and Cochran (1977 ) claimed that multiple doses of various interferon- 
inducers given intracerebrally significantly shortened the incubation 
period, as did intracerebrally administered Sendai Virus, but intravenous 
injection of Newcastle disease virus (Worthington, 1972), or intracerebral 
injection of West Nile virus or rabies virus (Katz and Koprowski, 1968), 
had no effect, nor was interferon production impaired in these super­
infected animals.
Immunosuppression with cyclophosphamide (Worthington and Clark, 
1971; Outram 1973) had no effect on the length of incubation period in mice 
infected intracerebrally or intraperitoneally with scrapie, although a 
combination of cyclophosphamide and prednisone acetate resulted in a 
significant lengthening of incubation period (Outram, 1973). The long term 
treatment with rabbit anti-mouse thymocyte serum also had no effect on the 
incubation period of scrapie (Hirsch, 1970). Surgical splenectomy or 
genetic asplenia resulted in a lengthening of the incubation period 
following intraperitoneal infection, but had no effect if agent was 
injected directly into the brain. This emphasised the significance of the 
spleen as an important site in pathogenesis when mice are infected 
intraperitoneally (Fraser and Dickinson, 1970; Clarke and Haig, 1971; 
Dickinson and Fraser, 1972) or intravenously (Fraser and Dickinson, 1978). 
Thymectomy of neonatal or adult mice (McFarlin et al, 1971; Fraser and 
Dickinson, 1978) also had no effect on scrapie pathogenesis. Recent work 
has shown that it is possible to alter the incubation period of scrapie, 
using compounds which are also known to be immune modulators. The 
incubation period can be reduced by giving a single intraperitoneal dose of 
methanol extraction residue of BCG vaccine 1/2-4 hours before injecting the 
mice intraperitoneally with strain 139A (Kimberlin and Cunnington, 1978),
and by giving phytohaemagglutinin 3 hours before strain ME7, both by the 
intraperitoneal route (Dickinson et al, 1978). HPA-23, a potent anti-viral 
compound, lengthens the incubation period if given intraperitoneally for 9 
days, begining 24 hours before scrapie (139A strain) is given by the same 
or different route (Kimberlin and Walker, 1979b).
1.5 LIMITATION ON EXPERIMENTAL DESIGN
The design and scope of all scrapie experiments are influenced by 
many operational and practical limitations. Much of the work reported in 
the literature fails to state the simple operational conditions employed in 
an experiment, but these are of major importance when considering any 
interactions which take place between an animal and the injected foreign 
material. One such example is the inoculation of two aliquots of 
identically prepared homogenate, one fresh, the other frozen and thawed. 
The aggregated particles obtained on thawing are visual evidence that the 
chemical (and hence immunological) nature of the inoculum may have been 
altered, and should not be used in comparability studies with freshly 
prepared homogenates. This is discussed further, as is the problem of 
defining suitable controls (see section 2.6:2)
The second limitation is concerned with the practicalities of
i
initiating experiments. The only assays for infectivity are animal assays.
♦
There is no conventional tissue-culture system to quickly * grow up * scrapie 
as is possible for many conventional viruses; this must be done in animals, 
and is time-consuming. There will then follow a further period of waiting 
whilst the inoculated animals react. Therefore there has to be even more 
careful planning than usual of all scrapie experiments, considering the 
operational restrictions and the practical limitations involved.
One further limitation for immunological studies is that of the 
environment in which the animals are maintained. Aside from infection, it
appears to be very difficult to modify pathogenesis, but recently it has 
been shown that minimal stimulation of experimental animals close to the 
time of infection can alter the dynamics of scrapie, either by changing the 
infectability of the host, or by modifying pathogenesis at early stages in 
the disease process (Dickinson, personal communication). It follows, 
therefore, that animals may be immunologically stimulated by environmental 
changes or by dietary changes, and these should be considered within the 
general framework of interpretation of the results, even though they may 
not be controlled.
1.6 BACKGROUND AND RATIONALE FOR THESIS
Mice can be infected with scrapie by a variety of routes. The 
shortest incubation periods are obtained when the infected material is 
introduced directly into the nervous system (intracerebrally, Kimberlin and 
Walker, 1978b or intraspinally, Kimberlin and Walker, 1983). Although the 
majority of the inoculum is removed from the brain, and can be detected in 
spleen and lymph modes, it is the residual amount of the infected material 
that eventually causes disease (Dickinson and Fraser, 1977). Peripheral 
routes of infection result in longer incubation periods because a series of 
extra-neural events occur which are a consistent feature of scrapie 
pathogenesis (Dickinson et al, 1968). This process of peripheral 
pathogenesis is shown in Figure 1, (Kimberlin, 1979b) and although the 
sequence of events is always the same, the timing and duration of each 
phase varies between models ( 'Model' will be used throughout this thesis to 
denote the strain of scrapie, the Sine genotype, age and sex of mice, the 
dose and route of infection, and the preparation of the inoculum. ) 
Following inoculation, there is a brief time (lasting from hours to 
a few days) when scrapie can be detected in blood and one or two peripheral 
organs (Millson et al, 1979). There may then be a period when infectious 
agent cannot be detected, by present methods, in lymphoreticular tissue,
Zero phase. Replication phase. to
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Figure 1 Schematic pathogenesis of experimental scrapie in mice following 
peripheral injection..
a) Duration of zero phase controlled by the murine gene Sine (in short 
incubation periods models, zero phase maybe almost non-existent; in long 
incubation periods models, zero phase may last for months).
b) Time from detectable agent in spleen and subsequently in brain. This 
varies between models.
c) Time from onset of detectable agent replication in brain to clinical 
disease. This varies between models.
and this is referred to as the 'zero phase'. In the short incubation 
period models, however, the zero phase cannot be detected (except with low 
infecting doses, Kimberlin and Walker, 1979c), as replication of agent 
begins in the spleen, for example, before the initial inoculum, (which has 
accumulated there) has been degraded. That the increase in titre in the 
spleen is caused by active replication and does not merely represent 
accumulation of agent from other locations, is difficult to prove, except 
perhaps when low doses of agent are given by an efficient route of 
infection (Kimberlin and Walker/ 1979c; Kimberlin, personal communication). 
This ambiguity does not apply to the brain when peripheral routes of 
infection are used (Outram, 1976), and replication appears to be the most 
plausible explanation for the titre increase in spleen and other 
lymphoreticular organs as well.
Early pathogenesis experiments established that spleen could be 
taken as representative of some, but not all lymphorecticular tissue (eg. 
Peyers patches, mesenteric lymph nodes and some other peripheral nodes) in 
the sense that no other tissue has been found where replication starts as 
early as it does in spleen or reaches a higher titre. Thymus and bone 
marrow appear to be quite different from spleen in that they do not 
consistently support replication of scrapie (Dickinson, personal 
communication; Kimberlin, personal communication), although earlier work by 
Eklund et al (1967) reported high titres of agent in both tissues. Despite 
earlier suggestions (Lavelle et al, 1972; Hotchin and Buckley, 1977), it is 
completely unknown in what cell types scrapie replication occurs, but a 
cell of lymphoreticular origin would be an excellent candidate.
The final (although still early) event of this extraneural phase is 
the establishment of a plateau of infectivity in the spleen and lymph 
nodes. Infection of the central nervous system follows later, but the 
timing depends on the models under study.
This plateau can last for a very long time and hence represents a
chronic stage of infection in lymphoreticular tissue. It therefore raises 
the question whether there are any immunological consequences of such a 
long established infection, which may be an acute process, with active 
turnover of agent, but could quite well represent a static situation. It 
would indeed be surprising if changes were not detected, no matter how 
subtle, at sometime during this plateau phase. Some of the work included 
in this thesis is therefore an attempt, using recently developed methods, 
to investigate immunologically this phase in the'pathogenesis of one 
particular model.
Quite separate from the plateau phase, there are other phases which 
might result in the stimulation of the host's immune processes; for 
example, during the active replication of agent in the spleen over a matter 
of a few weeks. Additionally, replication of agent in the brain may result 
in the release of altered brain antigens, which may or may not be identical 
to those which arrived at the spleen many weeks earlier from the inoculum; 
the latter may therefore have a pre-sensitising effect. Hence it is 
necessary to specify at what particular time during the incubation period 
of a specified model one is testing for immunological involvement. 
Moreover, different aspects of cellular and humoral responses could be 
involved at different phases of the incubation period.
The transmission of scrapie to small laboratory mammals in the 
early 1960's was of great significance as it enabled researchers to 
investigate many aspects of the disease which would otherwise have been 
impracticable using sheep and goats. This, however, resulted in 
generalised statements on the characteristics of 'the scrapie agent', 
because many laboratories chose to work with one particular isolate 
( 'Chandler' now designated 139A) since it has a short incubation period in 
most strains of mice, and comparison of results with other laboratories was 
possible. Observations on the physico-chemical properties of scrapie based 
on 139A have proved misleading, as recent studies now indicate; this
particular isolate is in fact less thermally stable than some other strains 
now identified (Dickinson and Taylor, 1978) and hence general conditions 
for decontamination, based solely on experiments with strain 139A are no 
longer valid. Similarly, the existence of white matter vacuolation, used 
for diagnosis of scrapie by early workers, was again based on 139A, and 
does not necessarily apply to other strains.
When the present immmunological studies were begun, there was a 
clear recognition that there were many strains of scrapie, and that each 
had different biological properties, some of which depend.on the Sine 
genotype of the host. In earlier work, general immunology was applied to
s7
two models only, 139A and ME7 both in Sine mice, with negative results 
and with hindsight the ones used would not now have been chosen, as they 
are not diverse enough to be representative. As there were no guidelines 
to assist in choosing which models to study, choice was in fact dictated by 
availability. Hence in the present work 2 widely divergent models were 
used; one model (87Vin Sinc^7 ) is characterised by deposits of amyloid in 
the brain (Bruce, 1980) and this may be of some significance to this work 
because systemic amyloid can occur as a consequence of chronic 
immunological stimulation. The second model was one of those studied
s7
earlier, 139A in Sine , but with the new techniques available, it might 
now be possible to detect subtle changes.
2 MATERIALS AND METHODS
2.1 MICE '
Strains of mice were used which represented different Sine
s7
genotypes (Section 1.6). Those of Sine were inbred lines of C57BL/6 and 
CBA, and random-bred lines of LAC G and Compton Whites (CW), whilst those 
of Sinc^7 genotype were inbred lines IM, VM and MB (all three originating 
from Moredum random-bred mice, as described by Dickinson et al (1968). All 
mice used at Compton were bred under SPF conditions, and the inbred IM mice 
used at Compton originated from stock kindly donated by Dr A.G. Dickinson. 
Animals were fed ad libitum on Spillers Rodent Pellets.
2.2 BIOLOGICAL FLUIDS Sera. Blood was obtained from anaesthetised 
animals by cardiac puncture and allowed to clot at 37°C for 4 hours. Serum 
was then obtained after centrifugation at lOOOxG at room temperature, and 
stored at -20°C until required. Bulk sera were divided into 50^ il aliquots 
prior to deep freezing to avoid protein precipitation which occurs after 
repeated freezing and thawing.
Cerebrospinal Fluid. (CSF). Mice were sacrificed using chloroform vapour 
and bled from the heart. The skin covering the skull was quickly removed 
and CSF was withdrawn from the subarachnoid space at the posterior end of 
the brain by puncturing the thin bone with a fine capillary tube. Only 
clear CSF was processed by spinning in a Beckman Microfuge B to remove cell 
debris; it was then stored at -20°C.
Urine. Normally extruded urine after killing mice with chloroform, was 
collected into small disposable petri dishes and 50jil aliquots were frozen 
at —20°C prior to assay.
Sheep red blood cells (SRBC). Commercially available SRBC in Alsevers 
solution at 25% V/V were obtained from Oxoid and used within 3 weeks of the 
delivery date. Before use, the red cells were washed x3 in phosphate
buffered saline (PBS) and then resuspended at the required concentration in 
the appropriate medium.
Guinea-Pia complement. Blood was obtained by cardiac puncture and serum was 
obtained after clotting at 4°C for 4 hours. Aliquots of 200jil of sera from 
individual animals were frozen at -70°C. Each source of complement was 
tested in the assay systems to be studied. The best one was used for all 
the assays undertaken.
Commercially prepared antisera. Rabbit antiserum against total mouse IgG 
was obtained from Miles Research Laboratories. Monospecific antisera to 
individual IgG isotypes (ie IgGl, IgG2a, IgG2b, IgG3) and horseradish 
peroxidase (HRP)- conjugated to goat anti-rabbit Immunoglobulins were 
obtained from Nordic Immunological Laboratories.
2.3 BIOCHEMICAL METHODS
1) Isolation of IgG from mouse serum bv affinity chromatographv on protein 
A-seoharose (Ey et al., 1978)
An unusual property of protein A (isolated from the cell wall of 
staphylococcus aureus) is that it will selectively bind IgG molecules. 
Therefore when linked to a support medium (e.g. sepharose) it becomes an 
excellent immunoadsorbent for the purification of IgG by affinity 
chromatography. The binding of IgG to the immunoadsorbent depends on pH and 
therefore IgG can be eluted by lowering the pH. The only problem is that 
there is some selectivity for the initial binding of subclasses in mice; 
IgGl, IgG2a and IgG2b are all bound, but IgG3 (approx 1% of total IgG) is 
not.
Materials
Protein A-Sepharose 4B (Pharmacia) 1.5g.
Fresh mouse serum.
0.14M phosphate buffer pH 8.0
0.IM citrate/citric acid buffer pH 3.5 
2M Tris buffer.
Procedure
Protein A-Sepharose was allowed to swell in 10 ml 0.14M phosphate 
buffer pH 8.0, packed into a small column (0.9x150cm) which was linked to a 
LKB fraction collector maintained at +4°C. Two ml of mouse serum were mixed 
with 2ml 0.14M phosphate buffer pH 8.0, applied to the column and the same 
buffer allowed to flow through the column until the unretained proteins had 
eluted and the optical density (at 280nm) of the eluate returned to 
background (see fig.2). The bound IgG was released by elution with 0.1M 
citrate/citric acid buffer pH 3.5 and 1ml fractions collected into an equal 
volume of 2M-Tris to neutralise the high pH. Optical density readings were 
carried out to locate the IgG. The protein containing solutions were pooled 
and dialysed at 4°C against several changes of sterile water prior to 
storage at -20°C.
Individual IgG isotypes were isolated by sequential elution of bound 
proteins; IgGl was eluted with 0.14M phosphate buffer pH6.0; IgG2a eluted 
with 0.14M phosphate buffer pH 5.0, and IgG2b with 0.1M citrate/citric acid 
pH 3.5.
2) Iodination of mouse letG (Hudson and Hay, 1980).
Isotopically labelled antibodies can be detected and quantified with 
relative ease. The chloramine T method (as described below) for the 
introduction of radioactive iodine was used. This method does not alter the 
immunological properties of the protein to be studied.
Materials (All the solution were prepared just before labelling).
Mouse IgG, 2mg/ml in PBS.
Chloramine T, 5mg/ml in 0.5M Tris/HCl pH 7.5.
Sodium 125 iodide (carrier free) lOOmCi/ml (Amersham International).
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Figure 2 Isolation of IgG from serum by affinity chromatography using a 
protein A-Sepharose column
Potassium iodide, lmg/lml in 0.5M Tris/HCl pH 7.5 
Sodium metabisulphite 2.8mg/ml in 0.5M Tris/HCl pH 7.5.
Procedure
125Into a small vial were dispensed 20jil sodium iodide, 20jil 0.5M 
Tris/HCl pH 7.5, 20jj1 mouse IgG and lastly, 20jj1 chloramine T. These were 
vortex mixed for 30 seconds. The reaction was then halted by the addition 
of lOOjil sodium metabisulphite, with mixing followed by lOOjil potassium 
iodide. After mixing, 500pl 0.5% non-radioactive ( 'cold' ) mouse IgG and 2 
drops of filtered phenol red were added. After a final mixing, the contents 
of the vial were loaded onto a column of sepharose G25 (Pharmacia) and 
eluted with 0.05M Tris/HCl pH 6.5 containing 0.5% ’cold' mouse IgG.
Fractions (0.5ml) were collected for a total of 10ml. Aliquots of lOjil were 
counted to find the peak of radio-protein (Figure 3). The fractions 
containing the labelled protein were pooled and then dialysed against PBS 
prior to use.
3) Isoelectricfocusina of Purified Mouse IqG
The technique of isoelectricfocusing involved electrophoresis in a 
continuous pH gradient, in which the proteins will migrate to their 
isoelectric point (i.e. the pH at which their charge is zero) and 
precipitate out. A protein fraction (e.g. IgG) purified as a single peak by 
conventional chromatography, may be resolved into many bands by 
isoelectricfocusing to produce a characteristic profile. Very subtle 
alterations to this profile can be detected by this method.
Materials
Prepared isoelectricfocusing gels, with a pH range of 3.5 to 9.5 (LKB)
IgG lmg/ml in PBS.
Anode solution lM-H^PCK3 4
Cathode solution lM-NaOH
Fixing solution 12.5% trichloroacetic acid (TCA) in methanol: water 1:3
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125 125Figure 3 Separation of I-IgG and I, using Sepharose G25.
(v/v).
Staining solution 0.1% Coomassie Brilliant Blue in acetic acid: ethanol: 
water 2:9:9 (v/v) and filtered.
Destaining solution Acetic acid : ethanol : water 1:6:13 (v/v).
Procedure
Uniformly-sized filter pads were soaked in purified mouse IgG and 
placed at the centre of an isoelectricfocusing gel. Electrophoresis was 
carried out on a LKB multiphore system using the recommended conditions. 
After electrophoresis the pH gradient of the gel was measured using a 
surface pH probe, and then the gel was immersed in fixing solution for 1 
hour, which not only fixed the proteins at their isoelectric point, but 
also washed the ampholines out of the gel. Following a rinse in destaining 
fluid, which removed the final traces of the ampholines and also the TCA, 
the gel was covered with staining solution and left at 65°C for 15 minutes.
The gel was then washed repeatedly with destaining fluid until the 
background stain had been cleared. Gels were either photographed or 
preserved by immersion for 1 hour in glycerol: destaining fluid (1:1,v/v), 
air drying overnight and covering with an acetate film to exclude all air.
4) Polvacrvlamide Gel Electrophoresis of Mouse IaG
The migration of proteins in an electric field is dependent upon
the charge, size and shape of molecules. When disulphide bonds are
disrupted, allowing the separation of individual peptide chains, a
different separation will be obtained. Disruption of IgG molecules by 2-
mercaptoethanol yields two light chains (L) and two heavy chains (H) per
molecule, and these are distinguished on the basis of their molecular
weights. In the experiment to measure the turnover of serum IgG, it was
necessary to show that the whole protein was being removed from serum. By
125
monitoring the distribution of I attached to both light and heavy 
chains, the relative proportions of the two can be shown to remain
constant, even though the actual amounts will reduce as the protein is 
removed.
The electrophoresis system chosen was that described by Laemmli 
(1970). Following treatment of the serum with buffer containing 2- 
mercaptoethanol (sample buffer), the sample initially enters a gel of large 
pore size (the stacking gel) which allows all the proteins to enter a gel of 
smaller pore size (the separation gel) at the same time. The sample buffer, 
the buffer used to make the gels, and the buffer used in the upper and lower 
reservoirs during electrophoresis (i.e. running buffers) all contain sodium 
dodecyl sulphate (SDS). In the presence of SDS, all the proteins become 
negatively charged, hence separation occurs only on size and shape.
Materials
Sample: Mouse serum (lOOul) heated at 95°C for 3 minutes in lOOul of sample
buffer (0.125M Tris/HCl pH 6.8 containing 4% SDS, 20% glycerol and 10% 2- 
mercaptoethanol).
Stacking Gel (upper): 3% acrylamide and 0.8% bis-acrylamide in 0.125M
Tris/HCl pH 6.8 containing 0.1% SDS, 0.08% TEMED and 0.1% ammonium 
persulphate.
Separation Gel (lower): 8.75% acrylamide and 0.23% bis-acrylamide in 0.375
Tris/HCl pH 8.8 containing 0.1% SDS, 0.07% TEMED and 0.05% ammonium 
persulphate.
Electrophoresis Buffer: 0.025M Tris/0.192M glycine pH 8.3 containing 10%
SDS.
Conditions for electrophoresis: Gels were run for 2 hours at lOOv at room
temperature. Electrophoresis was stopped when the solvent front came to 
within 5mm of the bottom of the gel. After electrophoresis, the gels were 
frozen on carriers placed on solid C02, chopped from the stacking 
gel/separation interface into 2mm thick slices and counted for 
radioactivity.
5) Protein Determination
The concentrations of protein was determined using the method of 
Lowry, Rosebrough, Farr and Randall (1951).
Materials
Samples - unknown solution of protein.
Standard solutions of purified bovine albumin in distilled water.
lM-sodium hydroxide
2% sodium carbonate (solution A)
0.5% cupric sulphate (5H20) in 1% sodium potassium tartrate (solution B) 
Folin and Ciocalteau phenol reagent (BDH).
Procedure
To 600jj1 of the sample to be analysed, 300pl of lM-sodium hydroxide 
were added, mixed and left for a minimum of 30 minutes. From a 50: 1 v/v 
mixture of A:B, 3ml were taken and added to each sample with mixing. After 
10 minutes, 300jil of 1:1 (v/v) phenol reagent : water was added. The 
resultant colour was allowed to develop for 30 minutes before measuring the 
optical density at 500mju.
2.4. IMMUNOLOGICAL TECHNIQUES 
1) Lvmphocvte preparations from spleen 
Media used
i) Phosphate buffered saline (PBS) 170mM sodium chloride in lOmM 
disodium hydrogen orthophosphate, 3mM potassium chloride and 2mM potassium 
dihydrogen orthophosphate.
ii) RPMI-1640 Medium. Commercially available (GIBC0) but supplemented 
with 200mM L-Glutamine, 20mM HEPES, 1% sodium bicarbonate, 5% heat- 
inactivated ( S G ^ ^ O 1 ) fetal calf serum, penicillin
(500units/ml)/streptomycin (500 mcg/ml)
iii) Earle's Balanced Salt Solution. Commercially available (GIBCO)
without calcium ions, magnesium ions and phenol red.
Procedure
Mice were routinely exsanguinated before the spleens were removed 
aseptically into 3ml sterile PBS, and then transferred to a sterile petri 
dish containing either 3ml RPMI-1640 medium, 2.5ml Earle's Balanced Salt 
Solution, or 3ml PBS (depending upon the assays to be carried out). Cells 
were released by teasing the spleens between two pairs of curved forceps, 
and the resultant suspension removed by pipette into sterile bijoux, 
leaving the trabeculi behind. Typical yields of cells throughout the
7
course of the experiments was 3.0-5.0 x 10 lymphocytes/spleen, with a 
viability of at least 90% as determined using trypan blue.
Cell counts of the lymphocyte suspension (stained or unstained) were 
carried out using a X10 objective and counting the central, triple-ruled 
area (25 squares) of a haemocytometer. The appropriate corrections for
4
dilution (X10 ) and the number of squares counted were made as follows:- 
Number of lymphocytes ml 1 spleen suspension =
Number of lymphocytes x 25 xlO4
counted Number of triple-ruled squares
counted
2.4.2 Assays involving lvmphocvte suspensions
a) Demonstration of Fc receptors on lvmphocvtes (Hudson and Hay,
1980).
Many cells carry receptors for the Fc region of immunoglobulin 
molecules. The majority of these Fc binding lymphocytes are B cells, 
although there is now evidence that some T cells, (especially those which 
have been antigen-activated) also have Fc binding sites which can be 
detected in this system. IgG antibody to sheep red cells is bound on to 
sheep red cells at a non-agglutinating dilution, and the Fc portion of
this antibody-erythrocyte complex then binds to the Fc binding site on the 
lymphocyte, forming a rosette. A rosette-forming cell is arbitrarily 
defined as a single lymphocyte binding 4 or more erythrocytes.
f
Materials
8 “1Sheep red blood cells, washed and resuspended at 4x10 cells ml PBS.
IgG antibody to sheep red blood cells.
Spleen lymphocytes, at 106 cells ml 1 PBS.
Procedures
Washed sheep red blood cells in PBS were incubated at 37°C for 30
minutes with an equal volume of mouse anti-sheep red blood cell serum
(previously determined as the lowest antiserum dilution not giving
agglutination). The cells were then washed 3 times with PBS and
8 —1resuspended to 2x10 cells ml . Spleen lymphocytes were obtained as 
previously described, and diluted with PBS to give a final concentration of 
106 cells per ml. To lOOjil aliquots of these spleen preparations, 200pl of 
antibody- coated sheep red cells were added, and incubated together at room 
temperature for 2 hours. Fifty jul 0.1% toluidine blue in PBS (filtered) 
were added to each sample, and the tube gently rotated to bring the cells 
back into suspension prior to counting in an haemocytometer. The number of 
rosette-forming cells are expressed as a percentage of the total number of 
lymphocytes observed in the same field.
b) Lvmphocvte transformation assays (Hudson and Hay, 1980)
When B and T cells meet a specific antigen they are stimulated to 
undergo cell division (proliferation) and also change in morphology. A 
sensitive method to determine the degree of lymphocyte stimulation is to 
measure the amount of radioactive DNA precursor (usually thymidine) 
incorporated into newly synthesised DNA in dividing cells. This index of
in vitro mitotic response has been shown to correlate well with the index 
derived in vivo. There are substances (mitogens) which stimulate this 
mitotic response by reacting with the lymphocyte cell surface. Plant 
mitogens, such as phytohaemagglutinin (PHA) and concanavalin A (ConA) are 
mitogenic for murine T cells, although there is now evidence that they 
stimulate different subpopulations of T cells (Stobo and Paul, 1973). 
Lipopolysaccharide (LPS), an E Coli endotoxin, stimulates exclusively 
murine B cells. It is therefore possible using these lymphocyte 
transformation assays to detect any overall changes in B and T cell 
activity of treated and control animals.
Materials
Spleen lymphocytes 6xl06 cells ml 1 in RPMI-1640 Medium. 
Phytohaemagglutinin 4pg ml 1 in medium (Wellcome Laboratories). 
Concanavalin A lOpg ml 1 in medium (Miles Research Laboratories) 
Lipopolysaccharide lOOpg ml 1 in medium (Difco).
[Methyl-3H] Thymidine 40pCi ml 1 medium. (19-25 Ci/mmole. Amersham 
International)
Scintillation fluid (Koch Light)
Procedure
Quadruplicate assays were set up in round-bottomed microtitre plates using 
’150jil spleen suspension (i.e. 106 cells) and 50jil of the appropriate 
mitogen. The microtitre plates with lids were placed into plastic sandwich 
boxes and were then left in a 5% CC>2 in air /hummidity (100%) 36°C 
incubator for 72 hours. Twenty-five pi of 3H-Thymidine (i.e. lpCi) were 
added to each culture and the plates returned to the same conditions for a 
further 16 hours. The trays were then removed and chilled (+4°C) for 3 
hours before harvesting the cells by filtration onto Whatman GFC filter 
pads. These were allowed to air dry, placed into scintillation vials, 5 ml 
scintillation fluid added and then counted in a LKB Rack B. The results 
are expressed as stimulation indexes (SI) as follows:-
S.I = cpm of stimulated cells
cpm of unstimulated cells
(in same medium, same concentration etc)
[NB Optimisation of conditions for the Lymphocyte transformation assays 
were based on data from C. J. Elleman (personal communication) and confirmed 
by me for IM mice.]
c ) Enumeration of antibody secreting cells in vitro (modified Jerne 
plaque assay; Hudson and Hay, 1980)
Plasma cells synthesise antibody and this property can be used to 
quantitate the number of plasma cells in an organ. Cells from an animal 
immunised with sheep erythrocytes are incubated with an excess of sheep red 
cells. The antibody-secreting cells will release their immunoglobulin 
which binds to the erythrocytes and on the addition of complement lysis of 
the erythrocytes occurs, leaving an area free of red cells (ie a plaque) 
but with a central lymphocyte. These 'direct' plaques result from cells 
secreting IgM antibody, which has a high haemolytic efficiency. To detect 
IgG secreting cells, it is necessary to increase the number of molecules 
binding to 1 site. One IgM molecule will initiate erythrocyte lysis, but 2 
adjacent IgG molecules are necessary for this. This is achieved by adding 
rabbit anti-IgG serum to the system. The number of 'direct' or IgM plaques 
are subtracted from the number obtained on the addition of antiserum (i.e. 
IgM and IgG antibody-secreting cells) and thus 'indirect' (IgG) plaque 
numbers can be obtained.
Materials
8 — ISpleen cells. 10 cells ml in Earles Balanced Salt Solution. Dilution 
of 1/5 (2xlo7cells) and 1/10 (107cells) were used.
7Sheep erythrocytes, washed x 3 PBS and resuspended at 2x10 in Earles BSS.
Guinea pig serum used at 1/5 and 1/10 dilutions in Earles BSS.
Rabbit anti-mouse IgG 1/40 dilution in Earles BSS.
'U' Shaped micrototitre plates were used as reaction chambers. Assay 
chambers: 3"xl’' glass microscope slides were soaked overnight in absolute
alcohol and then air-dried. Ten slides were placed in line with 
I their long edges adjacent, and double-sided
tape placed along each edge and centre as 
shown. The backing paper was removed and 
a second row of slides placed firmly on top 
of the first row, thus completing the sandwich. Each chamber accepted 70jil 
of the cell suspension as a monolayer. The open sides were sealed by 
dipping in a dish of molten wax/vaseline mixtire, which solidified 
immediately on removal.
'Direct' IaM Plaaue forming Cells
To 35jil sheep red blood cells, 35pl of the diluted spleen 
suspension were added, followed by 50pl 1/10 guinea pig serum. The 
contents of the chamber were quickly mixed and 70)il dispensed into the 
assay chamber. The slides were incubated at 37°C for 30 minutes, and then 
the number of plaques per chamber was counted over a light source 
'Indirect' IgG plague forming cells
To 35jil sheep erythocytes and 35jil of the diluted spleen 
suspensions 25pl of 1/40 rabbit anti-mouse IgG and 25jil of 1/5 guinea pig 
serum were added. After mixing 70 jul were placed in the assay chamber, 
which was then incubated at 37°C for 60 minutes. The number of plaques per 
chamber was then counted over a light source.
The IgM and IgG plaque forming cells per spleen could thus be calculated.
2.4.3 Detection of specific antibodies
a) Haemagglutination assays (Hudson and Hay, 1980)
The specific antibody content of sera may be compared by
determining their titration end points (i.e. the dilution at which they no 
longer give a visible reaction with antigen, eg either precipitation or 
agglutination). This is a relative measure of the antigen-binding capacity 
of a serum, and can only be used to compare antisera when they are tested 
with the same antigen under the same conditions. All dilutions of the 
sera are done in duplicate, with addition of 2- mercaptoethanol to one row.
This causes disruption of IgM molecules which therefore cannot agglutinate 
the antigen. Hence residual aggultination of the 2-mercaptoethanol-treated 
sera is attributable to IgG antibodies.
Materials
8 "1Sheep erythocytes, washed and resuspended at 4x10 cell ml in PBS.
Mouse sera
0.1M 2-mercaptoethanol.
Procedure
Beginning at a 1 in 10 dilution of mouse serum, doubling dilutions 
of lOOjil in PBS were made across V shaped microtitre plates to 1 in 20,480.
To one row was added 50jil 2-mercaptoethanol, and to the duplicate row 50pl 
PBS. The trays were incubated at 37°C for 30 minutes, and then 50^ tl of 
sheep red blood cells added to each well, and then left to settle before 
the highest dilution causing lysis of the erythocytes could be determined. 
[Note. Some species have naturally-occurring heterophile antibodies to 
antigens on sheep erythrocytes, but are usually of very low titre. Hence 
dilutions are made starting at 1 in 10 to avoid this complication] 
b) Enzyme-linked immunoadsorbent assay (ELISA)
In the assays to be described, excess antigen is bound first onto a 
solid phase (using a specially prepared ELISA plate), and is followed by 
the antibody-containing solution under test. After washing, the amount of 
antibody bound to the antigen is assessed by adding a labelled antibody 
directed against the first immunoglobulin. This label may be a radio­
isotope or an enzyme.
(Note. An additional step may be inserted after the antigen /antibody 
reaction, to determine the subclass of the initial antibody by using a 
specific antiserum).
This technique was used for quantifying of serum antibodies in mice 
stimulated with ovalbumin, keyhole limpet haemocyanin and 
lipopolysaccharide. Optimum assay conditions for each antigen had first to 
be determined, and will be described (below). All assays for antibodies to 
a given antigen were performed on the same day with the same batches of 
antisera and horseradish peroxidase conjugate. All buffers were freshly 
prepared, and the substrates mixed together just before use.
Materials
Antigens (ovalbumin, keyhole limpet haemocyanin and lipopolysaccharide) at 
lmg ml 1 in 0.05M carbonate buffer pH 9.5
Standard solution of mouse IgG (total), IgGl, IgG2a and IgG2b in 0.05M 
carbonate buffer pH 9.5 (see section 2.3. for preparation).
Rabbit anti-mouse IgG (total) Miles Research Laboratories.
Rabbit anti-mouse IgGl, IgG2a, IgG2b and IgG3 (Nordic Immunological 
laboratories).
0.1% Bovine serum albumin (Sigma) in PBS.
10% Fetal calf serum (Gibco).
Horseradish peroxidase - goat anti-rabbit Ig (Nordic Immunological 
Laboratories).
5- Aminosalicylic acid (Sigma) 0.1% in lOmM sodium phosphate/lOmM EDTA pH 
6.8
0.5% Tween 20 (Sigma) in PBS.
Hydrogen Peroxide, 30 volumes (BDH).
Optimisation of Assay Conditions
i) Coating of microtitre wells with antigen.
It has been demonstrated that if excess protein is used for antigen 
coating, the sensitivity of the assay is reduced (antigen / antibody
complexes are soluble in excess antigen; Engvall & Perlmann 1972). Various
concentrations of antigen (ovalbumin, keyhole limpet haemocyanin and
lipopolysaccharide) were coated onto microtitre wells, and each well
incubated with a small amount of specific mouse antibody. It was found
that coating concentrations of 500ng ml 1 ovalbumin and keyhole limpet
haemocyanin, and lOOOng ml 1 lipopolysaccaride were optimal, increasing the
concentrations thereafter bound the same amount of antibody. Each well was
coated with lOCfyil of the optimum concentration of antigen by leaving the
e o
plates at room temperature (20 C ) for 16 hours.
Following incubation with the antigen, it was necessary to incubate 
the wells with 0.1% Bovine serum albumin in PBS to reduce direct binding of 
the IgG in the test sample to each well.
ii) Optimisation of Antigen / Antibody Binding
It was necessary to determine a suitable time for the first 
antibody binding reaction. Antigen was bound to each well at the optimum 
concentration, and the specific antibody at doubling dilutions for 4
o
different periods of time (30 minutes, 1 hour, 2 hours, 4 hours) at 37 C. 
Two hours was optimum; thereafter the amount of binding did not increase 
significantly.
iii) Optimisation of Second Antibody
Rabbit antisera specific for total mouse IgG or IgG subclasses were 
used as the second antibody layer to specify the type of the antibody 
produced during* the response. Two dilutions of antisera were used, 1 in 
250 and 1 in 500 and incubated at 37°C for 2 hours. Similar results were 
obtained with both dilutions, and so for purely economic reasons the 1 in 
500 dilution was used.
iv) Optimisation of Goat anti-rabbit Ig-horseradish peroxidase conjugate
Various dilutions of conjugate in 5% fetal calf serum were 
incubated at 37°C for 2 hours with 1/500 dilution of rabbit anti-mouse IgG 
(second antibody). It was found that a 1 in 2000 dilution gave the highest
sensitivity. (Higher sensitivity could be achieved if the incubation times 
were significantly lengthened but, for purely practical reasons, i.e.
duration of the actual assay, were not used).
v) Standard curves
Under optimum conditions previously described, standard curves were 
obtained for total IgG, IgGl, IgG2a and IgG2b (see figs. 4-5). The
specific immunoglobulins were isolated by affinity chromatography as
described in Section 2.3, and dissolved in 0.05M carbonate buffer pH 9.5 at 
various concentrations.
General Assay Procedures
Six binding steps were used, as described below. Between each 
binding step, the contents of the wells were tipped off and the plates 
washed thoroughly 3 times with copious amounts of 0.5% Tween-20 in PBS, and 
fully drained to dryness on absorbent paper. All volumes used in the assay 
were 100 pi.
1) Antigen in 0.05M carbonate buffer pH 9.5 was coated onto EIA microtitre 
plates at room temperature (20°C) overnight.
2) Bovine serum albumin (0.1% in PBS) was added and incubated at 37°C for 1 
hour.
3) Sera under test at doubling dilutions were added and incubated at 37°C 
for 2 hours. Range of dilutions used were as follows:-
Ovalbumin 1 in 100 to 1 in 204,800 in PBS
Keyhole .limpet haemocyanin 1 in 100 to 1 in 204800 in PBS
Lipopolysaccaride 1 in 2 to 1 in 4096 in PBS
4) Rabbit anti-mouse IgG (or IgG subclass) at 1 in 500 dilution in PBS was
incubated at 37°C for 2 hours.
5) Goat anti-rabbit Ig Horseradish peroxidase conjugate at 1 in 2000 in 5% 
fetal calf serum was incubated at 37°C for 2 hours.
6) 10ml of 5-aminosalicylic acid were mixed with IOjjI 0.5% hydrogen 
peroxide, and lOOpl added to each well. The trays were left at room
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Figure 4 Standard curve for mouse IgGl, using a micro ELISA method.
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Figure 5 Standard curve for mouse IgG2a, using a micro ELISA method.
temperature for 1 hour, and the resultant colour was measured at 492nm on 
an ELISA plate reader (Titertek). Standard solutions of the appropriate 
IgG isotype for the assay were included to quantify the antibody in the 
serum sample.
Note IgG3 is a very minor component of total mouse IgG ( <1%) and could not 
be obtained in sufficient quantities to prepare standard solutions. In 
theory IgG3 antibodies to LPS could be obtained from the summation of 
levels in IgGl, G2a and G2b subclasses and subtracting from total IgG 
levels. In practice this was not necessary, as LPS, under the regime used, 
produced antibodies only of IgG3 class, hence the level of total IgG 
antibodies was equivalent to IgG3 antibodies.
ELISA tests for antibodies against brain and spleen antigens
The sensitivity of microELISA tests makes them useful in 
quantifying low levels of antibodies in serum. Optimum assay conditions 
for each antigen source had first to be determined, using the buffers and 
commercially-available reagents, as specified above.
Preparation of antigens
Brain and spleen were taken from a healthy IM mouse, and each
—2 % homogenised at 10 dilution (w/v) in PBS containing a final concentration
of 1% SDS. The homogenate was incubated at 37°C for 4 hours and produced a
/ '
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clear viscous solution, which was diluted 1 in 10 (i.e. 10 ) with PBS
prior to centrifuging in a Beckman microfuge B for 5 minutes. The debris-
ofree solution was then dialysed at 4 C for 48 hours against several changes
of PBS to remove the SDS; no protein precipitation occurred. This dialysis
solution was used as the source of heterogeneous proteins.
Optimisation of antigen concentration
To determine the optimum antigen concentration for coating the
- 4 - 9microELISA plates, dilutions of the protein solutions (10 to 10 ) m
0.5M carbonate buffer pH 9.6 (to give a final concentration of 0.05M
carbonate buffer) were made, and the plates were incubated at 37°C
overnight. Each well was then incubated with 1/500 dilution of serum from
—3
a mouse which had received 0.03ml of 10 brain homogenate 
intraperitoneally at 4-weekly intervals over a 3-month period. It was 
found that a 10 6 dilution of brain or spleen homogenate in carbonate 
buffer was the optimum binding concentration of antigen. The procedure for 
the Elisa test, using brain or spleen antigens, was then as described above 
,for ovalbumin, etc. Only total IgG antibodies were determined.
2.4.4 c) Quantitative detection of antibody bv single radial diffusion 
(Hudson and Hay, 1980).
Antiserum is incorporated into a support medium, either agar or 
agarose, and antigen is placed into wells cut in the medium. The antigen 
will diffuse radially from the well and a ring of precipitation is thus 
formed round the well as it moves outwards, eventually halting at the point 
of equivalence (i.e. when all antibody and antigen have reacted and neither 
is in excess). The higher the concentration of antigen, the greater the 
diameter of this ring. Thus by incorporating standards of known antigen 
concentrations onto the plate, a calibration curve can be obtained and can 
be used to determine the amount of antigen in the samples under test. 
Materials 
Sera under test
Standards of known concentration (prepared by affinity chromatography)
0.7% agarose in 1 in 10 immunoelectrophresis buffer pH8.6 (51mM barbitone, 
3ImM sodium barbitone, 90mM glycine and 45mM Tris).
Procedure
The agarose in buffer was melted on a hot plate and then 
transferred to a water bath maintained at 56°C. To 9.7 ml of the molten
agarose were added 300jil of antiserum, gently mixed and then poured onto a 
plastic immunodiffusion plate held on a leveling table. When set, a gel 
punch and template were used to punch 17 holes of lOpl capacity, and the 
gel plugs removed by suction. For each plate, serum samples each of 4pl 
were dispensed into 13 of the wells; the 4 remaining wells received 4 pi of y 
the standard solutions. The plates were then covered with lids, placed in 
a plastic sandwich box and left for about 24 hours at room temperature to 
diffuse. The diameter of each ring was measured using a calibrated viewer.
d) Qualitative detection of antibody double diffusion in 2 
dimensions (Hudson and Hay, 1980)
Antigen and antibody diffuse towards each other through a support 
medium and a line of precipitation is produced when the two reactants meet.
This precipitate is soluble in excess antigen, hence a sharp line is 
obtained when all the antigen has reacted with available antibody (i.e. at 
equivalence). The relative position of this line is determined by the 
concentrations of antigen and antibody in the gel. Multiple lines of 
precipitation are seen if the antigen and antibody contain several 
molecular species.
Materials
0.7% agarose in 10% immunoelectrophoresis buffer (Section 2.4.4.C)
Antiserum and sources of antigen
Procedure
Alcohol-washed glass slides ( 3"x2") on a leveling tray each received 8ml of 
molten agarose and were allowed to cool. Using a hole punch and template, 
the required pattern (see below) was produced, and the plugs of agarose 
were removed by suction. Usually the outer wells received 5pl of the 
samples under test, and the inner well 5-10pl antiserum. The slides were 
then placed onto moistened tissues in a covered plastic box and were held 
at room temperature for 10 hours whilst the lines developed.
Ie) Qualitative detection of antibody bv immunoelectrophoresis 
(Hudson and Hay, 1980)
Serum proteins can be separated in a gel medium under the influence 
of an electric field into albumin, , <x2~ , JB- and ^-globulins. After
electrophroresis, antiserum is added to a trough which is parallel to the 
direction of the protein separation. Antigen will diffuse from a point 
source and interact with antiserum advancing towards it from the trough, 
producing an arc of precipitation at equivalence.
Materials
As for double diffusion (above).
Procedure
Agarose plates were prepared as described in (a) A pattern (see 
below) was produced using a template punch, and the agarose plugs of only 
the wells were removed by suction. Samples to be electrophoresed (5-lOpl 
volume) were placed in the wells together with lpl bromophenol blue as a 
marker dye.
veve
The slides were placed in an immunoelectrophoresis tank, each end of the
slide being connected to chambers containing 10% immunoelectrophoresis 
buffer (pH 8.6) by paper wicks, and 100 volts (maximum) applied for 2 
hours. Following electrophoresis, the agarose in the central troughs was 
removed, and 50jj1 of antiserum added. The slides were then placed in a 
humidity chamber at constant temperature for 16 hours to allow diffusion to 
take place. Records of gel patterns were kept either from diagrams, 
photographs or by staining for protein with Coomassie Brilliant Blue.
2.5 Biological assays
Serum IaG Half-life
Several methods have been developed to measure the rate of 
synthesis or breakdown of proteins, and most of these employ radioisotopic 
labelling techniques. The 'half-life' of a protein is the time required 
for the removal and /or breakdown of one half of the labelled molecules, in 
this case IgG. An apparent excess of the IgG can occur, either because of 
an increased synthesis or decreased catabolism. By measuring the 'half- 
life' of IgG, it is possible to assess which of the two processes is 
responsible for the increase in concentration. Tracer labelled protein is 
mixed with syngeneic serum so as to give normal biological concentrations 
and then injected intraperitoneally (under such conditions there should be 
no alterations in the catabolic rate of the labelled protein).
Procedure
In these experiments, total IgG was first isolated from normal
serum of the appropriate mouse strain. The IgG was iodinated, as described
previously (section 2.3.), and added to normal syngeneic mouse serum such
125that lOOpl contained ljiCi I-IgG. Mice at the early clinical phase of 
scrapie (2 different agents were used; 87V and 22A in IMmice (Sinc^7 )) and 
age, sex-matched controls each received lOOul of the labelled serum 
intraperitoneally. Three animals from each group were killed at 2 day
intervals throughout the 14-day experiment. Fifty jil of urine and a
minimum volume of 750jil whole blood were taken from each animal; 500/il of
whole blood were taken for measurement of total radioactivity, the
remainder was allowed to clot to provide serum samples for IgG
determinations (section 2.4), and for electrophoresis analyses (section
2.3). The latter was carried out to ensure that the radio-label remained
firmly bound to the protein throughout the experiment. All samples were
stored at -20°C and then the radioactivity in each was measured in a LKB
Mini-Gamma counter on the same day at the end of the experiment to ensure
that all the samples were identical with respect to the radioactive decay 
125of I (tl/2=64 days). Those animals with abnormally high amounts of
5 —1radioactivity in the urine (> 10 cpm ml ) and correspondingly low levels 
in the blood were excluded from the analyses as this indicated that the 
labelled protein had been administered incorrectly (i.e. the injection 
needle had penetrated the bladder).
The results were expressed as (uncorrected) counts per minute of
125
I per mg IgG per ml serum at each sample time, and converted into 
values . Using these figures it was possible to calculate a regression line 
which showed the clearance of the radio-labelled protein as a function of 
time (Swinscow, 1976). From this line it was possible to determine the 
time taken for half of the IgG to be removed from the serum (i.e. the 
’half-life’ of the protein).
2.6.1 Animal inoculation schedules
a) Stimulation with Antigens
In a primary response there is an early production of IgM antibody 
but this soon declines, and is replaced by IgG antibody. In contrast, IgG 
production is greatly increased and accelerated in a secondary response, 
the peak titre is rapidly attained, and it declines slowly. Some antigens, 
using certain immunisation regimes, will produce antibodies of restricted
heterogeneity (i.e. of a specific IgG subclass) during a secondary 
response. Thus an animal's ability to mount a specific immune response can 
be measured. This was used to investigate any variations in the same 
response which may occur during scrapie infection.
Ovalbumin This antigen should produce antibodies of predominately IgGl 
class when the following regime is used. Ovalbumin was emulsified in 
complete Freunds adjuvant to give a final concentration of lmg ml 1 in 50% 
adjuvant. For the primary and booster injections, 0.1ml was injected 
subcutaneously (into the scruff of the neck) from a glass syringe fitted 
with a 23G disposable needle. The two booster injections of ovalbumin in 
incomplete Freunds adjuvant were given at 28 day intervals, and all the 
injections were carried out on mice lightly anaesthetised with a 
halothane/oxygen mixture.- The animals were killed 7 days after the third 
injection. Sera were collected and stored at -20°C
Kevhole Limpet Haemocyanin (KLH\ Using the regime described for ovalbumin 
(see above), antibodies of IgG2 subclass are induced.
Lipopolysaccharide (LPS^ Antibodies restricted to IgG3 subclass (normally 
present at<l% of mouse IgG) are produced following stimulation with LPS 
using the following regime. LPS was dispersed in sterile PBS at 2mg ml 1 
concentration, and 50jil injected intraperitoneally into mice lightly 
anaesthetised with a halothane/ oxygen mixture. The response was boosted 
with an identical dose 7 days later. The animals were killed 35 days after 
the second injection, and sera collected and stored at -20°C.
Sheep Red Blood Cells (SRBC>
Sheep red blood cells (a T-cell dependant antigen) in Alsevers
7
solution were washed 3 times in PBS and then resuspended at 2x10 cells/ml 
in PBS. Mice were lightly anesthetised with halothane/oxygen mixture and 
injected with lOOyul of the SRBC intraperitoneally. Animals were killed at 
various times up to 14 days post inoculation, and animal-matched sera and 
spleens were taken for assay (section 2.4).
b) Scrapie infection 
Tissues (spleen, brain) were removed using separate instruments for 
each tissue and donor group, and homogenised in sterile saline at a wet 
weight of 5 or 10% with a glass-teflon homogeniser. Groups of weanling 
mice of about 21-28 days old were injected intracerebrally (0.025ml per 
animal) or intraperitoneally (0.10ml per animal). All injections used 
plastic disposable syringes with 26G 3/8" needles. Unless otherwise 
stated, all mice were lightly anaesthetised with ether before injection. 
Source of Scrapie Various strains of scrapie were used in the biological 
experiments; their sources and passage history are given in below
STRAINS OF SCRAPIE USED IN EXPERIMENTS
STRAIN SOURCE MOUSE PASSAGE HISTORY
ME7 Suffolk sheep 2 passes in Moredun random bred
(Natural case) mice, and 2s^ines maintaine^, 
one in SincS . one in Sinc^
22A Cheviot sheep 
Experimental 21st i.e. 
pass of SSBP/1
1 pass in Moredun random bred 
mice, passed and maintained 
in Sinc^
22C Cheviot sheep 
Experimental 21st i.e. 
pass of SSBP/1
2 passes in Moredun random bred 
mice, p«|^sed and maintained 
in Sine
79A Goat (Experimental 
case of 'drowsy' scrapie
Isolated and passaged in 
Sine
87V Cheviot x Border Leicester 
(Natural case)
Isolated and passaged in 
Sinc^ mice
13 9A Cheviot sheep (SSBP/1 Pool) 
experimentally passed through 
Cheviot sheep and goats
Isolated and maintained in 
Sine mice
Measurement of Incubation Period All mice were examined twice a week for 
clinical signs, the nature of which depend on the combinations of agent and 
mouse strain used. Animals were scored positive when characteristic 
clinical symptoms were evident and killed when unequivocal signs had been 
observed for 3 consecutive scoring times. The average incubation period
for each group was calculated from the time after inoculation to first 
positive clinical signs in each mouse with scrapie.
2.6:2 Controls for scrapie studies
In common with all studies on scrapie, fully adequate controls are 
difficult to obtain. Most studies use clinical brain as inoculum because 
titres are high and most passage data are based on standard intracerebral 
injection of brain homogenates. Attempts to purify scrapie have been 
largely unsuccessful, and hence brain inoculum is quite crude, containing 
not only infectious agent, but products of infection. Little is known 
about these, except that clinical brain contains pathologically damaged 
tissue. This could be an important issue in any immunological studies 
undertaken because scrapie brain could be antigenically different from 
normal brain. Hence controlling for the complexity of the inoculum itself 
is difficult, but there are several approaches which will now be briefly 
discussed.
It is possible to use 'early brain' from infected animals as a 
source of inoculum. The titre would be considerably lower, and hence would 
result in lengthened incubation periods. This would be a distinct 
disadvantage in scrapie models which have a long minimum incubation period. 
Once scrapie agent has entered the brain and started to replicate, 
pathological changes will also begin, and so there will probably never be a 
situation where agent only is present. Taking early brain will therefore 
only reduce the severity of these pathological changes.
There are some chemical compounds, such as cuprizone and 
hexachlorophene (Fraser, 1976) which, when included in the diet, mimic 
some, but not all, of the pathological changes, and so are of limited use. 
Other examples of 'damaged brain controls' which could be considered are 
brains from animals affected with other neurological diseases, or brains 
from senile animals, but these again have restricted use. It is possible
to use spleen as a source of agent, and thus eliminate the problems of 
damaged brain material. Titres are lower in spleen compared with brain, 
and so there are again the problems with lengthened incubation periods. 
Scrapie does not produce any histological damage in the spleen, but it is 
not known what changes might occur. Autoclaved scrapie brain inoculum can 
be used on the basis that agent is inactivated but the products of 
infection are present. However, inactivation would have to be confirmed 
for each agent under the conditions of the experiment; it would need only a 
small amount of infectivity to remain to eventually produce disease in 
controls. The actual process of heating will in itself result in 
denaturation and other alterations to brain antigens, and hence affect 
their antigenicity. This problem could be reduced by infecting with 
inocula, heated to a lower temperature so that some agent survived. But 
again the conditions of heating control and scrapie inocula would have to 
be carefully checked and inevitably, scrapie animals would have longer 
incubation periods than otherwise.
Hence an ideal situation would have been to use a combination of 
controls, but in practice this would have overburdened much of the work, 
especially in those models which have long incubation periods. Hence for 
expediency, the studies on IgG changes in various scrapie models used age 
and sex-matched animals injected with uninfected syngeneic brain tissue as 
controls. The limitations of this approach are recognised and the 
consequences will be discussed in the context of each type of experiment.
2.6:3 Operational restrictions on scrapie experiments
The previous section describes just one of the operational 
restrictions in scrapie research, namely the problem of control animals. 
However, there are several other restrictions and variables which need to 
be discussed because of their implications on experimental design.
The route of infection affects the length of incubation period, 
lesion profiles and the estimated titres of standard inocula. Agent 
injected by a peripheral route (eg i.p. ) has to undergo an obligatory phase 
of extra-neural replication before entering the central nervous system, 
whilst agent injected directly into the brain (the target organ) usually 
produces a shorter incubation period because some of the injected agent 
will begin to replicate in the CNS relatively soon. There is some evidence 
that the physico-chemical condition of the inoculum may have some effect on 
the way it is dealt with by the host. For example, some chemical 
treatments modify intracerebral dose response curves (Kimberlin, 1977), and 
when heat-treated inoculum is injected intracerebrally, it has to undergo 
this extra-neural replication phase in lymphoid tissue before it can infect 
the CNS (Dickinson, personal communication).
The Sine genotype of the recipient mice is a major variable in 
biological experiments as Sine controls the duration of the zero phase, and 
thus the length of the incubation period. Moreover, the nature of this 
control varies with the strain of agent. In infection experiments the Sine 
genotype of the donor mouse is important; changing the sine genotype 
between donor and recipient mice can favour mutational changes of agents of 
Class II and Class III stability (Bruce, 1980).
Pretreatments of the recipient mice by drugs, hormones, or by 
disturbing the immunocompetance of the mice (eg by splenectomy, Fraser and 
Dickinson, 1978) will have effects on incubation period and must be 
controlled. The age and sex of recipient mice must also be specified; 
intraperitoneally- infected neonatal mice produce prolonged incubation 
periods compared with weanling mice (Outram, 1973), and almost invariably, 
male mice have longer incubation periods than female mice of the same 
strain (Outram, 1973).
Therefore in designing all the biological experiments for inclusion 
in this thesis, there has been careful consideration of the practical
variables involved. Two main routes of infection were used, intracerebral 
and intraperitoneal. The source of agent, with the exception of one series 
of experiments (using 79A) was brain of standard preparation (i.e. 
uncentrifuged whole brain homogenate in saline) and from the same Sine 
genotype as the recipient mice when possible. The recipient mice were age 
and sex-matched with control animals. Mice were housed under the same 
conditions and fed the same diet. Any variations were recorded and will be 
considered in the discussion of the results.
3. COMPARATIVE STUDIES OF SERUM IMMUNOGLOBULIN G CONCENTRATIONS IN SEVERAL
MURINE MODELS OF SCRAPIE AND INVESTIGATIONS INTO THE MECHANISMS RESPONSIBLE 
FOR THESE CHANGES
Introduction
Earlier work with Herdwick sheep affected with natural or 
experimental scrapie demonstrated a significant increase in serum IgG 
levels in some, but not all, animals as the disease progressed (Collis et 
al, 1979; Collis and Kimberlin, 1983). It was therefore decided initially 
to measure serum immunoglobulin G( IgG) concentrations as a simple indicator 
of humoral immune involvement, during the incubation periods of two 
arbitrarily chosen models of mouse scrapie. Comparisons between a given 
model and a suitable control present problems which are discussed elsewhere 
(section 2.6.2) but comparisons between models is also difficult because 
often their clinical end points will occur at different ages. Hence it was 
decided that failure to produce positive findings should not deter studies 
of other models. Only when a representative number of the many available 
models had been investigated could generalisations of a negative nature be 
made. In the event, the first two models produced positive information, 
and part of this thesis describes a study of other models to evaluate these 
initial observations, to determine the biological significance of the 
changes found, and to investigate the mechanisms responsible for the 
changes.
3.1. Comparative studies
3.1.1. Initial models
The two arbitrarily chosen models for the initial studies were 87V 
strain of scrapie in Sinc^7 (IM) mice, and 139A strain in Sincs7 (Compton 
Whites, CW) mice. The incubation period for 87V in IM females when
TABLE 1. SERUM IgG CONCENTRATIONS IN SincP? MICE INJECTED WITH
87V STRAIN OF SCRAPIE, AND CONTROLS
mglgG/lOOml SERUM
DAYS POST mean ± SEM (4)
TH TPriPTOM
4> K A 11U  DUIvirX£«
CONTROLS 8 7V—INJECTED CONTROL
28 418+19 514+27* 1.23
56 408+19 515+22** 1.26
84 408+19 390+62 0.96
112 327+39 382+34 1.17
140 280+ 0 375+9 *** 1.34
168 325+ 3 405+15*** 1.25
196 284+18 405+15*** 1.42
224 270+20 365+9 ** 1.35
252 289+4 314+34 1.09
280 265+30 418+43** 1.58
308 249+21 477+77** 1.92
315 240+10$ 452+30** 1.88
—3+ Each mouse received 0.025ml of 10 homogenate (unspun) of
uninfected sinc^ brain. Mice were age and sex-matched with the 
infected group. $ 2 mice only in group.
—3
t Each mouse receive^ 0.025ml of 10 homogenate (unspun) of
87V-clinical Sinc^ brain intracerebrally. All mice were IMO
Significances (t.test) *p<.05; **p<.01; ***p<.001
TABLE 2. SERUM IgG CONCENTRATIONS IN 
139A STRAIN OF SCRAPIE, AND
SincS? MICE INJECTED 
CONTROLS
WITH
DAYS POST 
INJECTION
mglgG/lOOml SERUM 
mean + SEM (4)
J. i. RATIO SCRAPIE
CONTROLS 139A INJECTED CONTROL
5 330+6 195+48* 0.59
20 643+77 440+20 0.68
34 440+12 43 3+47 0.98
48 478+9 542+28 1.13
63 417+26 430+30 1.03
77 620+83 420+46** 0.68
91 703+92 537+33 0.76
105 660+23 468+8** 0.71
119 690+114 490+11 0.71
126 620+60 500+30 0.81
131 660+23 492+45* 0.75
—3
+ Each mouse received 0.025ml of 10 homogenate (unspun) of
uninfected Sine brain intracerebrally. All mice were age 
and sex matched with the infected group.
—3
t Each mouse received,^.025ml of 10 homogenate (unspun) of
139A-clinical Sine mouse brain intracerebrally. All mice 
used were o Compton Whites
Significances (t. test) * p<.05; ** pc.01
—3
infected intracerebrally with a 10 homogenate of clinically-affected
brain was 315+3 days. The serum Ig levels for these mice and their normal
brain-injected controls are given in Table 1. Both groups of mice showed
an initial rise in serum IgG, possibly caused by the inoculation of the
crude brain homogenate. Thereafter the IgG levels for the control mice
decreased and remained fairly constant over the experimental period. For
those mice infected with 87V, the serum IgG levels were significantly
increased from day 140 (with the exception of the sample taken on day 252 ).
The serum levels of IM mice used in this experiment were much lower than
those of IM mice used in later experiments; this difference may reflect a
change in the early breeding programme of IM mice (see Discussion) or some
reduction in the sensitivity of the assay, which in turn would depend upon
the specificity of the antiserum used.
s7In contrast, the Sine mice infected with 139A strain of scrapie 
had serum IgG levels which were generally lower than their normal brain- 
injected controls throughout the 131+2 day incubation period. However the 
significance of this is hard to determine as the control animals showed an 
age-related IgG increase over the 19 week sampling period (Table 2).
A very obvious point to emerge from these initial comparisons was 
that both the strain of agent and the Sine genotype of the mice were 
different in the two models studied. Two additional complications also 
became apparent; namely the age-related increase of serum IgG in the 
uninfected Compton White mice, and secondly that some IM mice, from both 
the control and scrapie groups, developed skin lesions which could in 
themselves result in serum IgG changes as part of an inflammatory reaction.
It therefore became necessary to include studies on other models to resolve 
some of these issues. The aims were defined as follows:-
a) To test for any correlation between presence of skin lesions and serum 
IgG changes.
b) To test whether these serum IgG changes are restricted to models in
Sinc^7 mouse strains
s7
c) To test whether other models in Sine mice show those changes.
d) To investigate the age-related changes in Compton White mice and to try 
and find another Sine mouse strain with more stable IgG levels.
e) To investigate any effect the route of inoculation might have on serum 
IgG concentrations.
3.1.2. Extension of studies
a) To test for any correlation between presence of skin lesions and serum 
IgG changes
Some IM mice develop skin lesions with age. When infected with 
certain strains of scrapie, including 87V, these lesions may become more 
pronounced (Dickinson, personal communication). The severity, duration and 
localisation of these lesions may vary in individual animals, and may 
eventually heal. MB mice, which were derived from a different line, but in 
parallel with IM mice (Dickinson, personal communincation) are also 
homozygous for Sinc^7 but do not usually develop skin lesions. Therefore 
MB mice were inoculated with either the 87V strain of scrapie or uninfected 
brain. Blood samples were collected over the latter third of the 
incubation period (284“3 days). The serum IgG concentrations for the two 
groups of animals are given in Table 3. Again, the 87V-injected mice 
showed significantly increased levels of IgG over the sample period, whilst 
the IgG concentration in the sera of the control mice remained unchanged, 
showing no age-related increases over this period. One 87V-injected mouse 
killed early (on day 265) as positive scrapie, had some evidence of 
scratching, but did not have a higher IgG level than the other 3 scrapie- 
injected animals killed at the same time. The remaining mice killed with 
positive scrapie signs all had significantly elevated levels of serum IgG 
and no evidence of scratching. Hence the increased IgG levels were
TABLE 3. SERUM IgG CONCENTRATIONS IN Sine P? MICE (MB) 
87V STRAIN OF SCRAPIE, AND CONTROLS
INJECTED WITH
DAYS POST 
INJECTION
mglgG/lOOml SERUM 
mean + SEM (n mice)
CONTROLS'1" 87V-INJECTEDt
RATIO SCRAPIE 
CONTROL
219 287+35(3) 440+60(2)* 1.53
235 333±17(3) 590+72(3 )* 1.77
250 300+29(3) 525+25(2 )** 1.75
265 300+29(3) 520+20(4 )** 1.73
277 333+44(3) 620+60(3)** 1.86
300 265+15(2) 680+0 (2)*** 2.57
—2+ Each animal received 0.02ml of 10 homogenate (unspun) of
uninfected Sinc^ brain intracerebrally. All mice were age 
and sex-matched with the injected group.
—2
t Each animal received 0.02ml of 10 homogenate (unspun) of
clinical 87V-infected Sincr brain intracerebrally. All mice 
were <j> MB.
Significances (t. test) * p<.05; ** p<.01; *** p<.001
probably the result of infection with 87V strain of scrapie, and were not 
produced as part of a secondary reaction during the development of skin
lesions. A comparison of IM mice (Table 1) and MB mice (Table 3), both
infected with 87V, showed that the scrapie: control serum IgG ratios were 
much higher in MB mice, and this will be discussed later in relation to
i
amyloid plaque numbers.
The conclusion that serum IgG changes were unrelated to the 
presence of skin lesions was substantiated by the results from a further
experiment, when uninjected IM mice were serially sampled at 4-week
intervals over a 68-week (476 days) period. Of the 100 animals in the 
esqperiment, only 6 had visible skin lesions on the day of sampling. All 
the sera were assayed individually rather than as pools to check such 
animals for abnormally high serum IgG levels. The concentrations of IgG 
for each of the six animals were well within tlx.S.D. of the mean levels of 
the remaining animals in that group. These results (Table 4) also 
confirmed that uninjected IM mice do not show any age-related serum IgG 
changes as occurred in CW’s (Table 2). The calculated regression line for 
these data did not have a significant slope (+ 0.0016. Figure 6). Further, 
there was no detectable sex effect on the serum IgG concentrations in IM 
mice.
b ) To test if serum IgG changes are consistent in models using Sinc^7 mice
Serial sampling was carried out on 4 scrapie models involving 2 
strains of mice homozygous for Sinc^7: IM mice were inoculated with either 
22A or 87V strain of scrapie, and VM mice with either 139A or 87V. The IgG 
concentrations in the sera of control and scrapie-infected mice are given 
in Tables (5,6,8,9). Again significant increases in serum IgG levels were 
noted in IM mice injected with 87V strain (Table 5), thus confirming the 
initial observations (Table 1). Similar results were obtained with the 
same agent but in another Sine?7 mouse strain, VM (Table 6). Hence in the
TABLE 4 SERUM IgG CONCENTRATIONS IN UNINJECTED Sinc^7 (IM) MICE
SAMPLE TIMES* 
(DAYS AFTER BIRTH)
mglgG/lOOml SERUM 
mean ± SEM(n.MICE)
ANIMALS SHOWING SKIN LESIONS 
mg IgG/lOOml SERUM (n MICE)
56 514+26(8)
84 579+12(7)
il2 535+23(8)
140 480+36(8)
168 458+27(6)
196 552+42(5)
224 518+35(5)
252 * 420+99(6)
280 538+80(6) 490.(1)
302 414+60(5)
336 550+0 ( 4)
365 492+31(6) 505+30(2)
392 594+62(7)
420 578+24(6) 590+10(2)
448 456+60(6) 555.(1)
476 574+79(7)
+ Both Cf7and £ IM mice were transferred from the SPF building to a 
holding area (non SPF conditions) 21 days after birth, and 
maintained under the same conditions throughout the sample period.
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TABLE 5 SERUM IgG CONCENTRATIONS IN Sincf7 MICE (IM) INJECTED WITH 87V
STRAIN OF SCRAPIE, AND CONTROLS
mglgG/lOOml SERUM 
DAYS POST mean + SEM (3 MICE)
INJECTION -------------      RATIO SCRAPIE
CONTROLS 8 7V-INJECTED CONTROL
' 28 760+20 600+60 0.78
56 540+40 586+93 1.09
84 457+23 547+7 * 1.20
112 497+23 503+27 1.01
140 436+52 477+43 1.09
168 433+17 456+23 1.05
196 397+27 466+17 1.17
224 483+17 580+20* 1.20
252 482+17 527+13* 1.09
280 527+17 725+48* 1.38
308 513+13 820+35** 1.60
315 513+13 780+20** 1.52
—3+ Each mouse received 0.025ml intracerebrally of 10 homogenate
(unspun) of an uninfected Sinc^ brain. All animals were age 
and sex-matched with the injected group.
—3
t Each animal received 0.025ml intracerebrally of 10 homogenate
(unspun) of a clinical 87V-infected Sine** brain. All mice were IM
9'
Significance (t.test) *p<.02, **pc.001.
TABLE 6. SERUM IgG CONCENTRATIONS IN Sincp7 MICE 
87V STRAIN OF SCRAPIE, AND CONTROLS
(VM) INJECTED WITH
mglgG/lOOml SERUM 
DAYS POST mean + SEM (n mice) 
INJECTION ----------- --------- - ---------- -----------  RATIO SCRAPIE
•
CONTROLS 8 7V-INJECTED CONTROL
220 300+41(4) 615+76(3)* 2.05
240 435+65(2) 633+23(3)** 1.46
260 285 (1) 655+75(3)* 2.30
280 370+0(2) 637+49(3)* 1.70
295 389+47(5)$ 703+2(2)** 1.77
418+19(5)
+ Control mice were uninjected, age and sex--matched VM mice,
except $, which were age and sex-matchgd VM mice but which 
received 0.02ml ^ntracerebrally of 10 homogenate (unspun) of 
uninfected Sine? brain.
— 3
t Each animal received 0.02ml ^.ntracerebrally of 10 homogenate
(spun) of 87V-infected Sinc^ brain. All mice were VM oT
Significances (t.test) *p<.01; **p<.001.
three mouse strains homozygous for Sinc^7, IM, VM and MB, infection with
87V strain was consistently characterised by elevated levels of serum IgG
by days 224,224 and 219, respectively, post injection, before clinical
symptoms became apparent (see Table 7 for details of incubation periods).
However, infection of IM mice with 22A strain (Table 8 ) and VM mice
with 139A strains (Table 9) resulted in no such IgG changes, compared to
their normal brain-injected controls. Both models developed characteristic
scrapie signs, and their incubation periods are given in Table 7. In
neither Sincs7 (Table 2) or Sinc^7 (Table 9) mice did 139A strain of
scrapie produce any detectable IgG response. The results from 139A in 
s7
S m c  mice were in accordance with the negative results from earlier 
immunological studies using different approaches (Porter et al, 1973).^ 
Some, but not all, IM mice infected with 22A strain of scrapie developed 
skin lesions, as did 3 of the 14 VM mice infected with 87V; but again their 
presence did not appear to influence the levels of serum immunoglobulins.
c) To test if serum IgG changes are absent in other models involving 
s7S m c  mice
The results presented so far show that intracerebral injection of 
Sincp7 mice with 87V strain of scrapie is characterised by elevated levels 
of IgG in the sera of infected mice, compared with normal brain-injected
s7controls. However, when the same strain of agent was injected into Sine 
mice (Compton whites) no such increases were apparent over the 84 week 
sampling period (Table 10). However, the animals did not show any clinical 
signs of disease which, in the light of available data (Bruce and Fraser, 
1975) was unexpected. The 22C (Table 11) and ME7 (Table 12) strains of 
agent also failed to evoke any IgG responses in Compton White mice when 
sampled throughout their incubation periods (Table 7). When 79A was 
injected into C57BL mice and sampled over the latter phase of the 
incubation period (from 100-160 days post injection) the serum IgG levels
TABLE 7 INCUBATION PERIODS OF SEVERAL MURINE MODELS OF SCRAPIE
INCUBATION PERIOD
STRAIN OF 
SCRAPIE
DILUTION 
OF SCRAPIE
KUUJLr. *
S7 S7p7 S m c  Sine * Sinc^7
BRAIN
87V
—2IS- i.e.i.e.i.e.i.e. no disease (CW) 315+3(IM) 284+7(MB) 286+4( VM)
13 9A
“ 210
i.e.
i.e.
125+2(CW)
206+3 (VM)
22A
<10
i.e.
i.e. 577+10( CWxIM )
357+3(IM)
22C 10-3 i.e. 218±1(CW)
ME7 10-3 i.e. 239+3(CW)
79A 10"2 i.e. 164+2(C57BL)
I
TABLE 8. SERUM IgG CONCENTRATIONS IN Sinc^7 MICE (IM) INJECTED WITH 
22A STRAIN OF SCRAPIE, AND CONTROLS
DAYS POST 
INJECTION
mglgG/lOOml SERUM 
mean + SEM (4 mice)
CONTROLS* t2 2A-INJECTED
Jvril J.U X£«
CONTROL
28 495+45 533+27 1.08
56 448+40 330+62 0.74
84 445+23 425+52 0.96
112 379+36 408+103 1.09
140 455+25 455+25 1.0
168 430±18 348+46 0.81
196 433+33 485+45 1.12
224 455+24 480+8 1.08
252 394+32 470+30 1.19
287 396+73 410+17 1.04
294 365+15 353+73 0.97
301 330+76 428+74 1.30
308 467+13(3) 500+0 1.07
350 N/A 598+69 1.28
364 440 (1) 357+62 0.81
385 410+30(2) 460+23 1.12
—3+ Each animal received 0.025ml intracerebrally of 10
homogenate (unspun) of uninfected Sinc^ brain. All animals 
were age and sex-matched with the infected group.
—3t Each animal received 0.025ml intracerebrally of 10P7 yr
homogenate (unspun) of a 22A-infected Sincr brain. Both 0 
and 0 IM mice were used at 1:1 ratio.
N/A None available
TABLE 9. SERUM IgG CONCENTRATIONS IN Sincp7 MICE (VM) INJECTED WITH 
13 9A STRAIN OF SCRAPIE, AND CONTROLS
DAYS POST 
INJECTION
mglgG/lOOml SERUM 
mean + SEM (n mice)
RATIO SCRAPIE 
CONTROLCONTROLS*1" 139A-INJECTEDt
25 N/A 293+18(6) 0.85
53 350+47(3) 333+56(6) 0.95
73 355+45(2) 260+14(4) 0.73
98 344+20( 4) 324+22( 5) 0.94
199.214 339+28(8) 394+23(9) 1.16
+ Control mice were uninjected age-matched VM O
—2t Each animal received 0.02ml intracerebrally of 2x10 homogenate
(unspun) of 139A-infected Sinc^ brain. All mice were VM or*
N/A None available.
TABLE 10. SERUM IgG CONCENTRATIONS IN SincS? MICE (CW) INJECTED WITH
87V STRAIN OF SCRAPIE, AND CONTROLS
DAYS POST 
INJECTION
4
mglgG/lOOml SERUM 
mean ± SEM (4)
CONTROLS* 87V-INJECTEDt
RATIO SCRAPIE 
CONTROL
28 388+12 398+8 1.03
56 500+41 428+3 0.86
84 525+67 428+17 0.82
112 595+56 770+39 1.29
140 750+21 768+53 1.02
168 698+68 690+45 0.99
196 763+24 700+52 0.92
224 715+33 708+35 0.99
252 700+42 713+13 1.02
287 718+60 695+25 0.97
308 745+26 705+33 0.95
336 723+55 686+46 0.95
392 663+39 708+29 1.07
420 677+7 710+40 1.05
448 880+0 916+60 1.04
504 850+0 675+75 0.80
588 900+50 816+73 0.91
—3+ Control mice each received 0.025ml intracerebrally 10
homogenate (unspun) of untreated Sincp mouse brain. All 
mice were age and sex-matched with the infected group.
t
—3
Each mouse received 0.025ml intracerebrally 10 homogenate 
(unspun) of clinical 87V-infected sinc^ brain. All mice were Jj> 
Compton Whites.
TABLE 11. SERUM IgG CONCENTRATIONS IN SincS? MICE (CW) INJECTED WITH
22C STRAIN OF SCRAPIE, AND CONTROLS
DAYS POST 
INJECTION
mglgG/lOOml SERUM 
mean + SEM (4 mice)
CONTROLS* 22C-INJECTEDt
---- RATIO SCRAPIE 
CONTROL
14 390+17 382+25 0.98
28 370+16 390+17 1.05
42 350+10 366+35 1.05
56 362+14 349+18 0.96
76 385+15. 470+0* 1.22
84 413+24 439+18 1.06
98 493+27 478+18 0.96
112 537+27 516+36 0.96
126 468+39 590+82 1.26
140 557+26 568+49 1.02
154 492+36 567+35 1.15
168 620+60 685+29 1.10
182 575+64 725+35 1.26
196 552+35 620+47* 1.12
210 610+17 618+48 1.01
224 593+36 655+29 1.10
— 3
+ Each mouse received 0.025mlgrntracerebrally of 10 homogenate
(unspun) of uninfected Sine brain. All mice were age 
and sex-matched to the infected group.
—3t Each mouse received 0.025ml intracerebrally of 10 homogenate
(unspun) of 22C-infected Sine brain. All mice were p Compton 
Whites.
Significance (t.test)*p<.02.
TABLE 12. SERUM IgG CONCENTRATIONS IN SincS7 MICE (CW) INJECTED WITH
ME7 STRAIN OF SCRAPIE, AND CONTROLS
DAYS POST 
INJECTION
mglgG/lOOml SERUM 
mean + SEM (4 mice)
•pTVmTn QnJUDTF
CONTROLS* ME7-INJECTEDt
KAi 1U OL*I\riir J.£j
CONTROL
14 285+12 323+1 1.13
28 294+15 261+14 0.89
42 313+22 278+9 0.89
56 269+10 320+23 1.19
70 322+23 346+14 1.07
84 420+30 304+20 0.72
98 411+37 368+27 0.90
112 379+18 345+24 0.91
126 381+18 471+45 1.24
140 499+7 501+32 1.10
154 538+23 498+13 0.93
168 506+9 475+47 0.94
182 515+29 520+18 1.01
196 459+24 483±83 1.05
210 470+38 420+35 0.89
224 510+18 612+27 1.20
238 456+24 566+9 1.11
245 485+20 593+62 1.22
—2
+ Control mice each received 0.025ml intracerebrally 10
homogenate (unspun) of uninfected Compton White brain. All mice 
were age and sex-matched with the infected group.
—2t Each mouse received 0.025ml intracerebrally 10 homogenate
(unspun) of ME7-infected C57BL/6 brain. All mice were p Compton 
Whites.
appeared to be constant but, compared to control animals, were elevated 
(Table 13). However none of the increases were statistically significant. 
Moreover the control animals used were not injected with normal brain 
material, nor were they set up in parallel with the 79A-infected group of 
mice. Thus the results from this experiment, although interesting, will
i
have to be repeated, with the appropriately inoculated controls before any 
firm conclusions can be drawn.
S7d ) To investigate the age-related changes in uninjected Sine mice
In all the scrapie models which used Compton White mice as a strain 
S7
homozygous for Sine , age-related increases in serum IgG concentrations in 
normal brain-injected controls were apparent (Tables 2,10-12). An 
experiment was set up to investigate this further by serial sampling of 
uninjected Compton White mice at 7-day intervals over a 55 week period.
Low levels of serum IgG were observed in the animals at day 7 (i.e.28 days 
from birth) after leaving the specific pathogen-free (SPF) environment, but 
after a further 7 days (i.e.at 35 days after birth) the IgG concentration 
had increased nearly two-fold, and thereafter continued to rise, eventually 
reaching a plateau level when the animals were 31 weeks old (217 days, 
Table 14). Previously published data in BALB/c and C57BLxC3H mice (Quinn 
et al., 1973) indicated that serum IgG levels increase with age. However, 
for many of the scrapie models studied, these large age-related increases 
would be occurring whilst the animals were incubating the disease, and 
consequently would mask any subtle changes which might be due to the 
presence of agent. It would also prove impracticable to delay the use of 
these mice for infection studies until they were beyond the stage of normal 
IgG increases as the incubation periods for some agent strains would thus 
exceed the lifespan of the animals.
s7In an attempt to find another mouse strain, homozygous for Sine , 
which did not show these age-related serum IgG increases, an identical
TABLE 13. SERUM IgG CONCENTRATIONS IN SincS? MICE (C57BL) INJECTED WITH
79A STRAIN OF SCRAPIE, AND CONTROLS
mglgG/lOOml SERUM 
DAYS POST mean + SEM (n.mice)
INJECTION ----          RATIO SCRAPIE
CONTROLS 7 9A-INJECTED CONTROL
100 N/A 685+75(2)
110 458+18(4) 582+39(4) 1.27
119 N/A 576+28(4) . —
130 430±10(2) 518+33(4) 1.20
140 425±35(2 ) 536+31(4) 1.26
151 423±17(3) 730+170(2) 1.73
160 428+57(2) 595+45(3) 1.39
+ Control mice were uninjected age-matched O^and J C57BL.
-2t Each mouse received 0.025ml intracerebrally of 10 homogenate
of 79A-infected C57BL brain. All mice were O C57BL.
N/A None available.
TABLE 14 SERUM IgG CONCENTRATIONS IN UNINJECTED SincS? (CW) MICEt
DAYS AFTER BIRTH mglgG/lOOml SERUM 
mean + SEM (6 mice)
28 142+18
35 236+21
* 49 403+17
77 433+15
105 466+20
133 566+34
161 569+20
189 576+38
217 520+35
245 611+39
273 560+24
301 676+33
329 638+37
357 560+13
386 568+34
+ Mice left SPF conditions when 21 days old, and thereafter
maintained in normal animal facilities.
t Only female mice used.
serial sampling experiment was set up with C57BL/6 mice. However, this
mouse strain also gave similar results to those obtained with Compton White
mice (Table 15); serum IgG levels rose gradually until the mice were 28
weeks old (196 days), and thereafter a plateau level was achieved. Hence
the results show that serum IgG levels rise when mice leave SPF conditions 
«
and are re-located in conventional animal holding facilities. However, 
these increases are not entirely caused by exposure to a 'dirtier' 
environment. Two groups of C57BL/6 female mice were sacrificed immediately 
on leaving SPF conditions; one group were 21 day old weanlings, and the 
second group consisted of ex-breeding stock, with an age range of 112-126 
days old. The serum IgG levels, although very low in both groups, showed a 
significant age-related increase (Table 16). In contrast, the Sinc^7 mice 
used in similar serial experiments showed no such age-related increases 
(Tables 1,4,5,8), and this will be discussed later in relation to their 
immune status.
e) To investigate what effect a peripheral route of infection might have 
on serum IgG levels
With all the previously described models in Section 3.1, various 
strains of scrapie were injected directly into the brain, the target organ. 
Most of this inoculum is quickly removed, and within minutes can be 
detected in low^amounts in the blood, spleen, salivary glands, liver and 
lungs (Millson et al, 1979). Although early agent replication does occur 
in spleen following infection by the i.e. route, this is not essential to 
the pathogenesis of the disease (Dickinson and Fraser, 1977; Kimberlin and 
Walker, 1979c), and it is the residual infectivity in the brain that causes 
disease. Infection by a peripheral route (eg. intraperitoneally [i.p. ] ) is 
followed by an obligatory phase of agent replication in extraneural tissue, 
such as the spleen. Thus the "processing" of agent in extraneural tissues 
of the host after inoculation by the i.p. route might be qualitatively
TABLE 15 SERUM IgG CONCENTRATIONS IN UNINJECTED C57BL/6 MICE (SincS7 )
DAYS AFTER BIRTH* mglgG/lOOml SERUM
meant SEM (n mice)
56 275+7(4)
'72 345+5(4)
112 383+16(4)
140 378+12(4)
168 400+21(3)
196 500+26(4)
224 460+30(3)
252 483+7(3)
280 496+18(4)
308 520+30(4)
336 498+17(3)
t Mice were transferred from SPF conditions to normal animal 
holding facilities when 21 days old. All animals were )^.
TABLE 16 SERUM IgG CONCENTRATIONS IN SPF C57BL/6 MICE (SincS7,>
GROUP NUMBER PER AGE mglgG/lOOml SERUM
GROUP (DAYS) mean + SEM
tWEANLINGS 12 21 50+1
ADULTSt 12 112-126 186+9*
t Animals were sampled immediately on leaving SPF conditions. All
mice were
Significance (t.test) *p<.001.
similar to that following an i.e. injection, but quantitatively there may
be more involvement of lymphoreticular tissue following peripheral
infection. It was therefore of interest to study serum IgG levels of some
combinations of agent and mouse strain in which the route of injection was
varied.
<
It has been shown that intracerebral injection of Sinc^7 mice with 
87V strain of scrapie results in elevated levels of serum IgG, in the 
latter phase of the incubation period before clinical symptoms became 
apparent (Table 1) and this was re-affirmed by the results from another 
such experiment (Table 17). Data from 3 separate experiments are given in 
Tables 18-20 which show that when 87V was injected intraperitoneally into 
Sinc^7 mice (IM), serum IgG concentrations were maintained at a generally 
higher level than their normal brain inoculated controls, as judged by the 
scrapie control ratio. In addition the levels were significantly elevated 
from weeks 48 (336 days) 52 (365 days) and 70 (490 days) onwards (also 
Figure 7 for a resume of all data for the injection of 87V in IM mice by 
the 2 routes). Such results are in accord with the rationale given above 
but the surprising feature of these 3 experiments was the absence of 
clinical disease. Consequently, pathogenesis studies were set up using 
tissues from mice in these experiments to investigate the presence or 
absence of agent in the brain and spleen. The results from these 
experiments are.given in Section 3.2.
s7
When Sine mice (Compton Whites) were injected with the 139A 
strain of scrapie, infection by intracerebral route again did not produce 
any IgG changes (Table 21) thus confirming previous results (Table 2 ). The 
intraperitoneal route of infection with the same agent in Compton Whites 
also failed to induce any IgG response (Table 22). These results show that 
the presence or absence of serum IgG changes in mice injected with scrapie 
is independent of route.
TABLE 17. SERUM IgG CONCENTRATIONS IN SincP? MICE (IM) INJECTED
INTRACEREBRALLY WITH 87V STRAIN OF SCRAPIE, AND CONTROLS
mglgG/lOOml SERUM 
DAYS POST mean + SEM (n.mice)
CONTROLS* 87V-INJECTEDt
~ RATIO SCRAPIE 
CONTROL
28 657+23(6) 723+30(6) 1.10
84 542+27(5) 516+25(5) 0.95
196 596+32(5) 638+94(5) 1.07
224 530+64(4) 537+30(4) 1.01
252 516+26(5) 650+43(5)* 1.26
280 428+57(5) 836+43(5)*** 1.95
287 423+57(3) 932+84(10)** 2.20
294 550+13(6) 765+55(8)** 1.39
+ Each mouse received 0.025ml ^ntracerebrally of 
(unsound of uninfected Sinc^ brain. All mice 
matched with the infected group.
10-2 homogenate
were age and sex-
t Each mouse received 0.025ml intracerebr^JLly of 
(unsound of clinical 87V-infected Sinc^ brain.
? IM*
io"2 homogenate
All mice were
Significances (t.test) *p<.05; **p<.oi; ***p<.001
TABLE 18. SERUM IgG CONCENTRATIONS IN SincP? MICE (IM) INJECTED
INTRAPERITONEALLY WITH 87V STRAIN OF SCRAPIE, AND CONTROLS.
(Experiment 1).
mglgG/lOOml SERUM 
DAYS POST mean ± SEM (4.mice)
INJECTION -----------      RATIO SCRAPIE
CONTROLS 8 7 V—INJECTED CONTROL
28 418+19 413+44 0.99
56 408+19 493+84 1.20
84 408+33 405+49 0.99
112 327+39 290+12 0.89
140 280+0 350+16 1.25
168 325+3 401+32 1.23
196 284+18 412+26 1.45
224 270+20 370+7 1.37
254 289+4 374+41 1.30
280 265+30 319+56 1.20
308 249+21 330+33 1.33
336 290+10 512+42** 1.77
364 295+35 463+17* 1.57
392 266+29 500+40* 1.88
+ Each mouse received
—3
0.1ml intraperit^neally of 10
homogenate (unspun) uninfected Sinc^ brain. Mice were age and
sex-matched to the infected group.
-3
t Each mouse received 0.1ml intraperitoneal^y of 10
homogenate (unspun) of clinical 87V Sincp brain. Both O^ 
and p IM were used.
Significances (t.test) *p<.01; **p,<.005
TABLE 19. SERUM IgG CONCENTRATIONS IN Sinc^ MICE (IM) INJECTED
INTRAPERITONEALLY WITH 87V STRAIN OF SCRAPIE, AND CONTROLS.
(Experiment 2)
mglgG/lOOml SERUM 
DAYS POST mean ± SEM (4 mice)
INJECTION -----------         RATIO SCRAPIE
CONTROLS 8 7 V-INJECTED CONTROL
28 608+37 595+116 0.98
56 548+42 653+87 1.19
84 490+34 718+60 1.47
112 573+48 43 8+47 0.76
140 443+51 448+17 1.01
168 450+39 403+23 0.96
196 578+73 670+164 1.16
224 520+99 530+62 1.02
252 468+116 695+69 1.48
287 480+39 660+71 1.38
308 575+74 578+74 1.01
336 540+28 523+95 0.97
365 543+34 803+30* 1.47
560 480+26(3) 953+40(3)* 1.99
+ Each mouse received
-3
O.lml intraperitone^JLly 10 
of uninfected Sinc^ brain.homogenate (unspun) All mice were
age and sex-matched with the infected group.
—3
t Each mouse received O.lml intraperitoneal^y 10
homogenate (unspun) of clinical 87V Sinc^ brain. Both 
and O IM mice were used.
Significance (t.test) *p<.01.
TABLE 20. SERUM IgG CONCENTRATIONS IN Sine5* MICE (IM) INJECTED
INTRAPERI TONE ALLY WITH 87V STRAIN OF SCRAPIE, AND CONTROLS.
(Experiment 3).
DAYS POST 
INJECTION
mglgG/lOOml SERUM 
mean + SEM (3 mice)
CONTROLS* 87V-INJECTEDt
RATIO SCRAPIE 
CONTROL
224 627+66 720+60 1.15
252 617+75 720+35 1.16
280 640+40 f 593+49 0.93
308 563+17 527+32 0.94
350 590+38 773+175 1.31
378 620+72 813+50 1.31
420 607+53 832+72(5) 1.37
462 660+60(2) 810+50 1.23
490 500+0(2) 970+85* 1.94
525 587+52 907+50 1.55
560 633+27 922+48*(5) 1.46
—2
+ Each mouse received 0. 1ml intraperitone^lly of 10
homogenate (unspun) of uninfected Sinc^ brain. All mice were age 
and sex-matched to the infected group.
-2
t Each mouse received O.lml intraperitoneally of 10
homogenate (unspun) of clinical 87V-infected Sincr brain. All mice 
were <j> IM.
Significances (t.test) *p<.01.
TABLE 21. SERUM IgG CONCENTRATIONS IN SincS? MICE (CW) 
INTRACEREBRALLY WITH 139A STRAIN OF SCRAPIE,
INJECTED 
AND CONTROLS.
DAYS POST 
INJECTION
mglgG/lOOml SERUM 
mean + SEM (3 mice)
CONTROLS4 13 9A—INJECTED^
RATIO SCRAPIE 
CONTROL
4 607+77 713+29 1.17
11 515+25 460+44 0.89
21 465+92 450+31 0.97
35 540+0 413+37 0.77
50 617+46, 630+70 1.02
64 610+69 377+37 0.62
78 517+48 398+52 0.77
93 625+75 482+95 0.77
107 580+90 690+44 1.19
121 650+82 547+35 0.84
128 670 (1) 677+102 1.01
—2+ Each animal received 0.025ral7intracerebrally 10 homogenate
(unspun) of uninfected Sine brain. All mice were age and sex-
matched with the infected group.
—2
t Each animal received 0.025ml inj^racerebrally 10 homogenate
(unspun) of clinical 139A Sine brain. All mice were <J) Compton 
Whites.
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TABLE 22. SERUM IgG CONCENTRATIONS IN Sine MICE (CW) INJECTED
INTRAPERITONEALLY WITH 139A STRAIN OF SCRAPIE, AND CONTROLS.
mglgG/lOOml SERUM 
DAYS POST mean + SEM (8 mice)
INJECTION -----------        RATIO SCRAPIE
CONTROLS 13 9A—INJECTED CONTROL
7 564+46 638+31 1.13
21 699+25 543+36 0.78
35 590+28 658+28 1.12
49 673+36 650±49 0.97
63 670+57 r 610+23 0.91
77 713+36 676+30 0.95
91 878+48 815+46 0.93
105 848+34 757+37 0.89
119 772+45 808+48 1.05
133 767+19 742+11 0.97
147 861+53 808+60 0.94
161 817+50 773+38 0.95
175 875+44 771+29 0.88
182 781+49 708+40 0.91
+ Each mouse received O.lml inj^raperitoneally 10 homogenate
(unspun) of uninfected Sine brain. All mice were age and sex-matched 
with the infected group.
Whites.
3.2 MECHANISMS RESPONSIBLE FOR SERUM IgG CHANGES 
1. Increased production and/or reduced na+aholism of IgG
Introduction
Previous studies have shown that in one scrapie model, 87V in 
Sinc^7 mice, serum IgG concentrations are significantly elevated, as 
compared with controls, whilst the majority of other models investigated 
showed no equivalent alterations (Section 3.1). In general, an increased
t
concentration of IgG may be due either to an overproduction of 
immunoglobulin or a reduced rate of catabolism. Measurement of the rate of 
disappearance of IgG from serum may indicate which of the two factors 
contributes to the increase. Of course, both factors may contribute, 
especially as a feature of polyclonal B cell activation is an increase in 
serum immunoglobulins with a corresponding increase in the catabolic rate 
of these proteins. Also, it has to be assumed that the rate of 
disappearance of the radioactively-labelled IgG from the serum is 
equivalent to the rate of catabolism for the protein. The studies 
described in this section attempt to investigate the contribution an 
altered rate of catabolism of IgG might make to the increased IgG levels 
observed in 87V-infected mice.
Total immunoglobulin G was isolated by affinity chromatography
Section 2.3) from untreated adult mice of the same strain as were under
experimentation. The purity of the preparation was checked by
immunoelectrophoresis using two antisera, one directed against whole mouse
serum, and the second specific for mouse IgG; the IgG produced a single,
identical immunoprecipitation line with both antisera. Purified IgG was
125then radioactively labelled with I using the chloramine T method 
(Section 2.3). The radioactive IgG (a trace amount) was added to 
syngeneic mouse serum to give a final concentration which fell within the 
normal range for each mouse strain, and injected intraperitoneally into
mice at the early clinical phase of scrapie and into normal brain-injected 
controls. Serum and urine samples were collected from individual animals 
over the 14 or 15 day experimental period, and counted for radioactivity 
(Section 2.3). Electrophoretic analyses were carried out on some of the 
sera to ensure that the radiolabel was attached to the immunoglobulin G 
(Section 2.3). The rate of disappearance of IgG was estimated by plotting 
the level of radioactivity per mg of IgG on a logarithmic scale against 
time on a linear scale. The half-life of IgG for each group of mice was
t
then calculated by regression analysis.
Two different scrapie models were available for this study, plus 
their normal brain-injected controls. Untreated SincP7 (IM) and Sine37 
(LAC G) mice were also included in these studies.
a ) Untreated Sincp7 and Sincs7 Mice
The rates of loss of radio-iodinated IgG from the sera of two 
strains of adult (approx 16 weeks of age) normal mice are given in Table 
23. In both strains, there was a gradual reduction in the levels of the 
radioprotein in the serum (Table 23). The data obtained were used to 
calculate a regression line for each group (Figure 8). Both regression 
lines showed a significant correlation coefficient; p<.01 for LAC G mice 
and p<.001 for IM mice. The calculated time taken for half of the 
radioactivity to disappear was different for the two mouse strains, 6.4 
days for LAC G mice and 7.9 days for IM mice (Table 25). These values were 
somewhat larger than expected from previously published data on other mouse 
strains (Quinn et al, 1973).
b) 87V-infected mice, mice injected with autoclaved 87V-infected brain 
and normal brain injected controls
Studies were made of 3 groups of IM mice. Group 1(13 mice) had 
been injected intracerebrally with 87V-infected Sinc^7 brain, and were at
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125Figure 8 Calculated regression lines for the loss of I-IgG from sera of 
uninfected Sinc^7 (IM) and Sincs7 (Lac G) mice.
the early clinical phase of scrapie, when serum IgG levels are known to be
elevated (Section 3.1.). The second group of mice (17 animals) had been
injected intracerebrally with the same source of inoculum as Group I, but
it had been autoclaved to destroy infectivity and thereby provide a control
for any possible effects due to the inoculation of histologically abnormal
brain (Section 2.6.2). Group 3 (18 mice) had been inoculated
intracerebrally with normal IM brain homogenate. All 3 groups showed a
125decrease in the levels of serum I-IgG over the 14 day sample period 
(Table 24). Both the clinically-affected mice and those inoculated with 
autoclaved 87V brain showed an accelerated rate of clearance of the radio­
protein from the serum (Figure 9). The regression analyses of the data 
(Table 25 and Figure 9) showed that all 3 regression lines had significant 
correlation coeffecients (P<.001). In control animals, the calculated 
half-life of serum IgG was 7.8 days, which was similar to that obtained for 
untreated IMmice, as described above. Groups 1 and 2 both showed similar 
but shortened IgG half-lives (2.6 days for the 87V infected mice and 3.3 
days for animals receiving autoclaved 87V). The latter result was highly 
surpising. The animals inoculated with autoclaved 87V brain homogenate 
were assumed to be uninfected. However tests for infectivity in this 
inoculum were not carried out and it might be considered that there was 
some failure of the autoclave procedure which left infectious agent in the 
inoculum.
It was necessary to check that all radiolabel remained bound to the 
protein throughout the experiment. The purified labelled protein, and 
aliquots of sera from all 3 groups taken at days 1,4,7, and 10, were 
analysed by SDS/polyacrylamide gel electrophoresis, as described previously 
(Section 2.3). The IgG molecules were dissociated into their light and 
heavy chain components by heating at 96°C for 3 minutes in 4% SDS buffer, 
and then samples were analysed on SDS-polyacrylamide gels. After 
electrophoresis the gels were sliced and counted for radioactivity. Figure
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87V-infected, autoclaved 87V-infected and normal brain injected Sincf7 (IM) 
mice.
TA
BL
E 
25 
RE
G
RE
SS
IO
N 
ON 
DA
TA
 
FO
R 
LO
SS
 
OF 
12
5I
-Ig
G
 
FR
OM
 
TH
E 
SE
RA
 
OF 
SE
VE
RA
L 
SC
RA
PI
E 
MO
DE
LS
 
AN
D*
 C
ON
TR
OL
 
M
IC
E
B
CM
Pi
w
cm
sw
Tj* CD 
CO I"
H  
H  O  
O O
O
t"
o
0
1
in H CM CO CM cno cn CM CO CD co
<d 00 CD 00 00 CO• • • • • •
0
1
0
1
0
1
0
1
0
1
0
1
CD CD C" cn CO cn
cn cn H CD cn COo o H o o O• • • • • - •
0
1
0
1
0
1
0
1
0
1
0
1
t-* r- 
IQ CM
co Qi
o
u
XH
GO ID
CM
cn
cn
r*00 
CM
1
cn
t"
CM
cn
H
r"00
CM
1
cn
t"
CM
r»
H
D'
00
CM
I
cn
Is*
CM
> S3 
r- h  e g
q  m
W > Q
& a s
H  U  U ^S1
09 n  <  H
r* r'
CM CM CMr* r-'
CM CM CM
X
H
X
H
in
oo
HOO
HOO
CO
H
00
CO
H
I
in
H
I"
H
00
CO
H
I
inH
Q
H
I<
CM
CM
CM CMr* r*
CM CM
X
H
X
H
10 shows the distribution of radioactivity throughout two such gels, one
gel separating serum from a normal brain-inoculated control and one, 87V-
infected serum, both taken 7 days after administration of the radiolabelled
protein. The two gels were not identical, as judged by the distance the
marker dye migrated, but the Rf values for the positions of the heavy and
light chains are similar (0.64:0.62; 0.86:0.81 control serum : 87V-infected
serum). The percentage of radioactivity associated with the light and
heavy chains of the originally prepared IgG was 32% and 68% respectively
(Table 26). This percentage distribution did not alter in serum samples
collected up to, and including, the 10 day point for either the control
mice or for those clinically-affected with scrapie (Table 26) and thus
125confirmed that the I was firmly bound to the IgG molecules over the 10 
day sample period. Similar data on samples at day 1 and day 10 were 
obtained for those mice injected with the autoclaved 87V-infected brain 
inoculum (Table 26).
c) 22A-injected and control W 7 mice (IM)
Comparative studies were carried out on the half-life of serum IgG
in a second scrapie model with IM mice. The 22A strain of scrapie in
Sincf7 mice does not result in elevated levels of serum IgG (Section 3.1.)
as does the 87V strain (Section 3.1.) and it was of interest to see if
there were any changes in the half-life of IgG in the serum in this second
model. Radiolabelled IgG (in syngeneic serum) was injected
intraperitoneally into animals taken at 154days after the original
injections of brain material. Those mice incubating scrapie were at the
early clinical phase of the disease, and the control mice had received
125
normal mouse brain homogenate. The loss of I-IgG from the sera of both 
groups of mice is given in Table 27. The regression analyses showed that 
the loss of labelled protein from serum in both groups "proceeded at a 
similar rate (Figure 11); the calculated half-lives were 4.8 days for the
c.
p.
m
.(x
10
2)
T
D/e
T
6020
DISTANCE (mm)
Figure 10 SDS/Polyacrylamide gel electrophoresis of labelled serum from 87V-
7 125
infected and normal brain injected Sinc^ (IM) mice, on day 7 following I-
IgG injection.
TABLE 26 PERCENTAGE DISTRIBUTION OF RADIOACTIVITY IN DISSOCIATED IgG 
LIGHT AND HEAVY CHAINS
TIME AFTER 
I-IgG
SERUM % DISTRIBUTION OF RADIOACTIVITY IN
SAMPLE HEAVY AND LIGHT CHAINS
INJECTION (NUMBER) (mean ± SEM)
(DAYS)
HEAVY CHAINS LIGHT CHAINS
0 PURIFIED 125I-IgG 68 32
1 CONTROL (1) 69 31
87V-INFECTED (3) 69+1.2 31+1.2
AUTOCLAVED 8 7V—INFECTED (1) 68 32
4 CONTROL (1) 75 25
87V—INFECTED (2) 71+1 29+1
7 CONTROL (1) 68 32
87V-INFECTED (2) 69+2 31+2
10 CONTROL SERUM (1) 71 29
87V—INFECTED (2) 70+0.5 30+0.5
AUTOCLAVED 8 7V—INFECTED (1) 69 31
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125Figure n  Calculated regression lines for the loss of I-IgG from sera of 
22A-infected and normal brain injected Sinc^7 (IM) mice
scrapie-affected mice, and 5.4 days for the control mice (Table 27). The 
half-life of IgG in these normal brain injected mice was shorter than that 
obtained for the control group in the previously described 87V experiment 
(7.8 days). The significance of this will be discussed later.
3.2.2 Persistence of 87v strain of scrapie in spleen
Two groups of donor Sinc^7 mice (IH) were injected with clinical
87V-infected SinsP7 brain; one group was inoculated intracerebrally, the 
second group intraperitoneally. At various times after inoculation, brains 
and spleens were removed from 3 donor animals in each group. The presence 
or absence of infectious agent in each tissue was determined by 
intracerebral inoculation of 1% homogenates into recipient groups of up to 
16 mice. The incubation period for each recipient group (2x8) was measured 
to give an indication of the relative amounts of infectivity present. The 
results are presented in Table 28. Measurement of incubation period was 
based on the time of appearance of clinical signs (Section 2.6.1.b). 
Animals were observed for up to 2 years after injection and histological 
confirmation of a clinical diagnosis was sought in all cases of doubt, 
especially in very old mice.
In mice injected intraperitoneally with scrapie, infectivity was
detected in spleen at the time of the first sample (7 days). During the
period from 7-li2 days, the incubation periods shortened progressively,
( from 371 to 302 days, Table 28) indicating replication of agent in spleen. 
These results suggest that 87V in Sinc^7 mice has a very short zero phase, 
(Section 1.6) if one at all. The replication phase was then followed by a 
plateau phase, as indicated by the similar incubation periods over the 
remaining time. However, it is not known if this represented a static 
plateau or one with an active turnover of agent. Agent was detected in 
brain in less than 10% of the animals injected intraperitoneally, and
occurred only after 350 days (Table 28). This is in contrast to several 
other models studied where shortly after the maximum spleen titres have 
been achieved, agent invades the CNS (Dickinson and Fraser, 1977; Kimberlin 
and Walker, 1979c; 1980; 1982). There is no information on the precise 
titre of agent in the spleen at these later sampling points (i.e. 350 days 
onwards), when the plateau has been reached. It could be that invasion of 
the CNS does not appear to occur because spleen titres are not high enough.
Replication in brain was detected in all groups of mice injected 
intracerebrally with the 87V strain of scrapie (Table 28). Agent was also 
present in the spleen from day 7 onwards, confirming other data that 
inoculum rapidly escapes from brain following an i.c injection, to be found 
in the spleen and other lymphoid tissue (Millson et al., 1979).
Hence using either the i.p. or i.c. route of injection, scrapie 
became quickly established in the spleen. Since the IgG changes found are 
similar, irrespective of route of inoculation, then it is highly likely 
that the increases in serum IgG concentration are a direct consequence of 
the presence of infectious 87V scrapie in the spleen.
Support for this conclusion was obtained from what was intended as 
a control experiment to measure the serum IgG levels in IM mice injected 
intracerebrally with autoclaved, 87V-infected brain homogenate. The 
autoclaving procedure was chosen with the intention of destroying all the 
infectivity so that the effect of inoculating scrapie-damaged tissue could 
be assessed. The data given in Table 29 show that serum IgG levels were 
significantly increased (p<0.01) compared with normal brain-inoculated 
controls, but only 462 days after injection. It seems extremely unlikely 
that so late an effect was caused by non-replicating components of the 
inoculum. It is more likely that low levels of agent must have remained in 
the sample after autoclaving, and that following i.c. injection most of the 
inoculum was distributed amongst other tissues, including the spleen. No 
scrapie symptoms were identified in any of these animals.
TABLE 28 PATHOGENESIS STUDIES OF 87V STRAIN OF SCRAPIE IN Sinc^7 
MICE (IM)
DONOR TISSUE ROUTE OF DAYS POST INCUBATION PERIOD SEX OF %
FOR ASSAY* INFECTION INOCULATION OF RECIPIENT MICE RECIPIENT CASES
OF DONOR MICE mean + SEM(n.Mice) MICE
SPLEEN i.p. 7 371+6 (15) M+F 100
28 322+6 (15) M+F 100
70 350+7 (16) M+F 100
112 303+6 (14) F 100
154 332+6 (15) M 100
280 307+1 (13) F 100
350 308+1 (13) F 100
420 291+3 (16) F 100
560 308+1 (23) F 100
SPLEEN i.e. 7 434+12 (15) M+F 100
28 460+24 (15) M+F 94
70 403+19 (14) F 93
112 382+18 (10) F 100
154 312+8 (15) F 100
BRAIN i.p. 280 - (0/11) F 0
350 585 (1/12) F 8
420 677 (1/10) M 10
560 697 (1/20) F 5
BRAIN i.c 70 352+11 (15) M+F 100
112 331+5 (13) M 100
154 268+5 (16) F 100
* Brains or spleens were removed from donor mice at intervals after
inoculation and assayed for infectivity.
+ Donor mice. Each mouse received either 0.03ml intracerebrally or
O.lml intraperitoneally of 10 homogenate (unspun) of clinical 
87V-injected Sinc^ brain.
2t Recipient mice. Each mouse received 0.03ml intracerebrally of 10-
homogenate (unspun) of donor brain or spleen tissue. Each 
homogenate was assayed in groups of 16 Sine** (IM) mice.
M = male; F = female.
TABLE 29 SERUM IgG CONCENTRATIONS IN Sine1*7 MICE (IM) INJECTED WITH
AUTOCLAVEDS 87V STRAIN OF SCRAPIE, AND CONTROLS
DAYS POST 
INJECTION
4
mg IgG/lOOml SERUM 
mean +SEM (n MICE)
CONTROL AUTOCLAVED 87V-
INJECTED
RATIO SCRAPIE 
CONTROL
28 693+41(4) 660+62(4) 0.95
56 553+35(4) 643±31( 4) 1.16
252 633+77(3) 613+71(3) 0.97
280 605+25(2) 600±70(2) 0.99
308 643+110(3) 636+67(3) 0.99
336 660+90(3) 673+45(4) 1.01
364 583+72(3) 530+21(3) 0.91
392 670+60(3) 615+55(2 ) 0.92
462 517+27(3) 800+55(3)* 1.55
—2
$ Autoclaving procedure: 10 homogenate of clinical 87V-infected
Sinc^ brain was autoclaved at 121°C (lBg.s.i.) for 2x30 minute
cycles, rehomogenised and diluted to 10 for inoculation.
—3
+ Each mouse received 0.025ml ^ ntracerebrally of 10 homogenate
(unspun) of uninfected Sinc^ brain. All mice were age and sex- 
matched with the scrapie-infected group.
—3
t Each mouse received 0.025ml intracerebrally of 10 homogenate
(unspun) of autoclaved 87V-infected Sinc^ brain. All mice were 
Sincr (IM) .
Significantly different from controls (t.test) *p<.01
Data presented in Section 3.2. showed that serum IgG was 
catabolised at a similar rate in IM mice clinically-affected with 87V 
strain of scrapie as in IM mice of the same age which were originally 
injected with the same inoculum but autoclaved. These rates were 
significantly accelerated compared to the rate for IgG in the normal brain- 
inoculated controls. Thus, it seems likely that the autoclaved inoculum 
contained sufficient agent to establish infection of mice and to cause 
increases in the rate of production and the rate of clearance of IgG in
f
serum.
Conclusion
The results presented in this section show that there is at least 
one model, 87V in Sinc^7 mice, that consistently demonstrated significant 
increases in serum IgG concentrations. These increases are independent of 
route of infection, and arise as a consequence of overproduction of IgG 
which an increased catabolism cannot regulate. Pathogenesis studies on 87V 
in Sinc^7 mice have shown that it is the continuing presence of agent in 
spleen which provides the stimulus for these changes.
4. INVESTIGATIONS INTO THE POSSIBLE SPECIFICITY OF SERUM IoG CHANGES 
4.1 Specificity of raised IgG to various antigens
a) Association with cerebral amyloid
The presence of cerebral amyloid plaques is one of several 
characteristic histopathological features of the 87V strain of scrapie in 
Sinc^7 mice (Bruce and Fraser, 1975). The deposition of cerebral amyloid 
against an overall background of degenerative pathology is an interesting 
feature because it may involve the synthesis of new protein. The chemical 
nature of cerebral amyloid, including that associated with scrapie, is 
unknown. However, some forms of systemic amyloid are known to be derived 
from immunoglobulin light chains (Glenner,et al., 1970; Ishii et al, 1976) 
and this could be the case for the cerebral amyloid in scrapie. It was 
therefore of considerable interest to examine the time of onset of amyloid 
deposition in relation to the serum IgG increases. Sera and brains were 
taken from mice at 28-day intervals over the 315 day incubation period of 
87V injected i.e. in IM mice, and the samples coded.
The serum IgG levels have already been presented in Table 5,
(Section 3.1) only the scrapie:control ratios are presented here (Table 
30). Increases were apparent from day 196 post inoculation, and were 
significantly elevated from day 224 until the end of the experiment. The 
brains were fixed in 10% formol saline and sections stained with Masson's 
Trichrome to reveal amyloid plaques, which were then counted (work kindly 
carried out by Dr M.E.Bruce). These results are given in Table 30. A few 
amyloid plaques were detectable as early as day 112, and were restricted to 
the corpus callosum. However, the progressive increase in plaque number 
detectable from day 252 onwards is confined mostly to the cortex (Bruce, 
personal communication). There would thus appear to be a significant rise 
in serum IgG concentration at about the same time as an increasing number 
of amyloid plaques in the cortex. Animals infected with 87V strain of 
scrapie may produce an increasing excess of IgG, most of which is quickly -
TABLE 30. INCIDENCE OF CEREBRAL AMYLOID PLAQUES IN Sincp7 MICE INJECTED
WITH 87V STRAIN -OF SCRAPIE$
DAYS POST 
INJECTION
RATIO SCRAPIE 
CONTROL
PLAQUE COUNTS**" 
mean ± SEM (3 MICE)
28 0.78 0
56 1.09 0
84 1.20* 0
112 1.01 2.3+ 1.9
140 1.09 2.7+ 1.4
168 1.05 0
196
HH
8.0 + 3 .1
224 1.20* 2.0+ 1.0
252 1.09* 35.3+19.5
280 1.38* 29.3+ 8.8
308 1.60** 113.3+25.8
315 1.52** 123.3+13.0
$ Serum IgG concentrations for control and 87V-injected Sincf mice
already presented in Table 5, Section 3.1.
+ For each case, a single section at 4 different levels was examined
and the amyloid plaques counted. The mean of these numbers for an 
experimental group is referred to as 'plaque count'. (Bruce and 
Fraser, 1981). Histological examination of brain tissue was carried 
out by Dr M.E.Bruce.
Significantly different to controls; (t.test) *p<.02; **p<.001.
degraded (Section 3.2) but some may cross the blood/brain barrier to be 
incorporated into amyloid fibrils in response to agent in cortex. However, 
there may be no direct causal relationship between serum IgG and cerebral 
amyloid, despite the temporal association.
Recent studies of three Sinc^7 mouse strains indicate the existence 
of a gene which controls the number of amyloid plaques with the 87V strain 
of scrapie (Bruce and Dickinson, 1982). MB mice show the greatest number 
of plaques, IM mice the lowest number and VM mice were intermediate. 
Analysis of the serum IgG ratios (scrapie/control) for these 3 mouse 
strains infected with 87V strain of scrapie showed a similar pattern; MB 
mice gave the highest ratios (Table 3) followed by VM mice (Table 6) and IM 
mice the lowest (Table 5). This again demonstrates an association between 
cerebral amyloid and elevated serum IgG levels with this one strain of 
scrapie. A second model was studied, 22A in Sincs7^ 7 (F^) mice, which is 
known to result in a high percentage of animals (78%) developing amyloid 
plaques (Bruce and Fraser, 1975). Serum IgG levels were measured in F 
mice (IM O^x Compton White ), control and infected (incubation period of 
577+10 days), and the results are given in Table 31. Although the serum 
IgG concentrations were at a slightly higher level in the scrapie injected
j
groups, as judged by scrapie:control ratios, the differences between the 
two groups of mice were not statistically significant. The plaque counts 
were not done on the brains from these animals. However, there are data 
from other experiments which indicate that the plaque count in the brains 
of terminal cases of Sincs7^7 (F^) mice injected i.e. with 22A strain of 
scrapie is considerably less (plaque count of 31) compared to clinically- 
affected Sinc^7 mice injected i.e. with the same dilution of 87V strain of 
scrapie (plaque count of 117, Bruce, personal communication). The lower 
scrapie s control serum IgG ratios may thus correspond to the lower plaque 
count in this second scrapie model, and again indicate some association 
between amyloid plaque deposition and serum IgG concentrations.
TABLE 31 SERUM IgG CONCENTRATIONS IN SincS7P? MICE INJECTED WITH
22A STRAIN OF SCRAPIE, AND CONTROLS
DAYS POST 
INJECTION
mg IgG/lOOml SERUM 
mean+SEM (n.MICE)
CONTROLS**" 22A-INJECTEDt
RATIO SCRAPIE 
CONTROL
28 475+45(4) 500+30(4) 1.05
56 500+33(4) 575+44(4) 1.15
84 493+19(4) 655+62(4) 1.33
504 494+31( 4) 580+49(4) 1.17
532 485+62(4) 595+42(4) 1.27
560 510+18(4) 634+30( 19) 1.24
602 N/A/ 580+45(10) -
616 484+53(9) 609+53(9) 1.26
—2+ Each mouse received 0.025ml intracerebr^lly of 10
homogenate (unspun) of uninfected Sincp brain. Animals 
were age and sex-matched with the scrapie-injected group.
—2t Each mouse received 0.025ml intracerebrally of 10
homogenate (unspun) of clinically affected 22A Sincp brain. 
All mice were Sine p (Compton Whites x IM) Cf^and 0 
(lsl ratio).
N/A None available.
b) Antibodies to brain and spleen antigens
During the latter half of the i.e. incubation period of the 87V 
strain of scrapie in Sincp7 mice, there is a considerable amount of damaged 
neural tissue which could act as a potential antigen source. Using a 
sensitive microELISA method, it was possible to investigate the presence of 
antibrain antibodies at a time when the concentration of IgG in serum was 
increased. Proteins were released by solubilisation of uninfected Sinc^7 
brain homogenate using 1% SDS (final concentration). The resulting clear 
viscous solution; when diluted to 10 6 with O.IM carbonate buffer pH 9.6, 
bound successfully to the microELISA plates and was used as a source of 
heterogeneous brain antigens. As can be seen in Table 32, antibrain 
antibodies were present at very low levels throughout the incubation period 
of 87V strain of scrapie, and were similar to the levels found in the two 
control groups. However, as the source of antigens was a brain from a 
healthy Sinc^7 mouse, it is possible that aged tissue or autolytic tissue 
might have provided antigens which reflected more closely the tissue damage 
caused by scrapie. Alternatively the negative data from the scrapie sera 
against normal antigens may simply mean that scrapie damage does not 
release new antigens.
A similar study was set up to investigate the presence, if any, of 
antispleen antibodies, using SDS solubilised normal spleen as the antigen 
source. Following an i.e. injection of scrapie, the majority of the 
inoculum rapidly escapes from the brain and is taken up by spleen (Section 
3.2), although it is the residual inoculum in the brain which causes the 
disease. Replication of agent occurs in the spleen at the same time as in 
brain (Section 3.2) but does not result in any histological damage to this 
tissue. Consistent with this is the nearly complete absence of antispleen 
antibodies in the sera of 87V-injected mice. The animals sampled in this 
experiment were the same as those tested for anti-brain antibodies (Table
32). No anti-spleen antibodies were found (data not shown) except on day 
28 when 2 of the 5 animals sampled had very low levels of anti-spleen 
antibodies (30+1 ^ig/lOOml sera).
These preliminary results show that low levels of anti-brain 
antibodies are present in animals injected with syngeneic brain, either 
control or scrapie-infected animals. The presence of low levels of 
circulating auto-antibodies is well documented (Elson et al, 1979) and will 
be discussed later.
i*
c ) Origin of IgG
Infection with certain conventional slow viruses can result in
inflammation and the synthesis of immunoglobulin within the brain,
producing specific and non-specific antibody (Griffin et al, 1978, Ludwig
and Becht, 1979). In contrast to these CNS diseases, there is no general
inflammatory reaction in scrapie brain, but there is one recent report
which indicated that after i.p. injection of the 139A strain of scrapie in 
s7
S m c  mice, perivascular leukocyte infiltrations occurred in the brains of 
infected mice (Museteanu and Diringer, 1981). In the light of this recent 
paper, it was of interest to test for synthesis of immunoglobulin within 
the CNS by analysis of CSF and serum samples from the same animal.
Although it was technically possible to collect approximately 5ul of CSF 
from individual animals (a sufficient volume for SRD analysis), each sample 
has to be centrifuged to remove cellular debris, and in practice only 3ul 
could be recovered. Therefore the cleared CSF samples were pooled and as 
many 5ul-aliquots as possible were analysed at each sample point. All 
haemolysed CSF samples were discarded.
The total serum IgG levels for the control and 87V-injected mice 
are given in Table 17, (Section 3.1); only the scrapie: control ratios are 
presented here (Table 33). The concentration of IgG in the CSF of the 
control and scrapie-injected mice over the 294-day experimental period are
TABLE 32. CONCENTRATION OF 
CONTROL AND 87 V-
IgG ANTI-BRAIN 
INFECTED Sinc^
ANTIBODIES IN THE SERA OF 
MICE.
DAYS POST GROUP NUMBER OF IgG ANTI-BRAIN ANTIBODIES
INJECTION MICE/GROUP ug/lOOml SERUM 
(mean + SEM)
28 co< 3 300+6
87V 5 315+15
84 87V 3 293+4
252 CON 3 300+1
87V 3 287+3
280 87 V 3 302+7
287 87V 5 309+
294 87V 6 294+3
—3+ Each mouse received 0.025ml ^ntracerebrally of 10 homogenate
(unspun) of uninfected Sinc^ brain. All mice were age and sex-1 
matched with the scrapie-injected group.
—3
t Each mouse received 0.025ml intracerebral^y of 10 homogenate
(unspun) of clinically-affected 87V Sinc^ brain. All mice 
were IM ij>.
  P7
TABLE 33 TOTAL IgG CONCENTRATIONS IN THE CSF OF Sine MICE (IM)
INJECTED WITH 87V STRAIN OF SCRAPIE, AND CONTROLS
DAYS POST 
INJECTION
SERUM IgG RATI0$ 
SCRAPIE
mg IgG/lOOml CSF
mean + SEM (n aliauots).
CSF IgG RATIO 
SCRAPIE
CONTROL CONTROL'*' 8 7 V—INJECTED U CONTROL
*28 1.10 34+3(4) 34+4(4) 1.0
84 0.95 N/A N/A -
196 1.07 84+3(5) 90+2(5) 1.07
224 1.01 70+4(4) 66+3(4) 0.94
252 1.26* 41+2(5 ) 47+2(5) 1.15
280 1.95**/ 30+3(5) 27±2(5) 0.90
287 2.20** 34+3(3) 31+2(10) 0.91
294 1.39** 33+2(6) 32+2(6) 0.97
—2+ Each animal received 0.025ml7intracerebrally of 10 homogenate
(unspun) of uninfected sinc^ brain. All mice were age and sex- 
matched with the scrapie-injected group.
—2
t Each animal received 0.025ml intracereb^ally of 10 homogenate
(unspun) of clinical 87V-infected sinc^ brain. All mice were
IM 0.
-f*
$ Data taken from Table 17, Section 3.1.
N/A No samples available
Significantly different from controls; (t.test) * p,.05; **p,.01;
***p<.001.
shown in Table 33. Serum IgG levels were significantly elevated from day 
252 in the scrapie-injected mice. Comparison of the IgG ratios of scrapie: 
controls for serum and CSF showed no obvious increase in CSF IgG at these 
times. It is therefore concluded that there is no synthesis of 
immunoglobulin within the CNS of mice infected with the 87V strain of 
scrapie.
4.2. Non—specific polyclonal expansion
F
a) IgG isotype analysis
The studies of total serum IgG in several murine models of scrapie 
demonstrated that the 87V strain inoculated intracerebrally into Sine 
mice was characterised by significant increases in serum IgG concentrations 
during the latter phase of the incubation period (Tables 1, 5 and 17). In 
contrast, a second strain of scrapie, 22A, inoculated intracerebrally into 
the same mouse strain resulted in no such serum IgG changes (Table 7). 
Comparison of the individual IgG isotype concentrations in both scrapie 
models was undertaken to see if the response caused by the 87V strain of 
agent was restricted to one subclass, or whether there was elevation in all 
3 major IgG subclasses. Isotypes IgGl, IgG2a and IgG2b were measured by 
single radial diffusion with purified standards (Section 2.3. ); IgG3 was 
not measured in these experiments as purified standards were not available, 
but its contribution to the total serum IgG is only a few percent (Grey et 
al, 1971).
The samples selected for the IgG isotype analyses in the 2 scrapie 
models were from experiments which have been previously described (Tables 5 
and 7, Section 3.1.), and consist of one early sample point (28 days post 
injection), and then sequential samples taken during the latter phase of 
the incubation period.
The total IgG concentrations and the percentage contribution each 
IgG isotype made to the total are given in Table 34 for the control-
injected mice, and in Table 35 for the 87V-injected mice. In the control 
animals, there was very little variation in the percentages of the 3 major 
isotypes. In those animals injected with 87V, there was an increase in the 
percentage of IgGl in parallel with a decrease in IgG2b, in the samples 
taken after day 252; IgG2a remained fairly constant (Table 35). The 
Results presented in Tables 34 and 35 were reorganised to produce 2 groups.
The first group contained all the samples up to and including those on day 
252, when there were no evident scrapie symptoms, and no serum IgG changes,
The second group included the samples taken between days 280 and 315 post 
inoculation, when serum IgG was significantly elevated and clinical 
symptoms were apparent (Table 36). Total serum IgG was the same in both 
groups of normal injected controls, as were the concentrations of IgGl and 
its percentage contribution to the total. However, for those mice injected 
with the 87V strain of scrapie, total IgG rose by 50% and could be 
accounted for by the increase in IgGl ( from 28% to 43% of the total, Tables 
35 and 36). In mice injected with 22A-infected brain, there were no 
changes in the total IgG concentrations (Tables 37-39).
Thus it would appear that i.e. infection of Sinc^7 mice with the 
87V strain of scrapie resulted in increased levels of IgGl antibody, 
together with a lower percentage of IgG2b antibody. The mechanism by which 
this is achieved is not known, but may be caused by either an increased 
activity of some IgGl-secreting B cells with a suppression of lgG2b- 
secreting clones by specific T suppressor cells (Lowy et al, 1982), or by 
some preferential switching of IgG2b-secreting cells to secrete IgGl 
antibody instead (Sakano et al, 1980).
b) Isoelectricfocusing of IgG
Chromatographic separation of serum usually isolates IgG as a 
single protein peak, but isoelectricfocusing of this peak will result in a 
spectrum of bands representing the component proteins. Each protein will
TABLE 34 TOTAL IgG CONCENTRATION AND SUBCLASS DISTRIBUTION IN THE SERA OF
Sine MICE INJECTED WITH NORMAL BRAIN
DAYS POST 
INJECTION
TOTAL IgG* 
mg/lOOml SERUM 
mean+SEM (3 mice)
SUM OF 
IgGl+IgG2a+IgG2b 
mg/10Oml SERUM 
mean+SEM (3 mice)
PERCENTAGE OF 
IgGl + IgG2a + IgG2b 
mean (3 mice)
IgGl IgG2a IgG2b
28 760+20 750+0 21 18 61
224 483+17 480+15 20 21 59
252 482+17 446+24 24 19 57
280 527+17 520+29 23 21 56
315 513+13 505+9 24 16 60
—3
+ Each mouse received.^. 025ml intracerebrally of 10 homogenate (unspun)
of uninfected Sinc^ brain. All mice were IM O.
* Data taken from Table 5, section 3.1.
TABLE 35 TOTAL IgG CONCENTRATION AND SUBCLASS DISTRIBUTION IN THE SERA OF 
Sine MICE INJECTED WITH 87V STRAIN OF SCRAPIE +
DAYS POST 
INJECTION
TOTAL IgG* 
mg/lOOml SERUM
SUM OF 
IgGl+IgG2a+IgG2b
PERCENTAGE OF 
IgGl + IgG2a + IgG2b 
mean (3 mice)
mean+SEM (3 mice) IgGl IgG2a IgG2b
28 600+60 600+23 29 21 50
224 580+20 5 +70 28 18 54
252 527+13 510+51 29 18 53
280 725+48 710+40 43 17 40
315 780+20 790+39 44 12 44
Each mouse received 
of clinically-affected
—3
0.025ml intracerebrally of 10 homogenate (unspun) 
 87V Sinc^ brain. All mice were IM O.
* Data taken from Table 5, Section 3.1.
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TABLE 37 TOTAL IgG CONCENTRATION AND SUBCLASS DISTRIBUTION IN THE SERA
OF SINC MICE INJECTED WITH NORMAL BRAIN
PERCENTAGE OF
DAYS POST TOTAL IgG$ SUM OF IgGl + IgG2a + IgG2b
INJECTION mg/100ml SERUM IgGl+IgG2a+IgG2b mean (3 mice)
mean+SEM (3 mice) mg/lOOml SERUM 
mean+SEM (3 mice) IgGl IgG2a IgG2b
28
252
287
308
350*
385**
495+45 490+30 
394+32 390+32 
396+73 390+50 
467+13 436+19 
N/A N/A 
410+30 4-00+40
27
28
29 
25
30
21 52
22 49 
15 55 
20 54
22 48
+ Each mouse received 0.025ml ^ntracerebrally of 
(unsound of uninfected Sinc^ brain. All mice
10"3
were
homogenate
$ Data taken from Table 8, Section 3.1
*
**
1 animal
2 animals
TABLE 38 TOTAL IgG CONCENTRATION AND SUBCLASS DISTRIBUTION IN THE 
Sine MICE INJECTED WITH 22A STRAIN OF SCRAPIE
SERA OF
DAYS POST 
INJECTION
TOTAL IgG$ 
mg/100ml SERUM 
mean+SEM (3 mice)
SUM OF 
IgGl+IgG2 a+1gG2b 
mg/lOOml SERUM
PERCENTAGE OF 
IgGl + IgG2a + IgG2b 
mean (3 mice)
mean±SEM (3 mice) IgGl IgG2a lgG2b
28 533+27 530+65 26 19 55
252 470+30 457+18 26 16 59
287 * 410+17 405+30 29 22 48
308 500+0 498+21 26 15 59
350 598+69 580+86 26 11 63
385 460+23 428+18 31 19 50
     ------------
t Each mouse received 0.025ml intracerebrally of 10 homogenate
(unspun) of clinically-affected 22A Sinc^ brain. All mice were IM O.
$ Data taken from Table 8, Section 3.1.
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migrate to (i.e. 'focus’) and precipitate at its isoelectric point (pi). 
Therefore it is possible with this technique to distinguish between a 
monoclonal response (when only one IgG protein is altered), an oligoclonal 
response (when up to 8 component IgG proteins are altered), and a 
polyclonal response (when more than 8 proteins are altered).
Total IgG (excluding IgG3) was isolated by affinity chromatography 
on a Protein A-Sepharose column from the sera of 3 groups of IM mice 
(Sinc^7 ); those clinically affected with the 22A strain of scrapie; those 
clinically-affected with the 87V strain of scrapie, and age-matched 
uninjected controls. After dialysis, the volumes of the solutions were 
adjusted to give the original concentrations of each protein sample in 
serum. Analyses of the 3 total IgG fractions by isoelectricfocusing on 
standard polyacrylamide gels (pH range 3.5 to 9.5) are shown in Figure 12. 
In all 3 samples, the range of the observed bands was identical,pi spread 
of 5.0 to 7.7; the only differences appeared to be in terms of their 
original concentrations in the sera. There was no evidence of any 
monoclonal or oligoclonal stimulation in either of the two scrapie- 
infected groups, compared with controls. Hence there would appear to be a 
generalised polyclonal activation of B cells in the 87V-infected mice, 
resulting in an identical spectrum of bands, compared to those in the sera 
of the 22A-infected mice, and the uninjected animals. The significance of 
these results will be discussed later.
c) Tests for polyclonal expansion of splenic lymphocytes 
A polyclonal expansion of some splenic lymphocytes during infection 
of Sincp7 mice with the 87V strain of scrapie is suggested by the results 
in Section 3. and above (4.2.2), but this conclusion did not seem to be 
supported by the data obtained from lymphocyte transformation assays 
carried out to study the effect lipopolysaccharide (LPS) has on B cells 
from control and 87V-infected mice at 30 and 54 weeks post injection; there
Figure 12 Isoelectric spectra of IgG from 87V-infected (a), 22A-infected 
(b) and uninjected (c) Sinc^7 (IM) mice.
( ^  samples at half concentration).
was no difference in the stimulation indices (SI) of the scrapie-injected 
animals, compared to their controls (Tables 40 and 41 respectively). Nor 
was there any increase in the lymphocyte count per spleen during infection 
with 87V at 4 (Table 56), 30 (Tables 40b and 64) and 54 (Tables 41b and 74) 
weeks post injection. However, LPS does not stimulate all B cells so there 
might well be changes in other subpopulations of splenic B cells which were 
undetected.
Similarly, lymphocyte transformation assays were used to study the
effect T cell mitogens (Con A and PHA) had on splenic lymphocytes at 30 and
54 weeks post injection, and the results are given in Tables 40b and 41b.
The experiment with Con A at 30 weeks post injection has been omitted from
this section because no stimulation of the cells occurred. Hence PHA was
3the only stimulator of T cells used. The overall uptake of H-Thymidine 
(Tables 40a and 41a) is expressed as stimulation indices to allow for 
animal to animal variation. On this basis, there were no differences 
between the two groups of animals in their response to PHA. However, at 54 
weeks post injection, the stimulation by both T cell mitogens, PHA and Con 
A, was reduced by 52.4% and 51.5% respectively in the scrapie-injected 
mice, compared to controls. This suggests a dysfunction in one or more 
subpopulations of T cells which, if they function as T suppressor cells, 
may contribute to the increased IgG secretion by B cells.
TABLE 40(a) LYMPHOCYTE TRANSFORMATION ASSAYS OF 87V-INJECTED AND CONTROL
Sine** MICEj 30 WEEKS POST INOCULATION
GROUP LYMPHOCYTE CELL 
COUNT/CULTURE 
(X10 )
UPTAKE OF H—THYMIDINE BY CELLS 
FOLLOWING STIMULATIONS (CPM) 
MEAN + SEM X 10 (4 ASSAYS)
NONE PHA LPS
NBr 1 6.0 13.3+0.7 86.9+6.4 32.3+1.4
2 4.8 11.3+1.1 89.3+3.5 43.9+3.4
3 5.0 11.7+1.0 75.6+0.9 39.4+2.6
t87V 1 6.4 10.8+0.7 7 9.0+4.2 31.7+1.0
2 6.2 8.2+0.4 84.9+7.2 41.2+1.6
3 6.9 10.4+1.1 66.1+4.3 30.6+1.5
4 7.0 15.2+0.5 43.4±3 .0 31.2+3.5
5 5.3 4.6+0.3 18.7+0.7 6.2+0.6
6 5.6 9.9+0.3 46.6+3.7 26.9+4.4
—3
+ Each animal received 0.1ml i^traperitoneally of 10 homogenate
(unspun) of uninfected Sincp brain. All mice were age and sex-matched 
with the scrapie-injected group.
—3
t Each animal received 0.1ml intraperitonea^ly of 10 homogenate
(unspun) of clinically affected 87V Sinc^ brain. Mice used were 
Sincr (IM)^)
$ See Material and Methods, section for stimulation regimes for the 2 
mitogens used.
TABLE 40b STIMULATION INDICES* FOR LYMPHOCYTE TRANSFORMATION ASSAYS OF
87V-INJECTED AND CONTROL Sine** MICE, 30 WEEKS POST INOCULATION
MITOGEN TOTAL NUMBER OF 
LYMPHOCYTES/
GROUP PHA LPS SPLEEN (X 10 )
NBr 1 6.7 2.4 4.5
2 6.3 3.9 3.6
3 7.2 3.4 3.75
mean + SEM 6.7+0.2 3.2+0.4 3.95+0.3
87V 1 6.6 2.9 4.77
2 6.9 5.1 4.65
3 6.3 3.0 5.2
4 3.5 2.1 5.2
5 5.9 1.3 3.94
6 4.7 2.7 4.2
mean + SEM 5.7+0.5 2.9+0.5 4.66+0.2
For calculation of stimulation indices, see Materials and 
Methods, Section 2.4
TABLE 41b STIMULATION INDICES* FOR LYMPHOCYTE TRANSFORMATION ASSAYS OF
87V-INJECTED AND CONTROL S i n /  MICE, 54 WEEKS POST INOCULATION
GROUP
PHA
MITOGEN 
CON A LPS
--—  TOTAL NUMBER OF
LYMPHOCYTES/ 
SPLEEN (X 10 )
$
NBr. 1 11.8 6.3 1.1 6.23
2 23.4 10.7 4.1 6.0
3 15.5 13.4 1.8 3.53
mean + SEM 16.9+3.4 10.1+2.0 2.3+0.9 5.23+0.9
87V 1 7.9 • 5.5 2.0 7.05
2 2.4 3.8 2.4 6.16
3 6.8 3.7 3 .8 5.55
4 13.5 9.1 2.8 4.05
5 9.9 4.4 2.3 3.71
6 7.7 3.0 1.3 5.37
mean & SEM 8.0+1.5** 4.9+0.9* 2.4+0.3 5.32+0.5
+ For calculation of stimulation indices, see materials and methods
Section 2.4
$ NBr = Normal brain injected.
Significance (t.test) * p<.05; **p<.02
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5 INVESTIGATIONS INTO THE IMMUNOLOGICAL CONSEQUENCES OF INFECTION OF 
SincP7 MICE (IM^ WITH 87V STRAIN OF SCRAPIE
Introduction
s7The scrapie model most widely studied at Compton used Sine mice 
(Compton Whites (CW)), and consequently, there is much background 
information on the biochemical and physiological characteristics of this 
mouse strain. However there is little immunological information on CW mice 
and none on IM mice. It was therefore important that data on normal 
immunological reactions should be established before testing immune 
responsiveness during scrapie infection. The need for such information 
became evident from the early experiments, which showed that IM mice do not 
respond to some immunological stimuli in the expected manner, and 
comparative studies with CW mice have been included to illustrate some of 
these differences.
5.1 Immunological Baseline Data For uninfected Sinc^7 Mice (IM^
a) Investigation into the primary response to sheep red blood
cells
7
A group of IM mice were stimulated intraperitoneally with 2x10 
washed sheep red blood cells, and sampled at intervals over a 14 day 
period. The number of spleen cells actively secreting antigen-specific IgM 
or IgG antibody are given in Table 42, and the same data are shown 
graphically in Figure 13; both show that IgM-plaque forming cells (PFC) 
were first evident on day 2, and that very low numbers of these cells were 
maintained over the 14 day period. There appeared to be two peaks of IgG- 
PFC, one detectable on day 7, and a second smaller peak on day 11. This 
result was unexpected and suggested that there may be two populations of IM
42 
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mice which differed in their primary IgG response to sheep erythrocytes.
Comparative studies with CW mice are given in Table 43. CW showed 
a higher IgM-PFC response on day 5, followed by a gradual decline, with the 
switch to IgG-secreting cells occuring between day 5 and 6, and the IgG 
response was maximal on day 11 (Table 43 (a )). Thus CW mice produced the 
Expected primary response to sheep red cells. IM mice again showed a low 
IgM response (Table 43 (a) and (b). By day 11, the IgM response in one 
group of IM mice could not be detected (Table 43 (a)) and was very low in 
the second group (Table 43 (b)), whilst the IgG response was beginning by 
day 5 (Table 43 (a)) and showed a second increase in the number of IgG- 
secreting cells by day 13. This again indicated that there might be two 
populations of IM mice, which differ in the timing of their IgG response. 
These two groups appear to be different from the 'high' and 'low' responder 
mice reported by Biozzi et al (1972), where the response occurred at the 
same time, but at different levels.
b) IgG responses following stimulation with ovalbumin
An initial experiment (not shown) involved stimulating 6 IM mice 
intraperitoneally with lOOug ovabumin in complete Freund's adjuvant (CFA), 
followed by a second, identical, i.p. injection 21 days later. The animals 
were killed after a further 5 days. Only 2 mice responded, as judged by 
double diffusion tests, and these had very low levels of antibody (1/5 and 
1/10). The stimulation regime was changed to that shown in Scheme 1, and 
included one group of mice which received the second antigen challenge 
intravenously (iv). Both IM and CW mice were tested.
All the CW mice which received the second injection of ovalbumin by 
the iv route died within minutes of the injection probably due to 
anaphylaxis, as did 2 mice from the group which received the second dose of 
antigen in incomplete Freund's adjuvant (IFA) by the subcutaneous route. 
However, the remaining 4 animals had very high titres of antibodies. In
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SCHEME 1. OVALBUMIN STIMULATION REGIMES FOR UNINFECTED Sine**7 MICE (IM^ 
AND Sine MICE (C.W. )
6
OVALBUMIN ( 50jjg) 
5 DAYS
I
SAMPLED
24 MICE
OVALBUMIN + CFA (lOOjug) s.c. route 
28 DAYS
12
i.V. SAMPLED OVALBUMIN+IFA (lOOjjg) s.c.route
7DAYS
SAMPLED 28 DAYS
OVALBUMIN+IFA (50/ug ) 
s.c. route
7 DAYS 
SAMPLED
t Mice were either Sinc^7 (IM) or Sincs7 (C.W. )
Control mice received saline instead of ovalbumin solution
contrast, the IM mice did not respond to the second antigen injection, 
using either the s.c. route or the i.v. route, but after the third s.c. 
injection, the last 6 mice had very low levels of antibodies. The levels 
of specific IgG antibodies produced after a third subcutaneous injection of 
ovalbumin (in IFA) for both CW and IM mice are given in Table 44, CW mice 
produced high levels of ovalbumin- specific antibodies which were almost 
exclusively of the IgGl subclass. In contrast, IM mice had very low 
levels of specific antibody (9.4+0.7 yig/ml serum), and these were not 
exclusively of one subclass. From these results, it can be concluded that 
IM mice do not respond as well to ovalbumin as CW mice, nor is the response 
exclusively of one subclass, and this will be discussed later.
c) IgG responses following stimulation with keyhole limpet 
haemocyanin
From the result obtained using ovalbumin as the antigen, a similar 
regime (see Scheme 1) was used for stimulating both CW and IM mice with 
keyhole limpet haemocyanin (KLH), but using only the subcutaneous route. 
Table 45 and 46 show the responses of both mouse strains 7 days after the 
second and third injections. After 2 injections (Table 45) the levels of 
specific antibodies were similar in both mouse strains, although those 
produce by CW mice were almost exclusively of the IgGl subclass, whilst IM 
mice produce antibodies of both major subclasses. Following the third 
subcutaneous injection (Table 46), IM mice produced higher levels of KLH- 
specific antibody (2346+840 jig/ml serum) than CW mice (1040+148 jig/ml 
serum), and again were of both major subclasses, whilst those produced by 
CW mice were restricted to the IgGl subclass. The results therefore show 
that IM mice respond better to KLH than CW but the response is not 
restricted to one subclass.
TABLE 44. IgG RESPONSES OF UNINFECTED SincP7 (IM) AND SincS? (CW) MICE
FOLLOWING STIMULATION WITH OVALBUMIN +
MOUSE
STRAIN
TREATMENT OF
INDIVIDUAL
MICE
jag ANTIGEN-SPECIFIC 
ANTIBODY/ml SERUM
IgGl IgG2
%
IgGl
OF TOTAL 
IgG2
IM SALINE 0 0 - -
IM STIMULATED 1 12 1 92 8
2 9 7 56 43
3 8 1 89 11
4 10 5 67 23
5 8 1 89 11
mean+SEM 9.4+0.7 3+1.3
CW SALINE 0 0 —
CW STIMULATED 1 848 7 99 1
2 280 5 98 2
3 671 1 99 1
4 560 4 99 1
5 576 4 99 1
mean + SEM 557+92 4.2+1.0
+ See scheme 1 for stimulation regime. Data given for mice following
third s.c. injection of ovalbumin in IFA.
TABLE 45 IgG RESPONSES OF UNINFECTED Sinc^7 (IM) AND SincS7 (CW) MICE
FOLLOWING A SECOND INJECTION OF KEYHOLE LIMPET HAEMOCYANIN+
MOUSE
STRAIN
TREATMENT OF
INDIVIDUAL
MICE
fiq ANTIGEN-, 
ANTIBODY/ml 
IgGl
SPECIFIC
SERUM
IgG2
% OF
IgGl
TOTAL
IgG2
IM SALINE 0 0 - -
IM STIMULATED 1 176 48 79 21
2 248 43 85 15
3 208 32 87 13
4 *■ 200 17 92 8
5 106 26 90 10
mean+SEM 188+23 33+6
CW SALINE 0 0 - -
CW STIMULATED 1 192 4 98 2
2 212 10 95 5
3 100 4 96 4
4 98 2 98 2
5 76 2 97 3
mean + SEM 136+28 4.4+1.5
+ See scheme 1 for stimulation regime. Data given for mice following
2nd s.c. injection of KLH in IFA.
TABLE 46 IgG RESPONSES OF UNINFECTED SincE>7 (IM) AND SincS? (CW) MICE
FOLLOWING A THIRD INJECTION OF KEYHOLE LIMPET HAEMOCYANIN+
MOUSE
STRAIN
TREATMENT OF
INDIVIDUAL
MICE
^g ANTIGEN-, 
ANTIBODY/ml 
IgGl
SPECIFIC
SERUM
IgG2
%
IgGl
OF TOTAL 
IgG2
IM SALINE 0 0 - -
IM STIMULATED 1 5120 832 86 14
2 3200 800 80 20
3 592 12 98 2
4 640 29 96 4
5 2180 80 96 4
mean+SEM 2346+850 351+190
CW SALINE 0 0 - • -
CW STIMULATED 1 928 59 94 6
2 800 17 98 2
3 960 13 99 1
4 1472 91 94 6
mean + SEM 1Q40+149. 45+19
+ For stimulation regime, see scheme 1. Data given for mice following
3rd s.c. injection of KLH in IFA.
d) IgG responses following stimulation with lipopolysaccharide 
Lipopolysacoharide (LPS) is a polyclonal B cell activator, but
using the protocol described in Section 2.6. it can be used to elicit a 
response which is restricted to antibody of IgG3 subclass. As can be seen 
in Table 47, no antibody of IgGl or IgG2 subclass directed specifically 
^against LPS could be demonstrated, only antibody IgG3 subclass was 
detected. Although the titre of this specific antibody was low (1/5-1/10), 
it was possible to quantify this response to LPS because of the sensitivity
r
of the ELISA test used. All 5 stimulated IMmice responded to the antigen, 
producing similar levels of antibody (range 10-21 ng/ml serum). A parallel 
experiment using CW mice was not undertaken.
e) Rosetting of lymphocytes with antibody-coated sheep 
erythrocytes
An initial experiment (Table 48) used two groups of IM mice. Group 
1 contained 6 females (8 weeks old), and group 2 had 3 mature males (>16 
weeks old). There was no difference between the two groups in the number 
of lymphocytes per spleen. However, based on the percentage of lymphocytes 
which formed rosettes with sheep erythrocytes coated with anti-sheep red 
blood cell IgG antibody, it was possible to identify two populations of 
animals. One group (5 mice) had a higher percentage of rosette-forming 
cells (RFC), 11.9+0.4% compared with the remaining 4 animals (6.8+0.3%). 
There appeared to be no effect of age on the differences between the two 
groups of mice. A second experiment, using 10, 8-week old female IM mice 
(Group 3, Table 48) was undertaken to investigate this further. Four of 
the 10 mice had a low percentage of RFC (5.7+0.4%), and the remaining 6 
mice had a higher percentage of RFC (12.5+0.4%) the difference between the 
two groups of data is statistically significant (P<.001), thus confirming 
the initial observation of distinct populations of mice. The lymphocyte 
counts per spleen for the 8 mice with the low percentage of RFC
TABLE 47 IgG RESPONSES OF UNINFECTED Sinc^7 MICE (IM) TO STIMULATION 
WITH LIPOPOLYSACCHARIDE
TREATMENT OF
INDIVIDUAL
MICE
na ANTIGEN-SPECIFIC ANTIBODY/ml SERUM
IgGl IgG2(a+b) IgG3*
SALINE 0 0 0
STIMULATED 1 0 0 19
2 0 0 13
3 0 0 10
4 0 0 21
5 0 0 15
mean±SEM 15.6±2.0
+ Stimulation regime for LPS/ Section 2.6.
For assesment of IgG3 specific antibodies, Section 2.4.
TABLE 48 ROSETTING OF LYMPHOCYTES FROM UNINFECTED SincP? MICE (IM) WITH 
ANTIBODY-COATED SHEEP ERYTHROCYTES
GROUP INDIVIDUAL
NUMBER
LYMPHOCYTES/SPLEEN 
( X I O  )
% LYMPHOCYTES OCCURING 
AS ROSETTES 
mean ± SEM (3 ASSAYS )
1*
2
3*
4
5
6
mean+SEM
4.88
5.03
6.60
5.85
3.98
5.55
5.32+0.4
6.9+1.0 
12.1+1.4 
6.6+0.7 
11.7+1.3 
12.4+0.9 
10.6+0.8
mean+SEM
1
2*
3*
4.98
4.73
6.45
5.38+0.5
12.5+0.6 
7.3+0.5 
6.6+0.6
1*
2
3*
4*
5*
6
7
8 
9
10
mean+SEM
7.73 
6.45
4.73 
7.13 
5.75 
4.28 
4.50 
4.05 
5.85 
6.68
5.72+0.4
4.0+0 
10.9+1.0 
5.7+0.6 
7.6+0.1 
5.3+0.7 
13.5+0.6 
12.9+0.5 
13.6+1.4 
11.4+0.3 
12.6+0.8
Age ranges Group 1 
2 
3
8 week old females 
16 week old males 
8 week old females
Mice identified as having low percentage of rosette-forming lymphocytes
7. (6.0+0. 4x10 ) were similar to those for the 11 mice with the high
7
percentage of RFC (5.2+0.3x10 ). Therefore it would appear that this 
phenomenon of mice with high and low percentages of lymphocytes bearing Fc 
receptors (i.e. RFC) is not related to differences in the numbers of 
lymphocytes per spleen; it presumably reflects other differences in the 
mouse population.
t
f) Lymphocyte transformation assays
These experiments used lipopolysaccharide (LPS) as a polyclonal B 
cell mitogen, and concanavalin A (Con A) and phytohaemagglutinin (PHA) as 
potent T cell mitogens. The results from these lymphocyte transformation
3
assays, expressed as the uptake of H-Thymidine are given in Table 49.
3
There appeared to be considerable variation in the incorporation of H- 
Thymidine by the unstimulated spleen cells (approx 106 cells). To correct 
for any contribution to this variation by slight differences in the numbers 
of spleen cells from individual mice used in the assays, the effect of each 
mitogen was expressed as a stimulation index (Section 2.4.), as shown in 
Table 50. The stimulation indices with LPS ranged from 3.8 to 6.6 for the 
six age and sex-matched IM mice. However, there appeared to be two 
populations of mice, with ranges of 3.8 to 4.9 (4 animals) and 6.0 to 6.6 
(2 mice), but the number of animals used was too small to draw any firm 
conclusions. Since LPS is known to stimulate only 30% of splenic B cells 
(Andersson et al 1977), it is also possible that the actual numbers of 
potential LPS-responding cells may vary from mouse to mouse.
Con A and PHA, although both T cell mitogens, are known to 
stimulate different subsets of T cells and the same was found in this work.
For example one animal, number 1, had the same stimulation index (SI) for 
both mitogens, the other 5 mice had S.I for Con A of 34-72% of those for 
PHA. PHA had a strong mitogenic effect on the T cells of 4 of the 6 mice,
TABLE 49 LYMPHOCYTE TRANSFORMATION ASSAYS FOR UNINFECTED Sine**7 MICE (IM)
UPTAKE OF 3H-THYMIDINE BY CELLS FOLLOWING STIMULATION4" (cpm) 
INDIVIDUAL mean+SEM x 10 (4 ASSAYS)
ANIMALS -- ----------------------- -------------------------------------
NONE PHA CON A LPS
1 1.3+0.2 9.9+0.9 8.9+1.5 5.1+0.3
2 4. 0±0.6 35.0+3.5 12.4+0.6 15.2±0.7
3 2.6+0.2 67.6+2.9 23.1+3.6 16.9+0.8
4 2.9+0.7 76.9+8.1 55.6+4.5 17.0+2.1
5 1.6+0.04 47.2+2.8 31.3+2.1 7.6+1.0
6 3 . 2±0.2 73.8+1.4 39.9+2.2 13.1±0.2
+ See Section 2.6 for stimulation regimes for the 3 mitogens used.
TABLE 50 STIMULATION INDICES* IN LYMPHOCYTE TRANSFORMATION 
ASSAYS FOR UNINFECTED Sincff MICE (IM)
INDIVIDUAL
ANIMALS
PHA
MITOGEN 
CON A LPS
1 7.5 6.7 3.9
2 8.7 3.7 3.8
3 26.4 9.0 6.6
4 27.3 19.7 6.0
5 30.4 12.1 4.9
6 23.0 12.4 4.1
* For calculation of stimulation indices, see section 2.4.
whilst Con A showed a similar effect with spleen cells from 3 of the same 4 
mice.
g) Serum IgG levels in uninfected IM mice 
The serum IgG levels of IM mice sampled at 28 day intervals from 56 
days to one year of age, have been presented earlier (Table 4). It was 
found that the serum IgG levels remained surprisingly constant over the 300 
day period studied, whilst CW (Table 14) and C57BL/6 (Tables 15 and 16) 
both showed significant, age-related increases.
Conclusion
The data presented in this section indicate that IM mice show 
variation in their responses to some standard immunological tests, such as 
their primary response following challenge with sheep enythrocytes. The 
low, constant levels of serum IgG over a time period when other strains of 
mice show significant age-effect increases is unusual, and may indicate a 
general low level of immune responsiveness, consistent with the data 
showing low numbers of splenic lymphocytes with Fc receptors. By 
comparison with CW’s, IM mice have an enhanced response to some antigens, 
such as KLH, whilst that to ovalbumin is significantly reduced. Within 
this general framework, there also seems to be heterogeneity in certain 
responses within the IM population itself even though it is designated as 
inbred (i . e . brother x sister matings beyond 20 generations). This must be 
born in mind when interpreting the results presented in Section 5.2.
5.. 2 Investigations into the immune responsiveness of Sinc^7 mice (O O  
whilst incubating 87V strain of scrapie
Introduction
Data presented in Section 3.1 have shown that the incubation of the
87V strain of scrapie in Sincp7 . . .......r ---- mice is associated with increased levels of
serum IgG. This increase was detectable during the latter third of the
incubation period, following an intracerebral injection and before clinical
signs were apparent. These elevated levels were maintained as the animals
became terminally sick. However, the unexpected result was that increased 
*
levels of serum IgG were detected in mice which had been injected by the 
intraperitoneal route. These increased levels were detectable from week 48 
onwards after injection, and remained elevated thereafter although the 
animals showed no clinical signs of scrapie. Table 51 (Figure 7, ) 
summarises the timing of these increases in relation to route of injection 
and onset of clinical disease.
Pathogenesis studies on several models (Kimberlin, 1979b, 
Dickinson, 1979.) have shown that using a peripheral route of infection, 
agent undergoes an extraneural replication phase before it enters the CNS 
to cause disease. Section 3.2 shows that 87V replicates in spleen 
following an i.e. or an i.p. injection, even though it is almost certainly 
not necessary for clinical disease to occur in the former case, because 
clinical disease did not occur within the lifespan in the latter.
Therefore the increased levels of serum IgG in the 87V-infected IM mice 
seems to be a direct consequence of agent in spleen and presumably other 
lymphoid organs. This suggests that there could also be alterations in the 
immune responsiveness of the host as a result of scrapie infection.
Therefore a series of immune function tests were carried out at 3 
specified times after infection by the i.p. route. The sample times were 
based on the pattern of serum IgG changes. The first time was 4 weeks 
after injection; when a slight rise in serum IgG was sometimes evident; the 
second sample point was at 30 weeks post infection when serum IgG levels 
were unchanged, and the third point was at 54 weeks when the serum IgG 
levels were elevated, as compared with controls.
TABLE 51 TIMING OF SERUM IgG CHANGES IN Sinc^7 MICE (IM) INJECTED WITH
87V STRAIN OF SCRAPIE BY DIFFERENT ROUTES
DILUTION OF DAYS POST INJECTION DATA
ROUTE SCRAPIE ----------------------------------------------GIVEN
BRAIN ONSET OF ONSET OF TERMINATION
IgG DISEASE OF
INCREASES EXPERIMENT
i.e.
10-3 196 308 315 TABLE 1.i.e. 10_2 224 308 315 TABLE 5.
i.e. 10_3 252 287 294 TABLE 17.
i.p. 10_3 336 NO DISEASE 392 TABLE 18.
i.p.
10-2
365 NO DISEASE 560 TABLE 19.
i.p. 10 2 350 NO DISEASE 560 TABLE 20.
TABLE 52 SERUM IgG CONCENTRATIONS, 4 WEEKS AFTER INJECTION OF 87V—INFECTED 
OR CONTROL BRAIN.
GROUP NUMBER PER DAYS POST INJECTION mg IgG/lOOml SERUM
GROUP (mean ± SEM)
NBr. 5 29 225+15
87V t 9 29 320+28*
—3Each mouse received,^.lml intraperitoneally of 10 homogenate (unspun) 
of uninfected Sinc^ brain. All mice were age and sex-matched with the 
scrapie-injected group.
—3Each mouse received 0.1ml intraperitoneally of 10 homogenate (unspun) 
of clinically-affected 87V ^incr brain. All mice used 
were Edinburgh source Sinc^ (IM) O^and ^  (1:1 ratio)
Significance (t.test) * p<.05
5.2.1 Immune responsiveness of Sincr^7 mice (IEO 4 weeks post injection of 
87V strain of scrapie or normal brain
The series of experiments to be described below were carried out at 
the ARC and MRC Neuropathogenesis Unit, Edinburgh. The Sinc^7 mice used 
were IM's which had been derived and maintained at the Unit as an inbred 
colony, an earlier stock of which had been sent to the ARC'S Institute for 
Research on Animal Diseases, Compton, to provide animals for other research 
purposes and for much of the work in this thesis. Therefore it was assumed 
that the data obtained using the two different sources of IM mice and 
presented in Sections 5.2.2 and 5.2.3 would be comparable. However, this 
was not so and it became clear that the mice used at Compton for this work 
described in Sections 5.2.2 and 5.2.3 were different from those used in 
Edinburgh for Section 5.2.1. (see below). Because the number of mice 
available in Edinburgh was small, only a few immunological tests were 
carried out, based on the information already available from Sections 5.2.2 
and 5.2.3.
a) Serum IgG Concentrations
The concentrations of IgG in the sera of 9 mice infected 4 weeks 
earlier with 87V strain of scrapie were on this occasion significantly 
elevated (p<.05) compared with 5 normal brain-inoculated controls (Table 
52); on some previous occasions there was no change (Tables 18 and 19). 
Agent is known to be present in the spleen at this time (Section 3.2) and 
this increase in serum IgG may be as a direct consequence of its presence 
and possible replication in lymphoid tissue (Section 3.2.2).
b) Primary response to sheep erythrocytes
Both male and female IM mice were used, which had been inoculated 
intraperitoneally 4 weeks earlier with either 87V-infected Sinc^7 brain, or 
normal Sine**7 brain material.
Two groups of 12 IM mice were stimulated intraperitoneally with
7
2x10 washed sheep red cells, and sampled at 4, 7 and 11 days. Their
primary responses were determined by measuring the number of plaque-forming
cells (PFC) in the spleen which were secreting antibody of either IgM or
IgG class to SRBC and by measuring the levels of specific antibodies in the 
«
sera.
There was no difference in the primary IgM response between the two 
groups of mice (Table 53), but these responses were considerably lower 
compared to those of IM mice bred at Compton (Table 42, 58 and 68). As 
would be expected from this, the levels of circulating IgM antibodies were 
also low (data not show). The primary IgG response for both groups of mice 
were similar, but unusual in that the IgG-plaque forming cells evident on 
days 7 and 11 were numerous but so minute that the numbers given in Table 
53 are an underestimate. Although there were many small lymphocytes with 
specific IgG antibody on the surface, no circulating IgG antibody against 
SRBC was detected (data not shown) which was again unusual. Also, there 
were no differences in the numbers of spleen lymphocytes between the two 
groups of brain injected mice (Table 54).
In conclusion, there was no difference between the two groups of 
mice in their primary response to sheep red cells tested 4 weeks after 
injection of either 87V-infected or control brain. However, IM mice of 
Edinburgh Source appeared to be less responsive than Compton IM mice in 
this test.
c ) IgG responses following stimulation with ovalbumin
IM mice (Edinburgh source) produced low levels of IgG antibody in 
response to ovalbumin stimulation, (Table 55) although the levels were 
higher than those for Compton IM mice (Table 44). However, the group of 6 
mice that had been injected 4 weeks earlier with 87V-infected brain had a 
significantly increased IgGl response (p<.02), compared to the normal
53
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TABLE 54 SPLEEN LYMPHOCYTE, COUNT OF 87V-INFECTED OR CONTROL BRAIN 4 WEEKS
AFTER INJECTION
DAYS POST 
SRBC
GROUP NUMBER PER 
GROUP
LYMPHOCYTE COUNT PER?SPLEEN 
(mean + SEM x 10 )
CONTROL NBr. 
NBr+SRBC
1 3.13
4 4 4.53+0.5
87V+SRBC 4 3.56+0.5
7 CONTROL NBr. 1 3.06
NBr+SRBC 4 3.08+0.6
87V+SRBC 4 2.86+0.2
11 CONTROL NBr. 1 3.44
NBr+SRBC 4 3.72+0.3
87V+SRBC 4 4.16+0.5
—3
+ Each mouse received 0.1ml intraperitoneally of 10 (unspun)
homogenate of uninfected Sinc^ brain. All mice were age and 
sex-matched with the scrapie injected group.
—3
t Each mouse received 0.1ml intraperitoneallv7of 10 (unspun)
homogenate of clinically affecte^ 87V Sincr brain. All mice 
used were Edinburgh source Sinc^ (IM) cT’and o (1:1 ratio)
TABLE 55 IgG RESPONSES TO STIMULATION WITH OVALBUMIN, 4 WEEKS AFTER
INJECTION OF 87V-INFECTED OR CONTROL BRAIN.
ANIMAL TREATMENT ug ANTIGEN-SPECIFIC ANTIBODY/ % OF TOTAL
GROUP ml SERUM
IgGl IgG2 IgGl IgG2
4
+
NBr. UNSTIMULATED ND ND
(1-4)
NBr.+ STIMULATED . 1 5 ND 100 0
2 12 6 66 33
3 90 14 86 14
4 51 9 85 15
5 40 36 53 47
6 36 6 86 14
mean+SEM 39+12 14+6
87Vt UNSTIMULATED ND ND _ _
(1-4)
87Vt STIMULATED 1 270 90 75 25
2 68 6 92 8
3 150 51 75 25
4 220 60 79 21
5 43 31 58 42
6 110 14 89 11
mean+SEM 144+36* 42+13
—3
+ Each mouse received 0.1ml inj^rapertoneally of 10 homogenate
(unspun) of uninfected Sinc^ brain. All mice were age and sex-matched 
with the scrapie injected group.
—3
t Each mouse received 0.1ml intraperitoneally of 10 homogenate
(unspun) of clinically7affected 87V sinc^ brain. Mice used were 
Edinburgh source Sincr (IM) O^and (1:1 ratio).
ND None detected
Significance (t.test) * p<.02
brain-injected group (Table 55). The specific antibody produced was not 
restricted to one subclass, although the level of IgG2 antibodies was not 
statistically different from the control group. These results suggest that 
those animals injected with 87V strain of scrapie may have IgGl-secreting 
clones which are slightly more active.
d) Rosetting of lymphocytes with antibody-coated sheep 
erythrocytes •
The results presented in Table 56 show that there was no difference 
in the number of these rosette-forming cells within the two groups of 
treated mice, nor was there any significant increase in the number of 
spleen lymphocytes. However, the overall percentage of spleen cells 
capable of forming rosettes were much higher than was found with the 
Compton IM stock (Tables 64 and 73). The same IgG antiserum was used for 
these assays as well as those reported in (Tables 64 and 73). Hence the IM 
mice of Edinburgh origin appear to be slightly different from those 
maintained at Compton.
5.2.2 Immune responsiveness of Sinc^7 mice (IM^ 30 weeks post injection of 
87V strain of scrapie or normal brain
a) Serum IgG Concentrations
The concentrations of IgG in the sera of control and 87V-injected 
mice are given in Table 57. The results show that at 280 days post 
injection, when agent is present in spleen (Section 3.2), there were no 
differences between the two groups. This finding is consistent with other 
data from the same model (Tables 18-20, Section 3.1).
b ) Primary response to sheep red blood cells
An initial experiment (Table 42) in which uninjected IM mice were
TABLE 56 ROSETTING OF SPLEEN LYMPHOCYTES WITH ANTIBODY-COATED SHEEP 
ERYTHROCYTES, 4 WEEKS AFTER INJECTION OF 87V-INFECTED OR 
CONTROL BRAIN.
GROUP LYMPHOCYTE COUNT/SPLEEN 
( X 1 0 7 )
% LYMPHOCYTES OCCURRING 
AS ROSETTES 
mean ± SEM (3 ASSAYS)
NBr.+ ' 1 3.02 30.8
2 3.87 25.2
3 3.65 26.7
mean+SEM 3.51+0.3 27.5+1t1
87Vt 1 4.01 , 25.6
2 4.64 23.4
3 3.83 31.8
4 4.93 26.4
5 3.68 30.0
mean+SEM 4.22+0.2 27.4+1.0
—3+ Each mouse received 0.1ml intraperitoneally OF 10 homogenate
(unspun) of uninfected Sinc^ brain. All mice were age and sex-matched 
with the scrapie-injected group.
—3
t Each mouse received 0.1ml intraperitoneally of 10 homogenate
(unspun) of clinically affected 87V Sinc^ brain. All mice used 
were Edinburgh source Sinc^ (IM) O^and (1:1 ratio)
TABLE 57 SERUM IgG CONCENTRATIONS, 30 WEEKS AFTER INJECTION OF 
87V—INFECTED OR CONTROL BRAIN.
GROUP NUMBER OF ANIMALS mg IgG/lOOml SERUM
PER GROUP (mean + SEM)
NBr.* 6 662+22
87V 13 602+35
—3
+ Each mouse received 0.1ml intraperitoneally 10
homogenate (unspun) of uninfected Sincr brain. All 
mice were age and sex-matched with the scrapie-injected 
group
—3
t Each mouse received 0.1ml intraperitoneally 10
homogenate (unspun) of clinically-affected 87V Sincr 
brain. All mice used were Sine (IM) )^.
7
stimulated intraperitoneally with 2x10 washed sheep erythrocytes, showed a
small but detectable IgM response 4 days later, followed by two higher IgG
responses, at days 7 and 11. Accordingly these 3 times were selected as
there were insufficient mice to allow continuous sampling over a 14 day
period.
«
Table 58 shows that in animals inoculated with normal Sinc^7 brain, 
the maximum IgM response appeared on day 7 (not on day 4) and occurred at a 
higher level than in uninjected mice (Table 42). Thus the peak IgG 
response did not appear until day 11, and was again higher than in
i
uninjected IM mice (Table 42). Animals injected with 87V strain of scrapie 
showed a similar temporal pattern to their controls, but with a lower IgM 
response. On day 11 an IgG response could be detected in only one of the 
six mice, and in this animal, the response was low (Table 58). There was 
too high a number of non-responders in the scrapie-injected group (5 out of
6) on day 11 to be accounted for by incorrect inoculation of antigen. 
Therefore animals which had been injected intraperitoneally 30 weeks 
earlier with 87V strain of scrapie probably had a diminished IgM response 
to sheep red cells, or a reduced or delayed ability of lymphocytes to 
switch from IgM to IgG antibody secretion.
Table 59 gives the splenic lymphocyte counts for each of the 4 
groups of mice per sample point. There was a slight but consistent rise in 
lymphocyte numbers in those animals which had received normal brain 30 
weeks before being stimulated with sheep erthrocytes, compared with animals 
receiving red cells only. However, in the scrapie-injected groups, there 
was only a slight transient rise in lymphocyte numbers on day 7 in those 
animals which had received sheep erythrocytes. The smaller increase in 
lymphocyte number caused by SRBC in scrapie mice compared to controls is 
consistent with the reduced primary response of scrapie mice, as shown in 
Table 58.
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TABLE 59 PRIMARY RESPONSE TO SHEEP RED BLOOD CELLS, 30 WEEKS AFTER 
INJECTION OF 87V-INFECTED OR CONTROL BRAIN. SPLEEN 
LYMPHOCYTE COUNT.
DAYS POST GROUP 
SRBC*
NUMBER PER 
GROUP
LYMPHOCYTE C^UNT PER SPLEEN 
(mean+SEMxlO )
4 CONTROL NBr. 
NBr+SRBC . 
CONTROL 87V 
87V+SRBC
1
3
1
6
5.75
6.38+0.07
4.0
5.52+0.57
7 CONTROL NBr. ' 
NBr+SRBC 
CONTROL 87V 
87V+SRBC
1
3
1
6
5.63
6.42+1.29
5.38
7.57+0.94
11 CONTROL NBr. 
NBr+SRBC 
CONTROL 87V 
87V+SRBC
1
3
1
6
5.63
6.79+1.89
4.50
4.19+0.39
+
—3
Each mouse received 0.1ml intraperitoneally of 10 homogenate 
of uninfected Sincr brain. All mice were aae and sex-matched 
scrapie-injected group.
(unspun) 
with
t Each mouse received 0. 
of clinically-affected 
were Sinc^ (IM}^>.
—3
1ml intraperitoneally of 10 homogenate 
87V Sincr brain. All mice used
(unspun)
*SRBC Sheep red blood cells.
c) IgG responses following stimulation with ovalbumin
Mice inoculated with normal brain homogenate and stimulated with 
ovalbumin showed the expected low levels of antigen-specific antibody 
(7.53+0.72 yg ml 1 serum) which were mainly of the IgGl isotype (Table 60); 
they responded similarly to the injected group of IM mice (Table 44). In 
contrast, the 6 mice injected with scrapie showed a significant elevation 
(P<.01) in the level of specific antibodies (25.1+5.3pg ml 1serum)/ which 
were predominantly of the IgGl subclass. Thus there is evidence that 
animals injected with 87V strain of scrapie have the potential to produce 
more IgGl in response to a specific stimulus.
d) IgG responses following stimulation with keyhole limpet 
haemocyanin
Data given in Table 61 show the IgG subclass responses in control 
and scrapie-injected mice to keyhole limpet haemocyanin. The total IgG 
response of the scrapie-injected group was slightly higher (1712+328 pg ml 
■^serum) that of the control animals (1278+416 jug ml 1 serum). There was a 
32% increase in the IgGl-specific antibody produced by the scrapie-infected 
mice compared with controls (Table 61). There was also a slight, but not 
significant, increase in IgG2 antigen-specific antibodies. These data 
complement those for the ovalbumin stimulation experiments (see above) and 
support the idea that there may be an increase in the activity of some 
IgGl-secreting cells as a consequence of 87V-infection.
Evidence that some, but not all IgGl-secreting cells may be more 
active during 87V-infection can be further substantiated by reanalysis of 
the data from Table 61 and Table 46. For the uninjected IM mice it was 
possible to classify the IM mice in their responses to KLH, as high or low 
IgGl producers (Table 62). In the 'high producers' group, those animals 
injected with either source of brain material had somewhat lower IgGl 
levels than those measured for the untreated mice. However, within the low
TABLE 60 IgG RESPONSES TO STIMULATION WITH OVALBUMIN, 30 WEEKS AFTER 
INJECTION OF 87V—INFECTED OR CONTROL BRAIN.
ug ANTIGEN-SPECIFIC 
ANIMAL TREATMENT ANTIBODY/ml SERUM % OF TOTAL
GROUP OF INDIVIDUAL--------- -------------------— ^ — --- ---------------
MOUSE IgGl IgG2 IgGl IgG2
NBr ’ UNSTIMULATED 0 0 -
NBr STIMULATED 1 9.4 • 0.7 94 6
2 9.0 0.6 94 6
3 6.0 0.7 89 11
4 - 6.0 0.7 90 10
5 8.0 0.7 92 8
mean+SEM
6 5.0
7.23+0.72
0.5
0.6+0.03
91 9
+
87V UNSTIMULATED 0 0 - -
87V STIMULATED 1 38.4 1.1 97 3
2 44.0 2.2 95 5
3 23.0 1.5 94 6
4 13.0 0.5 96 4
5 19.0 0.4 98 2
mean+SEM
6 13.3
25.1+5.3*
0.4
1.0+0.3
97 3
—3+ Each mouse received 0.1ml in^raperitoneally of 10 homogenate
(unspun) of uninfected SincP brain. All mice were age and sex-matched 
with the scrapie-injected group.
—3
t Each mouse received 0.1ml intraperitoneal^y of 10 homogenate
(unspun) of clinically-affected 87V Sdjicp brain. Mice used were 
Sincr (IM) (£.
Significance (t .test) *p<.01
TABLE 61 IgG RESPONSES FOLLOWING STIMULATION WITH KEYHOLE LIMPET
HAEMOCYANIN, 30 WEEKS AFTER INJECTION OF 87V-INFECTED OR CONTROL 
BRAIN.
ug ANTIGEN-SPECIFIC
ANIMAL TREATMENT ANTIBODY/ml SERUM % OF TOTAL
GROUP OF INDIVIDUAL 
MOUSE IgGl IgG2 IgGl IgG2
“1"
NBr UNSTIMULATED 0 0 - -
NBr STIMULATED 1 2650 260 91 9
2 370 30 93 7
3 2050 140 94 6
4 640 120 84 16
5 580 80 89 11
6 600 150 80 20
mean+SEM 1148+390 130+32
t
87V UNSTIMULATED 0 0 - -
87V STIMULATED 1 1420 250 85 15
2 1520 230 87 13
3 1420 380 79 21
4 520 30 95 5
5 2800 250 92 8
6 1400 50 97 3
mean+SEM 1513+298* 198+55
— 3
+ Each mouse received 0.1ml intraperitoneally of 10 homogenate (unspun)
of uninfected Sincr brain. All mice were age and sex-matched with the 
scrapie-injected group.
—3t Each mouse received 0.1ml intraperitoneally of 10 homogenate (unspun)
of clinically-affected 87V Sincr brain. Mice used were Sincr (IM) )^.
Significance (t.test) *p<.01
TABLE 62 IgGl SPECIFIC RESPONSES TO KEYHOLE LIMPET HAEMOCYANIN
KLH RESPONSE
P9 IgGl ANTIBODY/ML SERUM 
(mean+SEM (n MICE)
UNTREATED* NORMAL BRAIN 
INJECTED
87V-BRAIN
INJECTED
HIGH 3500+862 2350+30 2800
(3) (2) (1)
LOW 616+24 548+30 1256+185*
(2) (4) (5 >
* Data taken from Table 46, Section 5.1.
t
+ Data taken from Table 61, Section 5.2.2
Significance (t.test) * p<.02
IgGl producers group, the 87V-injected mice had significantly elevated 
levels (P<.02) of IgGl (1256+185 pg ml 1 serum) compared with both the 
normal brain-injected controls (548+30 pg ml 1 serum) and the untreated 
mice (616+24 jig ml 1 serum).
e) IgG response following stimulation with lipopolysaccharide
IM mice, injected with normal.brain, or brain from a clinical case 
of 87V scrapie, and then stimulated with lipopolysaccharide, produced 
antigen specific IgG antibodies, as shown in Table 63. Antibodies of IgGl 
or IgG2 subclasses were not detected in either group of animals, hence 
those detected were probably of IgG3 subclass. The levels of antigen 
specific antibodies were lower, but not significantly so, in those animals 
injected with 87V scrapie (34+3ng ml 1 serum) compared with normal brain- 
injected controls (43+2ng ml ^serum).
f) Rosetting of lymphocytes with antibody-coated sheep 
erythrocytes
From Table 64, it can be seen that there was no difference in 
spleen lymphocyte numbers between the two groups of inoculated mice. 
Studies of the percentage of lymphocytes forming rosettes with antibody- 
coated sheep erythrocytes showed that both groups could be divided into 
high or low producers of rosettes (Table 65). There was no difference 
between the two inoculated groups in the percentage of rosette forming 
cells (RFC) in the high producers (12.5% in the controls, compared to 12.2% 
in the infected group). However, in those animals with low percentage of 
splenic RFC, the 87V-injected animals showed an increase in the numbers of 
cells capable of forming rosettes (7.49+0.5%) compared with control mice 
(4.79+0.5%), significant at p<.05. Thus there may be a slight increase in 
the number of cells with certain Fc receptors in 87V-infected animals at 30 
weeks post injection.
TABLE 63 IgG RESPONSES FOLLOWING STIMULATION WITH LIPOPOLYSCACCHARIDE, 30 
WEEKS AFTER INJECTION OF 87V—INFECTED OR CONTROL BRAIN.
ANIMAL
GROUP
TREATMENT 
OF INDIVIDUAL 
MOUSE
ng ANTIGEN-SPECIFIC 
ANTIBODY /ML SERUM
+
NBr UNSTIMULATED ND
NBr STIMULATED 1 45
2 36
3 41
4 42
5 46
6 , 48
mean+SEM 43+2
t87V UNSTIMULATED ND
87V STIMULATED 1 33
2 19
3 30
4 40
5 41
6 48
mean+SEM 34+3
—3
+ Each mouse received,^.lml intraperitoneally of 10 homogenate (unspun)
of uninfected sinc^ brain. All mice were age and sex-matched with the 
scrapie-injected group.
—3
t Each mouse received 0.1ml intraperitoneally of 10 homogenate (unspun)
of clinically-affected 87V Sinc^ brain. Mice used were Sincr (IM) ^ ).
ND None detected
$ Antigen-specific antibody was not detected in either IgGl or IgG2
subclasses. Figures giy$n are those detected using antiserum 
against total IgG fraction.
TABLE 64 ROSETTING OF SPLEEN LYMPHOCYTES WITH ANTIBODY-COATED SHEEP 
ERYTHROCYTES, 30 WEEKS AFTER INJECTION OF 87V-INFECTED OR 
CONTROL BRAIN.
GROUP ANIMAL 
NUMBER
TOTAL NUMBER OF 
LYMPHOCYTES PER 
SPLEEN (X10 )
% LYMPHOCYTES OCCURRING AS ROSETTES 
mean + SEM (3 ASSAYS )
NBr+ 1 6.68 12.5+1.0$
' 2 6.58 5.3+0.4
3 5.70 4.3+0.4
mean + SEM 6.32+0.31
87V 1 5.63 5.8+0.2
2 4.58 13.2+1.2$
3 7.28 11.3+0.5$
4 6.30 7.0+0.5
5 6.08 7.5+0.8
6 5.33 8.9+0.3
7* 9.75 8.3+0.8
mean + SEM 6.42+0.64
3
+ Each mouse received O.lml intraperitoneally of 10- homogenate (unspun)
of uninfected Sincr brain. All mice were age and sex-matched with the 
scrapie- injected group.
3
t Each mouse received O.lml intraperitoneally of 10- homogenate (unspun)
of clinically-affected 87V Sincr brain. All mice used 
were Sinc^ (IM) £>.
* Mouse had marked facial eczema.
$ Mice designated as high IgGl-producers.
TABLE 65 ROSETTING OF SPLEEN LYMPHOCYTES WITH ANTIBODY-COATED SHEEP 
ERYTHROCYTES; IDENTIFICATION OF 2 POPULATIONS OF RESPONDERS
% LYMPHOCYTES FORMING ROSETTES 
mean ± SEM (n MICE)
CONTROL INJECTED 87V—INJECTED
LOW ROSETTE-FORMING* 4.79+0.5 7.49+0.5*
MICE (2) (5)
HIGH ROSETTE—FORMING+ 12.5 12.22+0.9
MICE (1) (2)
+ Data taken from Table 64
Significance (t.test) * p<.05
g) Lymphocyte transformation assays
The results from these assays with Con A as the T cell mitogen and 
UPS as the B cell mitogen have been presented eleswhere (Table 40). There 
was no difference between the 87V-injected mice and their controls in their 
responses to either mitogen. However, as both mitogens stimulate only a 
proportion of the total T and B cell populations, there may be other 
changes which were not detected. There was a small difference in the
7
number of lymphocytes per spleen in the control group (3.95x10 cells) and
7
m  the scrapie-inoculated group (4.66x10 cells). This may indicate a 
slight increase in a population of reactive lymphocytes in 87V-infected 
mice.
5.2.3 Immune responsiveness of Sinc^7 mice (IM^ 54 weeks post injection 
with 87V strain of scrapie or normal brain
a) Serum IgG Concentrations
At 54 weeks post injection, the 12 animals which received 87V 
strain of scrapie had significantly elevated (p<.01) levels of serum IgG 
(768+38 mg/lOOml serum) compared to the 7 normal brain-inoculated controls 
(590+43 mg/lOOml serum), as given in Table 66. The lymphocyte numbers for 
the two groups of animals were similar (Table 67), and may indicate that an 
increase in cell activity rather than cell numbers is responsible for the 
increase in serum IgG concentrations.
b) Primary response to sheep red blood cells
The data presented in Table 68 show the primary response to sheep 
erythrocytes of mice 54 weeks after injection of scrapie or of normal 
brain. In the latter, the IgM response was maximal on day 5, followed by a
TABLE 66 SERUM IgG CONCENTRATIONS, 54 WEEKS AFTER INJECTION OF 87V—INFECTED
OR CONTROL BRAIN.
GROUP NUMBER OF ANIMALS 
PER GROUP
mglgG/lOOml SERUM 
( mean+SEM)
LYMPHOCYTE COUNT/ 
SPLEEN (X10 )
+NBr 7 590+43 5.32+0.49
t87V 12 768+38* 5.62+0.31
—3+ Each mouse received O.lml intraperitoneally of 10 homogenate
(unspun) of uninjected Sinc^ brain. All mice were age and sex-matched 
with the scrapie-injected group.
i 1
—3
t Each mouse received O.lml intraperitoneally of 10 homogenate
(unspun) of clinically affected 87V Sinc^ brain. All mice used were 
Sincr (IM) £.
Significance (t.test) * p<.01
TABLE 67 PRIMARY RESPONSE 
INJECTION OF 87 V- 
COUNTS
TO SHEEP RED BLOOD CELLS, 54 WEEKS AFTER 
-INFECTED OR CONTROL BRAIN. SPLEEN LYMPHOCYTE
DAYS POST 
SRBC*
GROUP NUMBER LYMPHOCYTE COUNT/SPLEEN 
PER GROUP (mean+SEM X 10 )
5 CONTROL NBr 1 4.88
« NBr + SRBC 3 4.19+0.43
CONTROL 87V - N/A
87V + SRBC 7 4.5+0.26
7 CONTROL NBr 
NBr + SRBC 
. CONTROL 87V 
87V + SRBC
1
3
7
4.83
4.70+0.12
N/A
4.90+0.62
11 CONTROL NBr 1 4.80
NBr + SRBC 3 4.04+0.38
CONTROL 87V - N/A
87V + SRBC 7 5.04+0.44
—3
+ Each mouse received O.lml intraperitoneally of 10 homogenate
(unspun) of uninfected Sincp brain. All mice were age and sex-matched 
with the scrapie-injected group.
—3
t Each mouse received O.lml intraperitoneally of 10 homogenate
(unspun) of clinically-affected 87V Sinc^ brain. All mice were Sincr 
(IM) £.
* SRBC Sheep red blood cells
N/A Not available
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gradual, but not total, reduction in the number of IgM-secreting 
lymphocytes. The IgG response in the control group was highest on day 7, 
and thereafter declined. The primary IgM and IgG responses of the scrapie 
injected group showed similar patterns, but at increased and sustained 
levels. This may indicate that scrapie is increasing the responsiveness of 
lymphocytes to antigen. There was, however, more variation in the number 
of scrapie-injected animals which responded to the antigen, compared to 
controls, but those 87V-injected animals which responded, did so at an 
increased level (Table 68). This data contrasts with that obtained for 
mice which had been inoculated 30 weeks earlier with 87V, where a 
diminished response to sheep erythrocytes was noted (Table 58).
c) IgG responses following stimulation with ovalbumin
Stimulation of both scrapie-injected IM mice, and their normal 
brain-injected controls produced ovalbumin-specific IgG antibodies which 
were predominatly of the IgGl isotype (Table 69). The 4 control mice had 
similar levels of IgGl antibodies (10.5+4.6^ig/ml serum) as the non-brain 
injected but stimulated IM mice (9.4+0.8pg/ml serum, Table 44), but the 
mice injected with 87Vbrain showed levels (37.5+7.8 jjg/ml serum) that were 
increased by 257% (p<.05). It was also possible to demonstrate a slight, 
but not statistically significant, increase in the IgG2 antibodies specific 
to ovalbumin in. the 87V-injected mice, as compared with controls (Table 
69). These results are similar to those obtained for mice at 4 weeks 
(Table 55) and at 30 weeks post injection of scrapie (Table 60), and 
support the conclusion that there are clones of IgGl-secreting cells which 
are more active in the 87V-injected mice, with the additional possibility 
of an increased activity in the IgG2-secreting cells at 54 weeks. It is 
unclear at the moment whether the increased output is due to an increase in 
the actual cell number> or an increased activity of the specific cells, or 
both.
TABLE 69 IgG RESPONSES 
INJECTION OF
TO 
87 V-
STIMULATION WITH OVALBUMIN, 54 
-INFECTED OR CONTROL BRAIN.
WEEKS AFTER
ANIMAL TREATMENT OF 
GROUP INDIVIDUAL 
MICE
J i g  ANTIGEN-SPECIFIC IgG 
ANTIBODY/ML SERUM
IgGl IgG2
%
IgGl
OF TOTAL
IgG2
NBr+ , UNSTIMULATED 0 0 - -
NBr STIMULATED 1 4.0 0.4 91 9
2 24.0 1.5 94 6
3 9.0 0.5 95 5
mean + SEM
4 5.0
10.5+4.6
0.7
0.78+0.3
99 1
t
8 7V UNSTIMULATED 0 0 -
87V STIMULATED 1 16.0 0.1 98 2
2 18.0 0.1 99 1
3 56.0 0.6 99 1
4 62.0 11 85 15
5 42.0 0.4 99 1
mean + SEM
6 31.0
37.5+7.8*
0.3
2.08+1.8
92 8
—3
Each mouse received O.lml intraperitoneally of 10 homogenate (unspun) 
of uninfected Sincr brain. All mice were age and sex-matched with the 
scrapie-injected group.
O.lml intraperitoneally of 10 
un) of clinically-affected 87V SjLncp brain. 
Sincr (IM) .$>•
Each mouse received 
(unsp n)
were
homogenate 
All mice used
Significance (t.test)* p<.05
d) IgG responses following stimulation with keyhole limpet 
haemocyanin
From Table 70 it can be seen that the overall IgG response 
following stimulation with keyhole limpet haemocyanin (KLH) was higher, but 
not significantly so, in the 87V-injected mice (3114+12r7pg/ml serum) than 
the control mice (1248+644 jig/ml serum). Studies of IgG isotypes, specific 
for KLH, demonstrated a 149% increase in IgGl antibodies and a 162% 
increase in IgG2 antibodies in the 87V-injected group, compared with 
control mice. Analysis of the individual IgGl responses of both groups 
again demonstrated two populations of responders (Table 71), and confirms 
the results obtained for the untreated IM mice and those at 30 weeks post 
injection (Table 62). Those mice injected with scrapie showed increases in 
IgGl antibodies in both the high and low response group, but the increase 
was significant in the 87V-injected low response group (p<.02) with IgGl 
levels of 1120+269 pg/ml serum, compared with 279+77 pg/ml for the control 
group. Even though the latter value was lower than that obtained for the 
30-weeks post injection controls (Table 62), the results again suggest that 
some clones of B cells secreting IgGl may be more responsive following 
injection of 87V strain of scrapie.
e) IgG responses following stimulation with lipopolysaccharide
Table 72 shows that the response to lipopolysaccharide (LPS) was
restricted to antibodies of IgG3 isotype in both the control and the 
scrapie-injected groups. There was a slight elevation in the LPS-specific 
IgG antibodies in the 87V-injected mice (22.2+0.7 ng/ml serum), as compared 
with controls (17.3+1.3 ng/ml serum), but the difference was not 
significant. Thus it appears that the response to LPS, as an IgG3 subclass 
stimulator, is unaltered as a consequence of infection with 87V strain of 
scrapie 30 (Table 63) and 54 weeks (Table 72) earlier.
TABLE 70 IgG RESPONSES FOLLOWING STIMULATION WITH KEYHOLE LIMPET
HAEMOCYANIN, 54 WEEKS AFTER INJECTION OF 87V-INFECTED OR CONTROL 
BRAIN.
ANIMAL
GROUP
TREATMENT OF
INDIVIDUAL
MICE
Jig ANTIGEN-SPECIFIC IgG 
ANTIBODY/ml SERUM % OF TOTAL
IgGl IgG2 IgGl IgG2
+NBr UNSTIMULATED 0 0 - -
NBr STIMULATED 1 4160 30 99 1
2 2040 112 95 5
3 456 10 98 2
4 152 16 91 9
5 ' 148 6 96 4
6 360 2 99 1
mean + SEM 1219+656 29+17
t87V UNSTIMULATED 0 0 - -
87V STIMULATED 1 8640 210 98 2
2 600 90 87 13
3 1260 15 99 1-
4 1500 114 93 7
5 3200 12 99 1
6 3040 15 99 1
mean + SEM 3040+1195 76+32
+ Each mouse received O.lml intraperitoneally of 10
-3
homogenate
(unspun) of uninfected Sincr brain. All mice were age and sex-mat<
with the scrapie-injected group.
t Each mouse received 0.1ml intraperitoneally of 10 3 homogenate
(unspun) of clinically-affected 87V Sipcr brain. All mice used
were Sincr (IM} <j>.
TABLE 71 IgGl—SPECIFIC RESPONSES TO KEYHOLE LIMPET HAEMOCYANIN
KLH
RESPONSES
Ajg IgGl ANTIBODIES/ml 
f mean + SEM (n.MICE)
NORMAL BRAIN 
INJECTED
SERUM
87V-BRAIN
INJECTED
HIGH 3100+1060 4960+1840
(2) (3)
LOW 279+77 1120+269*
(4) (3)
+ Data taken from Table 70
Significance (t.test) *p<.02
TABLE 72 IgG RESPONSES TO STIMULATION WITH LIPOPOLYSACCHARIDE, 54 
WEEKS AFTER INJECTION OF 87V—INFECTED OR CONTROL BRAIN.
GROUP TREATMENT OF ng ANTIGEN-SPECIFIC ANTIBODY^/
INDIVIDUAL MICE ml SERUM
N.Br.*
N.Br. ‘
mean + SEM
t
87V UNSTIMULATED 0
87V STIMULATED 1 20
2 24
3 23
4 23
5 21
mean & SEM 22.2+0.7
—3+ Each mouse received O.lml intraperitoneally of 10
homogenate (unspun) of uninfected Sinc^ brain. All 
mice were age and sex-matched with the scrapie-injected 
group.
—3t Each mouse received O.lml intraperitoneally of 10
homogenate (unspun) of clinically-affected 87V Sinc^ 
brain. All mice used were Sincr^ (IM) j).
$ Antigen-specific antibody was not detected in either IgGl
or IgG2 subclases Figures given are those detected using 
antiserum against total IgG.
UNSTIMULATED 0
STIMULATED 1 21
2 20
3 16
4 18
5 12
,6 17
17.3+1.3
f) Rosetting of lymphocytes with antibody-coated sheep 
erythrocytes
Measurements of the percentage of rosette-forming lymphocytes in 
the spleens of both groups of mice showed no evidence for the two
populations of mice (Table 73), as was identified in untreated IM mice
(Table 48), and in those mice sampled 30 weeks post inoculation (Table 64).
All the animals were of the low response type. Both the control group and 
the scrapie-injected animals showed similar percentages of rosette-forming 
cells from spleens (6.15+0.7 and 5.80+0.2 respectively) and similar 
lymphocyte cell counts per spleen (Table 73). Thus data from these assays 
imply that there was no overall increase in the number of spleen 
lymphocytes with Fc receptors, 54 weeks after scrapie inoculation, and 
contrasts with data obtained at 30 weeks after inoculation when a rise in
FcY cells was noted (Table 64).
g) Lymphocyte transformation assays
These results have been presented earlier (Table 41). There was no 
difference in the response to the B cell mitogen, LPS, but in the 87V- 
injected mice, the stimulation by both T cell mitogens PHA and Con A was 
reduced by 52.4% and 51.5%, respectively. The total number of lymphocytes
per spleen for each group were similar; the control group had an average
7 7lymphocyte count of 5.23+0.9x10 cells, against a count of 5.32+0.5x10
cells for the 87V-infected group.
Conclusions
There is evidence from these studies that in those animals injected 
with the 87V strain of scrapie IgGl-secreting lymphocytes are more 
responsive when exposed to antigens known to stimulate IgGl-secreting cells 
(eg ovalbumin and keyhole limpet haemocyanin). This is a consistent
TABLE 73 ROSETTING OF SPLEEN LYMPHOCYTES WITH ANTIBODY-COATED SHEEP 
ERYTHROCYTES, 54 WEEKS AFTER INJECTION OF 87V-INFECTED OR 
CONTROL BRAIN.
TOTAL NUMBER OF
GROUP ANIMAL LYMPHOCYTES PER % LYMPHOCYTES OCCURRING AS ROSETTES
NUMBER SPLEEN (X 10 ) mean + SEM (3 ASSAYS)
+
N.Br.
mean + SEM
87Vtf
mean & SEM
1 7.33 5.8+0.2
2 5.08 4.4+0.3
3 4.78 7.9+0.5
4 4.25 6.5+0.5
5.36+0.68 6.15+0.7
1 7.54 *■ 5.6+0.3
2 5.32 6.1+0.4
3 5.90 6.7+0.6
4 5.73 5.7+0.2
5 5.05 6.0+0.7
6 5.83 4.8+0.6
5.68+0.43 5.8+0.2
—3
Lml intraperitoneally of 10 homogenate 
Sinc^ brain. All mice were age and sex-:
Each mouse received O.lm j
(unspun) of uninfected p' x-matched 
with the scrapie-injected group.
—3
Each mouse received O.lml intraperitoneally of 10 homogenate 
(unspun) of clinically-affected 87V Sinc^ brain. All mice used 
were Sinc^ (IM) 0.
feature and it is probably due to the early and sustained presence of agent 
in the spleen. There was no consistent increase in spleen lymphocyte 
numbers during the 4-54 week period studied, but serum IgG levels were 
significantly increased at 54 weeks post injection of scrapie, which might 
imply a hyperactivity of some B cells. There appeared to be a reduction in 
the responsiveness of some subpopulations of T cells to both Con A and PHA 
in those animals injected 54 weeks earlier with scrapie.
6 DISCUSSION
Scrapie has, over a considerable period of time, come to be 
regarded as somewhat unusual. The causal agent has so far eluded the 
biochemist's purification procedures; even in high-titre material the 
electron microscopist has been unable to visualise agent, and the 
immunologist has failed to detect any agent/host interactions. Yet scrapie 
can be experimentally transmitted, using crude homogenates, to other 
susceptible animals, producing a recognisable, clinical syndrome. Many 
strains of scrapie have now been isolated, each one being identified by 
precise incubation period characteristics and distinctive lesion profiles 
in specified Sine genotypes of mice infected under defined conditions.
Early studies on immunological aspects of murine scrapie 
concentrated on one or two strains which, with hindsight, are known not to 
be representative of the range of strains now available, but from the 
negative results obtained generalisations were made on the absence of 
immunological reactions as a result of scrapie infection and incubation 
(Section 1.4). However, for a disease to develop without stimulating the 
host into some immunological reaction (or inaction) is clearly unusual.
Recent comparative studies on serum protein levels in sheep when 
clinically affected with either natural or experimental scrapie indicated 
that a large prpportion of animals had significantly elevated IgG levels, 
compared with healthy age-matched flock mates (Collis et al, 1979; Collis 
and Kimberlin, 1983 ). Quantification of serum IgG was therefore used as an 
initial indicator of humoral immune responses in inbred strains of mice 
(which, by definition, are genetically more homogeneous in their immune 
reactions than sheep) infected with single strains of scrapie.
Comparability studies between different models of mouse scrapie 
pose problems, as discussed in section 1.5, because the incubation periods 
for each model are often different from one another, and therefore clinical
disease occurs in mice at different ages. Hence the inclusion of suitable 
'control" animals becomes most important for the interpretation of results,
In the majority of experiments presented in this thesis, control animals 
were inoculated with tissue taken from uninfected mice of the same age, sex 
and Sine genotype as those used for scrapie infection.
S7The initial studies were of two models, 139A in Sine mice, and 
87V in Sine**7 mice, each one with appropriate age-matched controls. 
Previous work by others on the first model failed to find any evidence of
r
immunological involvement (Section 1.4). From 4 serial killing experiments 
of animals infected with 139A by the i.e. or i.p. route, the serum IgG 
levels were unchanged throughout the incubation period, thus confirming 
previously published data. Altering the genotype of the host to Sinc^7 did 
not result in any IgG changes after infection with 13 9A.
However, the second model, 87V in Sincp7 mice, did show serum IgG
changes during the late incubation period, and this was a repeatable
observation. In 3 experiments using i.e. infection, serum IgG levels were
significantly elevated, compared to controls, in the latter third of the
incubation period, and remained elevated during clinical disease (Tables
1,5 and 17 Section 3.1). This phenomenon was also detected in 3 separate
experiments after intraperitoneal injection of scrapie brain (Tables 18-20,
Section 3.1). This result was unexpected as the animals failed to develop
clinical disease, and although two of the experiments were terminated
rather early, in the third one the final sample was taken at 80 weeks post
injection when these animals were still healthy. Two other available
strains of Sinc^7 mice also developed elevated levels of serum IgG
following intracerebral injection of the 87V strain of scrapie (Tables 3
and 6, Section 3.1). The evidence that this phenomenon was restricted to
models involving only particular strains of agent, such as 87\^  in the
7
specified Sine genotype (p .), was further supported by negative data from 6 
other available models (Tables 8,9, 11-13, Section 3.1 and Table 31,
S7
Section 4.1a). Significantly, changing the host genotype to Sine did not 
result in serum IgG changes after the injection of 87V (Table 10, Section
3.1).
The main problem of interpretation using i.e. infection of IM mice 
with 87V was that some animals developed skin lesions which could in 
themselves have caused altered levels of serum IgG as part of a secondary 
response. However, i.e. infected MB mice (also Sinc^7 ) produced serum IgG 
changes in animals which did not develop skin lesions (Table 3, Section
3.1) and IM mice infected intraperitoneally with 87V had minimal skin 
lesions (and did not develop clinical disease) but the serum IgG levels 
were still increased (Tables 18-20, Section 3.1). Further, a second strain 
of scrapie, 22A, injected i.e. in IM mice, did riot induce these serum 
protein changes, although some animals did develop skin lesions (Table 8, 
Section 3.1).
Hence the results of 8 separate experiments involving infection of 
Sinc^7 mice (3 different strains) with 87V strain of scrapie, by two 
different routes, consistently showed that some humoral immune reaction was 
occurring, as indicated by elevated levels of serum IgG. It was therefore 
important to investigate this model further.
Studies were made on the nature of the increased serum IgG in 87 V- 
infected IM mice; measurements of the concentration of the major IgG 
isotypes showed differences in 2 of the 3 subclasses. The concentration of 
IgG2a isotype did not vary greatly between the 87V-infected mice and their 
controls. However, the most striking differences between these two groups 
was the increased concentration of IgGl, with a decrease in IgG2b 
concentration (Table 35, Section 4.2). By comparison, 22A-infected IM mice 
did not show any such changes in the IgGl concentration (Table 36, Section
4.2). It would therefore appear that following infection with the 87V 
strain of scrapie, there is some specific involvement of clones of 
lymphocytes secreting IgGl, although the isoelectricfocusing data presented
in 4.2 indicate some kind of polyclonal response within this subclass (see 
later)
6.2 Investigations into the mechanisms contributing to serum IgG increases
a) Catabolism of IgG
Measured increases in serum' IgG may be the result of either over 
production or reduced catabolism. By estimating the latter, it seemed 
possible to identify which of the two mechanisms contributed most to the 
increased IgG concentration. IM mice were used as the common Sincp7 host 
for intracerebral infections with either 87V or 22A scrapie (the latter 
showing no IgG changes). The controls for each group were inoculated with 
normal brain material. Animals at the clinical phase of 87V scrapie had a 
significantly shorter half-life of serum IgG, compared to controls, 
suggesting an enhanced catabolic rate (Table 25, Section 3.2.1). Therefore 
the elevated concentration of IgG in serum may be due to an overproduction 
of IgG which the increased catabolic rate fails to control.
However, a surprising result was obtained with the second ’control’ 
group of healthy IM mice which had been injected intracerebrally with 
autoclaved 87V brain material. These mice had a half-life of serum IgG 
similar to that of the mice showing clinical disease, even though the 
levels of IgG were not significantly different from the normal brain 
inoculated controls (Table 25, Section 3.2.1). For reasons discussed in 
Section 3.2.2 it seems possible, if not likely, that the autoclaving regime 
used did not fully inactivate scrapie, and residual agent injected i.e. may 
have been unable to establish directly infection of brain but could have 
infected extraneural tissue, as is known to occur following i.e. injection 
of boiled inoculum containing ME7 scrapie (Dickinson and Taylor, 1978 ). 
This interpretation, taken with the findings of increased serum IgG levels 
in the 3 i.p. experiments with 87V (in which there was no clinical disease) 
suggest that it is the presence of agent in the spleen and other lymphoid
organs which provides the stimulus, either directly or indirectly, for the 
serum IgG changes. This interpretation is supported by a variety of other 
data, to be discussed later (Section 6.4). However, the experiment using 
the autoclaved inoculum is of interest in that it demonstated a separation 
of the two phenomena, namely IgG increases and increased clearance of IgG, 
since the latter occurred without the former. This may mean that the 
increased clearance of IgG is not in this case simply a homeostatic 
consequence of the increased levels of IgG as suggested above.
In contrast to the findings with 87V, the estimated half-life of 
IgG in animals infected with the 22A strain of scrapie was identical to 
that of the normal brain-inoculated controls (Table 25, Section 3.2.1). 
This is consistent with the serum IgG data showing that there is no 
overproduction of IgG in the 22A model. However, there was a discrepancy 
in the half-life of IgG in the two IM control groups, 7.8 days for those 
used as controls for the 87V-infected mice, and 5.4 days for the 22A 
experiment. It was only after the results of the 87V-infection experiment 
had been obtained that the 22A experiment was initiated some 50 weeks 
later. During this time, the breeding programme for the IM mice had been 
altered in several important respects. The mice used in the 87V experiment 
had been bred and maintained under conventional animal house conditions, 
whilst those used in the 22A-experiment were from stock which had been bred 
under SPF conditions following caesarian derivation. Moreover, the latter 
were 5-6 generations more inbred. It has been shown by others that there 
were no significant differences in the IgG half-life of mice reared in 
conventional animal farms, SPF farms and 'dirty' farms (Quinn et al, 1973), 
so environment may not be the most important factor. It is also known that 
half-life varies with age, it decreases sharply until 6 months of age, then 
remains unchanged until 24 months of age, when the rate falls again (Quinn 
et al, 1973). The mice used for the 22A-infection experiment were 
approximately 30 weeks old, and those for the 87V experiment 45 weeks old,
and hence both would be at this plateau phase. Therefore it seems possible 
that the caesarian derivation and inbreeding of IM mice was the major 
factor responsible for the discrepancy between the two groups of controls.
These two experiments highlight the central necessity of adequate 
controls. If in the 87V experiment, the group inoculated with autoclaved 
87V brain material had been used as the sole control, then there would have 
been no apparent difference in the IgG half-life of the clinically-affected 
animals (Table 25, Section 3.2.1). Similarly, with the 22A experiment, if 
the contemporary control had been omitted, then one might have concluded 
erroneously that the IgG half-life was decreased in 22A infection, compared 
to uninfected mice, or the normal brain control used in the 87V experiment 
(Table 25, Section 3.2.1).
b) Polyclonal stimulation
The data showing an increased serum IgG concentration in the 87V 
infected Sinc^7 mice, coupled with the finding of a decreased half-life of 
serum IgG suggests a hypergammaglobulinaemia due to overproduction of IgG. 
This conclusion led to isoelectricfocusing studies of IgG isolated from 
pooled sera from 3 groups of IM mice (one group at the clinical phase of 
infection with 87V, one at the clinical phase with 22A, and the third group 
of uninjected animals). Qualitatively, the spectrum of bands was identical 
for all 3 groups with no evidence of monoclonal or oligoclonal stimulation 
(Figure 12, Section 4.2). However, there was clearly a polyclonal 
overproduction of IgG in the first group of mice. There are two possible 
mechanisms to account for this, the most obvious one being a stimulation of 
systemic B cells to secrete IgG into the serum. The second one is more 
unusual, but is known to occur in some slow virus infections of the central 
nervous system (Ludwig and Becht, 1977; Griffin et al, 1978). Local 
synthesis of IgG can occur by lymphoid cells in the brain, simultaneously 
with systemic production of immunoglobulin. The possibility that local
production of IgG might contribute to the total IgG levels in serum after 
i.e. infection with the 87V strain of scrapie was investigated by measuring 
CSF:serum IgG ratios. The data showed that there was no evidence of IgG 
synthesis within the brain (Table 33, Section 4.1). In any case, this 
would be a most unlikely explanation for increased serum IgG levels in mice 
injected i.p. when, as was shown later, there was no detectable agent in 
the CNS (Table 28, Section 3.2.2). Hence it is concluded that the 
increased levels of serum IgG arise from a conventional polyclonal 
activation of certain subsets of systemic B cells. The stimuli that could 
be responsible for this response are discussed later (Section 6.5).
6.3 Immunological consequences of infection with 87V strain of scrapie
The work described in this thesis developed initially from 
biochemical observations (Sections 3 and 4), and it soon became apparent 
that immunological studies were needed to understand more of the nature of 
the IgG changes found and of their possible significance. However, IMmice 
have been used only by two research groups in the U.K., and then only for 
work on scrapie. It was therefore necessary to establish the normal 
spectrum of immune reactions of these mice and these will be considered 
first before discussing the variations which seem to be caused by infection 
with 87V scrapie.
Studies of uninfected IM mice indicated the presence of at least 
two populations which could be distinguished by a number of tests. First, 
IM mice did not respond to a primary challenge with sheep erythrocytes in 
the usual way (Tables 42, 43, Section 5.1). The IgM response appeared 
normally on day 4 after stimulation, but the switch to IgG secretion did 
not occur in all mice at the same time; some mice produced the expected IgG 
response on day 7 whilst in other animals the response was delayed until 
day 11, but the level of the response was the same in both groups. This 
situation differs from the two groups of mice described by Biozii et al
(1972), when the response to sheep erthrocytes occurred at the same time, 
but at different levels. Further evidence for two populations of 
responders was again suggested by data on the ability of splenic 
lymphocytes to form rosettes with antibody-coated sheep red cells (which is 
an assay to enumerate cells with Fc receptors (Table 48, Section 5.1), and 
also from data on the responses of spleen cells to two T cell mitogens (Con 
A and PHA, Table 50, Section 5.1). IM mice responded well to the T- 
dependent antigen keyhole limpet haemocyanin (KLH, Table 46, Section 5.1), 
but were non-responsive to high doses of ovalbumin (i.e. >100jig/mouse, Table 
44, Section 5.1), which is a T-independent antigen.
It has been shown that the genetic control of immune responsiveness
to low doses of antigen (i.e. cljjg/mouse) is controlled by the H-2 type.
b <3For example, with a single low dose of ovalbumin, mice of H-2 , H-2 and H-
q
2 type produce a good primary response (Vaz et al, 1971), but with a high 
dose of ovalbumin as booster, only mice of H-2^ type produce a good 
secondary response. VM mice are of the H-213 type (Festing, 1979). IM mice 
were derived from VM stock with the intention of preserving Sinc^7 but with 
the addition of distinguishing coat colour genes. This means that IM’s are 
related to VM's and share sinc^7 (Dickinson, personal communication) and 
are also of the same H-2 type as VM (i.e. H -2*5) ,  because of their response 
to ovalbumin (Table 44, Section 5.1). Also the use of the two antigens, 
KLH and ovalbumin, which produce antibodies restricted to the same subclass 
(IgGl) was of value as they involve two different methods of antigen 
processing by the host, differing in their dependence on T cells. It was 
also noted that the immune response to KLH was variable among individual 
mice of the same strain (Table 62, Section 5.2.2). However, such 
variations are not unknown and have been identified in several strains of 
mice, including C57BL/6 and C3H (Rosenstreich, 1978; Taghabne, 1978). 
Variation in two sublines of IM mice, (at Compton and at Edinburgh) was 
also noted, and again serves to emphasise the importance of the appropriate
controls for all scrapie experiments.
These immunological tests were carried out on mice injected i.p. 
(to ensure greater access of agent to lymphoid tissue) with either 87V 
strain of scrapie, or with normal brain, at 3 different times after 
injection. The times chosen were based on the pattern of serum IgG levels 
following i.e. injection (before the confirmatory i.p. data was obtained): 
an occasional increase at 4 weeks, no increase at 30 weeks and a 
significant increase at 54 weeks. When the pathogenesis data became 
available it was seen that week 4 was the time when agent replication had 
started in the spleen, and weeks 30 and 54 corresponded to the early and 
late plateau phase, repectively (when agent titres in the spleen were 
maximal (Table 28, Section 3.2.2).
Stimulation of both control and 87V-infected groups with either 
ovalbumin or KLH resulted in antibodies restricted to the IgGl subclass. 
Ovalbumin stimulation resulted in the expected low levels of IgGl 
antibodies, but those animals injected with 87Vhad 3.7, 3.4 and 3.6 - fold 
increases in specific IgGl antibodies at 4, 30 and 54 weeks, respectively, 
post-inoculation (Table 51, Section 5.2.1; Table 60, Section 5.2.2 and 
Table 69, Section 5.2.3). This suggests that there is an early and 
sustained hyperactivity of IgGl-secreting B cells which react more readily 
to IgGl-stimulating antigens. Other workers have reported a similar 
finding in uninfected mice (Gronowicz and Coutinho 1974), which had been 
stimulated with LPS (apolyclonal B cell activator, PBA) and prestimulation 
with another PBA, dextran sulphate, produced a higher .response than with 
the single antigen. With KLH, IgGl-specific antibodies were again 
increased in the 87V-infected animals, as compared with controls, at both 
30 and 54 weeks post-injection times (Table 61, Section 5.2.2 and Table 70, 
Section 5.2.3). Quantitatively, the response varied between 2 
subpopulations of animals. In those mice showing the higher level of 
response, there was no difference between the infected and control groups
at either times, but in those animals showing the lower level of response, 
the mice infected with 87V had significantly elevated levels of antibody 
(Table 62, Section 5.2.2 and Table 71, Section 5.2.3). Thus there is some 
preliminary evidence to suggest that within the repertoire of IgGl- 
secreting B cells, some clones may be more active in scrapie than others.
The primary response to sheep erthrocytes was identical in mice 
injected 4 weeks earlier with either 87V strain of scrapie or control brain 
(Table 53, Section 5.2.1). However, at 30 weeks post-injection of scrapie, 
some animals failed to produce the expected primary response to sheep 
erthrocytes. Those scrapie-injected mice which did react had a diminished 
IgM response, and the subsequent switch to IgG secretion was at a reduced 
level, concomitant with a reduced splenic lymphocyte count (Table 58 and 
59, Section 5.2.2). At 54 weeks post infection, those scrapie-injected 
mice which did respond to sheep erthrocytes showed an enhanced number of 
IgM and IgG plaque-forming cells, compared to controls (Table 67, Section 
5.2.3). There was also some evidence of increased numbers of splenic 
lymphocytes in the scrapie animals at this time (i.e. 54 weeks) when the 
serum IgG concentrations were increased (Table 68, Section 5.2.3). Other 
experiments (detailed in Section 4.2.C) also indicated a consistent 
increase in splenic lymphocytes at week 54, with a more variable response 
at week 30.
Recently, it has been claimed that there is an alteration in the 
capping process of spleen cells taken from mice injected with 139A strain 
of scrapie (Vetterman et al, 1981). Although these mice were infected 
intracerebrally, the sample period (12-62 days post injection) was during 
the time this agent is known to be actively replicating in lymphoid tissue 
(Kimberlin and Walker, 1979c), and provides further evidence of some 
changes occuring in B cell activity. A parallel study of spleen cell 
capping in 87V-infected Sincp7 mice would be a useful extension of the 
findings reported by Vetterman.
The majority of experiments in this thesis indicated that infection 
with the 87V strain of scrapie results in changes restricted largely to B 
lymphocytes. However, studies using Con A and PHA as potent T cell 
mitogens in lymphocyte transformation assays showed reduced responses of 
some T cell subpopulation at 54 weeks post infection (Table 41, Section 
4.2; note that Con A and PHA do not stimulate the same subsets of T cells; 
Stobo and Paul, 1973). A reduced T cell activity may explain the over­
reactivity of some of the B cell clones if these T cell subsets function as 
T supressors in the regulation of B cell activity (if the T cell subsets 
which were reduced functioned as T helper cells, then a decrease in IgG 
concentration would have been detected, which was not the case). Further, 
IgGl is known to be the most thymus dependent antibody subclass (Pritchard 
et al, 1973), and it is this isotype which appears to be preferentially 
increased in scrapie infection (87V). Earlier work (with different scrapie 
models) indicated no T cell involvement in producing clinical scrapie after 
peripheral injection* (McFarlin et al, 1971; Fraser and Dickinson, 1978, 
Ellerman, personal communication). A more recent paper, using techniques 
also used in this work, (Kingsbury et al, 1981) arrived at similar 
conclusions. In this study the strain used was C506, injected 
intracerebrally. No details were given of titres of agent in lymphoid 
tissue, although it is likely that agent was present. However, it may be 
significant that the short incubation period obtained was insufficient to 
induce T cell dysfunction if, as the present work with 87V in Sinc^7 mice 
suggests, long term stimulation of lymphocytes is needed to produce 
effects.
The data presented above suggest the possible occurrence of two 
separate immunological phenomena during the pathogenesis of the 87V strain 
of scrapie in Sinc^7 mice. There is an early but sustained reaction which 
is independent of T cell involvement, and a second, much later, reaction 
which is probably T cell regulated. An increased activity of IgGl-reactive
lymphocytes was demonstrated in scrapie-injected animals, using two 
antigens, ovalbumin and KLH. The processing of each protein differs 
markedly in the degree of T cell involvement: ovalbumin is independent of T 
cell control, whilst KLH is T cell dependent. The early (at 4 weeks) and 
sustained (at 30 and 54 weeks post injection) increase in IgGl B cell 
activity is at a similar level throughout this period for ovalbumin (Table 
50, Section 5.2.1; Table 60, Section 5.2.2 and Table 69, Section 5.2.3) and 
KLH (Table 70, Section 5.2.3) and thus parallels the concentration of agent 
in spleen following an i.p. injection (Table 28, Section 3.2.2). Thus T 
cells are probably not involved either in the initial extraneural phase of 
scrapie pathogenesis, or in the initial alteration in the IgGl lymphocyte 
activity due to infection with 87V.
However, the prolonged presence of the 87V strain of scrapie in the 
spleen ultimately results in some loss of immunological control. The 
hypergammaglobulinaemia, detectable only at the 54 week point, seems to 
occur as a consequence of the failure of two or more host control 
mechanisms. There is a reduction of some T cell subsets (as demonstrated 
in lymphocyte transformation assays, using Con A and PHA, Table 41, Section
4.2); if these cells function as T suppressor cells, then restriction of B 
cell immunoglobulin secretion (and in particular IgGl) will be reduced. 
Further, an increased catabolism of IgG has been demonstrated in mice 
infected i.e. with 87V strain of scrapie, when serum IgG was increased 
(Table 25, Section 3.2.1), but as the serum changes are independent of 
route, it is likely the same applies to the i.p. route. Hence an increased 
breakdown of IgG probably occurs but fails to control the continuing 
secretion of protein by the desuppressed B cells.
6.4 The significance of IaG changes in relation to pathogenesis of
a) Scrapie
Pathogenesis studies of some murine models of scrapie have shown 
that following an i.e. injection, infected material leaves the brain and 
can be found in other tissues, including the spleen and lymph nodes, where 
it will eventually begin to replicate (Kimberlin and Walker, 1979c; Millson 
et al, 1979), but it is the residual agent in brain that causes disease 
(Outram, 1973; Fraser and Dickinson, 1978; Kimberlin and Walker, 1979c).
f
In this thesis it has been shown that i.e. injection leads to clearly 
detectable replication of 87V agent in brain by week 10, the earliest time 
studied, and probably much earlier. In spleen, agent is detectable one 
week after injection, and replication starts after 4-10 weeks. Therefore 
the pattern of events with 87V is similar to that for other strains of 
scrapie, with early simultaneous replication of agent in the brain and 
spleen, and probably in other lymphoid organs not studied. After infection 
by the i.p. route, agent was detected in the spleen at 1 week, followed by 
rapid replication to a plateau concentration by week 16 onwards. Hence, 
irrespective of route, agent becomes quickly established in the spleen and 
persists there. The developing hypergammaglobulinaemia is likely to be due 
to the hyperactivity of some B cell subsets due to the continuing presence 
of 87V scrapie in this tissue.
It is important to identify those interactions between host and 
pathogen which are important to the control of the disease process. The 
late appearance of the increased levels of IgG implies that they are 
probably not involved in this control; for example definite replication of 
agent occurred in the spleen at week 10 following infection by the i.p. 
route, but serum IgG was not significantly elevated until 46 weeks later 
(section 3.1) Therefore these IgG changes do not seem to be part of the 
conventional defense mechanisms of the host against foreign antigens. For 
example, normal responses to foreign antigens have been shown in Section
5.1. when uninfected IM mice produced detectable specific IgG antibody 
against sheep erthrocytes within 7-11 days of i.p. injection (Table 42) and 
IgG antibodies against ovalbumin by 5 weeks (Table 44). Moreover, it is 
clear that the IgG changes observed in scrapie cannot be the cause of 
clinical disease, since following an i.e. injection of the 87V strain of 
scrapie, serum IgG levels are significantly elevated from week 36 onwards, 
while agent is probably approaching maximum titre and clinical signs become 
apparent some 4 weeks later. However following i.p. injection, there are
r
only minimal amounts of agent in brain by day 560 and no apparent signs 
(Section 3.2.2) but serum IgG levels are significantly elevated.
The biochemical characteristics and general immune functions of 
each IgG isotype in mice are well documented (for review, see Spiegelberg, 
1974), but only recently have data been obtained on isotypic responses 
following stimulation with single or mixed antigens, mitogens and 
infectious agents. For example, studies of infection with Semliki Forest 
Virus have shown that IgG3 (the minor IgG isotype in mice) permeates 
membranes, and may be associated with the clearance of virus from the CNS. 
IgG2a was detectable before virus infectivity was eliminated from the 
brain, and this may be responsible for the immunopathogenesis of disease, 
especially as this class of antibody can fix complement and penetrate brain 
tissues (Flemming, 1977). It has been shown that IgG2a is not increased 
during infection with either 22A or 87V strains of scrapie (Tables 35 and 
38, Section 4.2); it is the non-complement-fixing isotype, IgGl, which is 
increased in 87V infection (Table 36, Section 4.2). Moreover, all three 
Sinc^7 strains of mice used here have adequate levels of C3 (Collis, 
unpublished) suggesting (along with the absence of inflammatory pathology 
in brain) that complement is not directly involved in the disease process. 
However, the same three Sinc^7 mouse strains are known to be deficient in 
C5 (Farquhar, personal communication) but the significance of this (if any) 
in the pathogenesis of scrapie is not known although scrapie incubation
period and pathology appears uninfluenced by the presence or absence of
S7this C5 deficiency in Sine mice
It is concluded that the persistence of the 87V strain of scrapie
in the spleen is responsible for the overproduction of IgG by certain B
cell subsets. This late IgG response seems to be an aberrant immune
reaction, possibly due to a reduction in T suppressor cells and which 
functions neither as part of the host's defence mechanism against scrapie 
nor as a cause of disease.
f
There is no firm information available on what cell type supports 
agent replication, or if these cells interact directly or indirectly with B 
or T cells to produce the immunological consequences described in this 
thesis. Modification of scrapie pathogenesis using mitogens such as PHA 
(Dickinson et al, 1978) and methanol extraction residue of BCG (Kimberlin 
and Cunnington, 1978) and other substances such as HPA-23 (Kimberlin and 
Walker, 1979b) which may affect the immune system, suggest that cells of 
lymphoid origin are the most likely candidate to support scrapie 
replication.
Other evidence to support the involvement of specialised lymphoid 
cells in scrapie pathogenesis comes from work using immunosuppressants, 
which are known to interfere with the normal accumulation of peripherally- 
injected antigen in spleen (Nettesheim and Hammons, 1970).
Cyclophosphamide alone failed to influence pathogenesis (Worthington and 
Clark, 1971; Outram, 1973). A combination of prednisone acetate and 
cyclophosphamide (a regime used to destroy specific stem cells; Makinodan 
et al, 1970) resulted in a significant lengthening of incubation period 
(Outram, 1973). This suggests that there is a population of cells required 
for scrapie pathogenesis which is destroyed by prednisone acetate, and that 
cell replacement is halted by cyclophosphamide. Also, standard scrapie 
homogenates injected by the i.p. route into mice during the first 3 days of 
life (instead of after weaning) resulted in greatly prolonged incubation
periods with survivors (Outram, 1973 ), implying the absence of a population 
of cells in newborn mice which are required for scrapie pathogenesis.
However, the persistence of 87V scrapie in the spleen suggests a 
possible mechanism for the overproduction by B cells and a cell type which 
may be involved. The mechanism of antigen presentation within spleen 
ensures efficient exposure to all circulating lymphoid traffic. Follicular 
dendritic cells, located in the germinal centres of splenic white pulp 
possess long cytoplasmic processes interwoven between B cells. These 
processes retain small amounts of antigen for many weeks, in the form of 
immune complexes attached to Fc and C3b receptors. Since these dendritic 
cells are in such close contact with B cells, it has been suggested that 
they play an important role in initiating T-independent responses (in this 
case the early overactivity of IgGl B cells) and in the development of 
memory B cells. These cells may thus become infected with scrapie and 
support agent replication.
In the natural infection in sheep, scarification of the skin has 
been suggested as a method of lateral spread of scrapie (Stamp et al, 
1959). Dendritic cells located in the skin (i.e. Langerhans cells) could 
remove agent and transport it via afferent lymphatic ducts to lymph nodes 
and spleen. This would also be consistant with the importance of dendritic 
cells in scrapie pathogenesis as the cell population which is closely 
associated with agent replication.
b ) Cerebral amyloid 
One obvious difference between the two main models studied, 22A and 
87V injected i.e. into Sinc^ mice, is that the latter is characterised by 
the deposition of discrete amyloid plaques in the brain. The chemical 
composition of cerebral amyloid is unknown, but there are several forms of 
amyloid found in other tissues (associated with other diseases) which have 
been characterised. One of them has immunoglobulin light chains forming
the amyloid fibrils (Glenner et al, 1971). Ishii and Haga (1976) found 
that in senile dementia the fibrils of senile plaques (which resemble those 
found in some scrapie models; Bruce, 1980) labelled with antisera against 
human IgG. It has been shown that following i.e. infection with 87V, 
plaque numbers begin to rise at about the same time as serum IgG levels 
begin to increase (Table 30, Section 4.1.a). Moreover, studies of the 
three strains of Sinc^7 mice (IM, VM and MB) infected with 87A scrapie show 
that the number of plaques formed (Bruce and Dickinson, 1982) varies in the 
same way as the IgG changes in serum, so that the mouse strain which gives 
the highest number of plaques in brain also has the highest ratio of IgG,
(scrapie s control), in serum (Table 3, Section 3.1). This reinforces the 
idea of a correlation between the two observations, but a cause-effect 
relationship is more difficult to evaluate.
It is conceivable that overproduction of IgG and its increased 
breakdown leads to an abundance of immunoglobulin fragments, some of which 
might become the basic fibrils for amyloid deposition.
Data from a second plaque-producing model, 22A in F mice (i.e. 
Sincs7P7) showed no significant increase in serum IgG concentrations 
although the levels were maintained slightly above control values, (Table 
31, Section 4.1a) but the amyloid plaque count for this model is 
considerably lower than for the equivalent 87V/SincP7 model. There could, 
therefore, be a different set of conditions needed for amyloid deposition 
in different models.
Work by Bruce and Fraser (1981) proposed that cerebral amyloid in 
scrapie was synthesised locally rather than systemically. They 
demonstrated that intracerebral injection consistently resulted in greater 
numbers of plaques than were obtained with the same inoculum injected 
intraperitoneally. Furthermore, when plaque counts after left and right­
sided intracerebral injections were compared, plaques were more frequent on 
the side of injection and were localised in areas where the inoculum was
initially distributed (Bruce and Fraser, 1981). Wisniewski et al (1981) 
also showed that clusters of plaques were seen in plose association with 
the needle tract following i.e. injection. Based on data from Shirahama 
and Cohen (1975), who implicated reticuloendothelial cells in the synthesis 
of amyloid in peripheral organs, Bruce and Fraser (1981) have suggested 
that phagocytic cells migrate to the intracerebral injection site and are 
involved in the deposition of amyloid protein. A plaque-inducing strain of 
scrapie, injected i.e. or i.p. into mice of the right Sine genotype, may 
thus stimulate similar reticuloendothelial cells outside the CNS to produce 
a protein, this time IgG. Thus agent may be the common stimulus for 
certain cells to synthesise protein; the location of agent and its 
interaction with specialised local cells in brain or extraneurally (in 
spleen, lymph nodes etc) may determine the type of protein produced. This 
may explain the association between the two phenomena, cerebral amyloid and 
increased serum IgG, in some of the models.
Mouse strains which show a high incidence of cerebral amyloid in 
scrapie do not seem to be associated with a high susceptibility to induced 
systemic amyloidosis (Bruce, personal communication). However the Sincp7 
mouse strains (IM and VM) which can develop chronic skin lesions, depending 
on the strain of agent and route of infection, sometimes have some systemic 
amyloid deposits in the spleen, liver and kidneys.
In summary, pathogenesis studies have shown that the pattern of 
extraneural events with the 87V strain of scrapie, injected 
intracerebrally, is similar to those for other scrapie models; scrapie 
infection is quickly established in the spleen, irrespective of route. The 
persistence of agent within this tissue probably results in IgG increases, 
which are a late event and appear not to be involved in either the control 
of the infection or the development of disease. It is suggested from 
pathogenesis studies that dendritic cells may be the specialised population 
of lymphoid cells in the spleen which supports agent replication and
contributes to the polyclonal B cell activation. A related population of 
cells may exist in the brain and be one of the cell types supporting agent 
replication there, and result in amyloid synthesis. This may explain the 
association between amyloid and IgG.
6.5 Stimulus responsible for the increase in serum IaG
A major unanswered question to be discussed concerns the mechanism 
responsible for the selective IgG increases during infection with the 87V 
strain of scrapie. Much of the data presented in this thesis suggest that 
it is the persistence of agent in the spleen which directly causes the 
enhanced and sustained increase in the activity of IgGl-secreting cells 
(Section 5.2) which undergo a typical selective but non-specific polyclonal 
B cell activation (PBA). The isoelectricfocusing spectra of IgG from 
control and 87V-infected sins*7 mice were identical, demonstrating the 
polyclonal nature of the increased IgG (Figure 12, Section 4.2). There are 
other stimuli which could augment and amplify this PBA further; for example 
the presence of Fc fragments of immunoglobulin molecules, produced as a 
consequence of increased catabolism of IgG (Berman and Weigle. 1977), and 
the depletion of certain T cell subsets (Section 4.2).
Other studies have indicated the presence of an ’immunomodulatory 
system' capable of influencing normal host immune responsiveness (Cross et 
al, 1980; Roszman et al, 1982), Destructive lesions of the pre-optic 
nucleus and anterior hypothalamic area in rats resulted in a diminished in 
vitro cell-mediated immune (CMI) responsiveness and lymphocyte reactivity 
to Con A. Valdimarsson and Santos (1983) have recently presented data 
which showed that brain injury (i.e. injection of antigen into the 
subarachnoid space) increased systemic antibody responses, and that damaged 
tissue had an enhancing, adjuvant effect. Such a system might contribute 
to the alteration in immunoglobulin concentration following i.e. infection 
with 87V, especially as some adjuvants are specific as to isotype.
However, as the IgG increases also occurred following infection by the i.p. 
route (together with other changes in immune responsiveness), with no 
evidence of agent in the brain, neuroimmunomodulation probably does not 
have a significant effect, at least in this particular scrapie model.
The IgG itself does not appear to be a specific response to scrapie 
agent as antigen, as judged by the polyclonality of the response and its 
late appearance during the incubation period. Preliminary work suggests 
that this IgG is not mainly produced as ' autoantibodies' to brain and
r
spleen antigens (Section 4.1). However, some antibodies to brain might be 
expected from the presence of histologically damaged tissue in the original 
inocula and, later, from similarly damaged brain occurring towards the 
clinical phase of the disease. It is quite common to find low levels of 
circulating autoantibodies (Elson, 1980) but the amounts of anti-brain 
antibodies identified in the sera of control and 87V-affected mice were 
similar throughout the incubation period. However IgG levels are elevated 
following i.p. injection of 87V where there is no evidence of agent in the 
brain. Hence the production of autoantibodies to brain, caused by the 
presence of agent, is not relevant. Autoantibodies to neurofilament 
proteins have been reported in the sera of sheep naturally-affected with 
scrapie (Aoki et al, 1982); of 20 such animals, 7 had anti-neurofilament 
antibodies with titres ranging from 1:64 to 1:1024, whereas the 13 
unspecified control sheep were negative.
6.6 Summary and Extension of work
This thesis has shown that there is at least one group of models of 
scrapie, 87V in Sincp7 mice, in which changes in the host's humoral immune 
responsiveness have been clearly demonstrated. The changes were identified 
initially as a significant increase in serum IgG which is not produced as a 
specific response to scrapie agent as antigen, nor to brain antigens, nor 
is it a cause of disease. However it would appear that there may be two
separate immunological consequences of infection with the 87V strain of 
scrapie, which are dependent on the degree of T cell involvement. There is 
an early (and sustained) increased activity of IgGl-secreting B cells, 
which is independent of T cell control, and which parallels the 
concentration of agent in the spleen. This also suggests that T cells are 
probably not involved in the initial extraneural phase of 87V scrapie 
pathogenesis. The second, late phenomenon occurs as a result of the 
failure of host control mechanisms, and as a direct consequence of the 
persistence of agent in the spleen. There is a reduction in some T cell 
subsets, possibly T suppressor cells, which result in the increased 
synthesis of IgG (and confirmed by isoelectricfocusing analysis), which an 
increased catabolism cannot control.
The persistence of the 87V strain of scrapie in the spleen (with 
the consequences summarised above) has led to the suggestion that 
follicular dendritic cells, which are antigen-presenting cells located in 
spleen white pulp, may be the specific cells necessary for peripheral agent 
replication. These cells possess long processes which pass between the B 
cells and are known to initiate T independent reactions (which the early 
event of IgGl-reactivity has been shown to be) and to stimulate B cell 
memory with the long term retention of antigen providing the continuing 
stimulus (a situation which has been demonstrated to occur during the 
extraneural pathogenesis of 87V). With the identification of specific cell * 
markers and improved separation techniques, preparations of some types of 
dendritic cells can now be obtained routinely. It should therefore be 
possible to investigate the role these cells play in scrapie pathogenesis.
From the limited studies reported here, there is a clear need to 
extend these findings into other mouse models of scrapie, perhaps 
concentrating initially on those which are also characterised by cerebral 
amyloid deposition. This would not only confirm the results presented 
here, but examine further the possible association between cerebral amyloid
and IgG. Murine models of scrapie are now not only relevant to the study 
of the 3 other scrapie-like diseases, but also to the field of the human 
dementias because of the presence of senile plaques in the brains of 
patients with dementia, and the reported increased levels of IgG in the 
sera of 16 Alzheimer patients (Acierno and Massaro, 1981).
There is also a priority to develop a test for early scrapie 
infection which does not rely on infectivity assays of material in 
recipient mice. The development of such a test has its most obvious 
application in the sheep industry. Since increased IgG concentrations have 
been found (Collis et al, 1979; Collis and Kimberlin, 1983) in the sera of 
a high proportion of naturally-or experimentally-infected sheep, a test for 
scrapie infection before clinical signs develop, could be useful in the 
control of the natural disease by selective culling, even if only a 
proportion of the infected sheep were identified in this way.
The development of a test for the early infection of mice with 
scrapie would also be invaluable to research. The increased activity of 
some IgGl-secreting B cells demonstrated at 4 weeks (and which may occur 
even earlier) could provide the basis for such a test. In addition to the 
kind of in vivo studies described in this thesis, lymphocytes (isolated 
from spleen or blood) from scrapie-injected animals could be cultured with 
IgGl stimulatory antigens, such as KLH and ovalbumin, and the response
measured in vitro. Until now, immunological studies of scrapie have
* s7concentrated predominantly on the model 139A in Sine mice, and to a
s7
lesser extent the ME7/Sinc model. These studies gave few positive 
results and led to the generalisation that there are no immune changes in 
the host following infection with scrapie. The work reported in this 
thesis challenges this generalisation and provides a positive basis for 
further immunological studies not only of the 87V/Sinc^>7 model, but of 
other murine models of scrapie and of the natural disease in sheep.
7. ACKNOWLEDGEMENTS
During the period of time this thesis took to complete, I received 
encouragement from many friends and colleagues, to those I omit to name, I 
apologise in advance.
The onerous task of supervisor fell to Richard Kimberlin. I am 
indebted to him, for without his help, encouragement and infinite patience 
this work would not have been planned and presented in what is, I hope,
t
such a cogent form. Michael Butler, my supervisor at the University of 
Surrey, seemed to have great confidence in my ability to succeed, I hope I 
have not disappointed him. I am also indebted to Carole Elleman, who 
taught me much of my basic immunology, offered help and advice on 
techniques and ideas; her reading of an illegible final draft was heroic 
and most constructive.
I am grateful to Professor J.M. Payne, Director of the ARC'S- 
Institute for Research of Animal Diseases at Compton, and Dr G.D. Hunter, 
Head of Biochemistry, for allowing me to embark on this thesis. Graham 
Osborne was most patient at coping with my requests for animals, and his 
staff provided excellent care of all my experimental animals. Geoff 
Millson and Carol Walker were always to hand when gloom and despondancy set 
in.
My transfer is the ARC and MRC Neuropathogenesis Unit in Edinburgh 
took place in November 1981. I am grateful to the Unit's Director, Dr A.G. 
Dickinson, for allowing me to complete the thesis here, and also for his 
earlier gift (in 1978) of 87V strain of scrapie in Sinc^7 mice, without 
which there would be no initial studies and ultimately, no thesis. I would 
also like to thank Moira Bruce, who did the amyloid plaque counts on badly 
removed mouse brains. I am also grateful to Christine Farquhar for 
discussions and help on matters immunological. Irene McConnell and her 
staff also provided mice and the necessary husbandry for my final
experiment.
The person with the unenviable task of reading an illegible script 
and transforming it into an excellently typed and organised manuscript was 
Angela McLaren; her indefatigable patience with me can only be admired, and 
I am also very grateful to her.
8. REFERENCES
Acierno, G. and Massaro, A.R. (1981). Gerontology 27, 100.
Allen, L.B. and Cochran, K.W. (1977). Annals New York Acadamy of Science
284. 676.
Andersson, J., Coutinho, A. and Melchers, F. (1977). Cell 10, 27.
Aoki, T., Gibbs, Jr., C.J., Sotello, J. and Gajdusek, D.C. (1982). 
Infection and Immunity 38. 316.
Berman, M.A. and Weigle, W.O. (1977). Journal of Experimental Medicine 
146. 241.
Biozzi, G., Stiffel, C., Monton, D., Bouthillier, Y. and Decreusefond, C.
(1972). Journal of Experimental Medicine 135. 1071.
Bruce, M.E. (1980) PhD Thesis, Open University, U.K.
Bruce, M.E. and Dickinson, A.G. (1982). Proceedings of the IXth 
International Congress of Neuropathology. Vienna.
Bruce, M.E. and Fraser, H. (1975 ). Neuropathology and Applied Neurobiology 
1, 189.
Bruce, M.E. and Fraser, H. (1981). Neuropathology and Applied 
Neurobiology 7./ 289.
Chandler, R.L. (1959). Veterinary Record 71, 58.
Chandler, R.L. (1961). Lancet i, 1378.
Chandler, R.L. (1963). Research in Veterinary Science 4, 276.
Clarke, M.C. (1968). Research in Veterinary Science 9, 595.
Clarke, M.C. and Haig, D.A. (1966). Veterinary Record 78., 647.
Clarke, M.C. and Haig, D.A. (1971). Research in Veterinary Science 12., 
195.
Collis, S.C. and Kiberlin, R.H. (1983). Journal of Comparative Pathology 
93. 331.
Collis, S.C., Kimberlin, R.H. and Millson, G.C. (1979). Journal of 
Comparative Pathology .89, 389.
Cross, R.J., Markesbery, W.R., Brooks, W.H. and Roszman, T.L. (1980). 
Brain Research 196. 79.
Cunnington, P.G., Kimberlin, R.H., Hunter, G.D. and Newsome, P.M. (1976). 
IRCS Medical Science 4, 250.
Dickinson, A.G. (1976). In 'Slow Virus Diseases of animals and Man’ p209,
R.H.Kimberlin, Ed., North-Holland, Amsterdam.
Dickinson, A.G. (1979). In'Slow Transmissible Diseases of the nervous
System'. p367, W.J.Hadlow and S.B.Prusiner, Eds., Academic Press. 
N.Y.
Dickinson, A.G. and Fraser, H. (1972). Heredity 29, 91.
Dickinson, A.G. and Fraser, H. (1977). In 'Slow Virus Infection of the 
Central Nervous System', p3, V.ter Meulen and M Katz, Eds., 
Springer-Verlag.
Dickinson, A.G., Fraser, H., McConnell, I and Outram, G.W. (1978). Nature 
272, 54.
Dickinson, A.G., Meikle, V.M.H. and Fraser, H. (1968). Journal of
Comarative Pathology 78, 293.
Dickinson, A.G. and Smith, W. (1966). In 'Report of Scrapie Seminar', 
p251, ARS 91-53, USDA Washington, D.C.
Dickinson, A.G. and Taylor, D.M. (1978). New England Journal of Medicine 
299. 1413.
Dickinson, A.G., Stamp, J.T. and Renwick, C.C. (1974). Journal of
Comparative Pathology 84, 19
Dickinson, A.G.,' Young, G.B. and Renwick, C.C. (1966). In 'Report of
Scrapie Seminar' p224, ARS 91-53, USDA Washington, D.C.
Eklund, C.M., Kennedy, R.C. and Hadlow, W.J. (1967). Journal of 
Infectious Diseases 117. 15.
Elson, C.J. (1980). Immunology Today 1, 42.
Elson, C . J., Naysmith, J.D. and Taylor, R.B. (1979). International Review 
of Experimental Pathology, 19, 137.
Engvall, E. and Perlman, P. (1972). Journal of Immunology 109, 129.
Resting, M.F.W. (1979). 'Inbred Strains in Biomedical Research'. 
Macmillan Press.
Field, E.J., Joyce, G.’ and Keith, A. (1969). Journal of General Virology
5., 149.
Flemming, P. (1977). Journal of General Virology 37, 93.
Fraser, H. (1976). In 'Slow Virus Diseases of Animals and Man’, p267. 
R.H. Kimberlin, Ed., North-Holland, Amsterdam.
Fraser, H. (1979), In 'Slow Transmissible Diseases of the Nervous
System'. p387 W. J. Hadlow and S.B. Prusiner, Eds., Academic Press, 
N.Y.
Fraser, H. and Dickinson, A.G. (1970). Nature 226, 462.
Fraser, H. and Dickinson, A.G. (1978). Journal of Comparative Pathology 
88. 563.
Gardiner, A.C. (1965). Research in Veterinary Science 1, 190.
Gardiner, A.C. and Marucci, A.A. (1969) Journal of Comparative Pathology
79. 233.
Gibbs, C.J. (Jnr) (1967). Current Topics in Microbiology 40, 44.
Glenner, G.G. and Terry, W.D. (1973). In 'Protide of the Biological
Fluids, 20th Colloquium', p55. H. Peeters, Ed., Pergamon Press, 
Oxford.
Glenner, G.G., Terry, W.D., Harada, M., Isersky, G. and Page, D. (1970). 
Science 171. 1150.
r
Gordon, W.S. (1957). Veterinary Record 69. 1324.
Gordon, W.S. (1966). In 'Report of Scrapie Seminar' p8. ARS 91-53, USDA
Washington, D .C .
Gresser, I. and Pattison, I.H. (1968). Journal of General Virology 3., 
295.
Grey, H.M., Hirst, J.W. and Cohn, M. (1971). Journal of Experimental 
Medicine 133. 289.
Griffin, D.E., Narayan, 0., Bukowski, J.F., Adams, R.J. and Cohen, S.R. 
(1978). Annals of Neurology 4, 212.
Haralambiev, H., Ivanov, I., Vesselinova, A. and Mersmerski, K. (1973). 
Zentrabl. Veterinaer med. Bieh. 20. 701.
Hirsch, M.S. (1970). Federation Proceedings 29, 169.
Hotchin, J. and Buckley, R. (1977). Science 169. 668.
Hourrigan, J.L., Klingsporn, A.L., Clark, W.W. and de Camp, M. (1979). In 
'Slow Transmissible Diseases of the Nervous System.' p331 
W.J.Hadlow and S.B. Prusiner, Eds., Academic press, N.Y.
Ishii, T. and Haga, S. (1976). Acta Neuropathologica 36, 243.
Katz, M. and Koprowski, H. (1968). Nature 219. 639.
Kimberlin, R.H. (1979a). Livestock Production Science 6, 233.
Kimberlin, R.H. (1979b). In 'Slow Transmissible Diseases of the Nervous 
System', p33. W. J. Hadlow and S.B. Prusiner, Eds., Academic Press, 
N.Y.
Kimberlin, R.H. and Cunnington, P.G. (1978). FEBS Microbiology Letters 3., 
169.
Kimberlin, R.H. and Walker, C.A. (1977). Journal of General Virology 34. 
295.
Kimberlin, R.H. and Walker, C.A. (1978a). Journal of General Virology 39.
487.
Kimberlin, R.H. and Walker, C.A. (1978b). Journal of Comparative 
Pathology 88., 39.
Kimberlin, R.H. and Walker, C.A. (1979a). Journal of General Virology 42,
107.
Kimberlin, R.H. and Walker, C.A. (1979b). Lancet ii 591.
Kimberlin, R.H. and Walker, C.A. (1979c). Journal of Comparative 
Pathology j39, 551.
Kimberlin, R.H. and Walker, C.A. (1983). In 'Virus non conventionnels et 
affections du systeme nerveux central' pl7 L.A. Court, ed., 
Masson,
Paris.
Kingsbury, D.T., Smeltzer, D.A., Gibbs, C.J. and Gajdusek, C.D. (1981). 
Infection and Immunity 32, 1176.
Laemmli, U.K. (1970). Nature 227, 680.
Lavelle, G.C., Struman, L. and Hadlow, W.J. (1972). Infection and 
Immunity 5, 319.
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951). 
Journal of Biological Chemistry 193. 265.
Lowy, I. Joskowicz, M. and Theze, J. (1982). Journal of Immunology 128. 
163.
Ludwig, H. and Becht, H. (1979). In 'Slow Virus Infections of the Central 
Nervous System' p75. V.ter Muelen and M. Katz, Eds. Springer- 
Verlag, N.Y.
Makinodan, J., Santo, G.W. and Quinn, R.P. (1970) Pharmacology Review 22.
1890.
McFarlin, D.E., Raff, M.C., Simpson, E. and Nehlsen, S.H. (1971), Nature 
233, 336.
Millson, G.C., Hunter, G.D. and Kimberlin, R.H. (1976) in 'Slow Virus 
Diseases of Animals and Han' p243. R.H. Kimberlin, Ed. North 
Holland, Amsterdam.
Millson, G.C., Kimberlin, R.H., Manning, E.J. and Collis, S.C. (1979). 
Veterinary Microbiology 4, 89.
Museteanu, C. and Diringer, H. (1981) Nature 294. 360.
Nettesheim, P. and Hammons, A.S. (1970) Proceedings of the Society of 
Experimental Biology and Medicine 133. 696
Nussbaum, R.E., Henderson, W.M., Pattison, I.H., Elcock, N.V. and Davies, 
D.C. (1975). Research in Veterinary Science 18., 49.
Outram, G.W. (1973). PhD Thesis, University of Edinburgh.
Palsson, P.A. (1976). In 'Slow Virus Diseases of Animals and Man' pl7, 
R.H. Kimberlin, Ed., North-Holland, Amsterdam.
Pattison, I.H. (1957). Lancet i, 104.
Pattison, I.H., Hoare, M.N., Jebbett, N.J. and Watson W.A. (1974). 
British Veterinary Journal 130. 65.
Pattison. I.H., Millson, G.C. (1961). Journal of Comparative Pathology 
71. 171.
Pattison, I.H., Millson, G.C. and Smith, K. (1964). Research in Veterinary 
Science 5, 116.
Porter, D.D., Porter, H.G. and Cox, N.A. (1973). Journal of Immunology ill. 
1407.
Pritchard, H., Riddaway, J. and Micklem, H.S. (1973). Clinical and 
Experimental Immunology 13. 125.
Quinn, R.P., Price, G.B., Ellis, J.M. and Makinodan, T. (1973). Journal of 
Gerontology 28., 257.
Rosenstreich, D.L. (1978). In 'Origins of Inbred Mice', p457. H.C. Morse 
III, Ed., Academic Press. N.Y.
Roszman, T.L., Cross. R.J., Brooks, W.H. and Markesbery, W.R. (1982). 
Immunology 45, 737.
Rutter, G. Asher, D.M., Rohwer, R.G., Gibbs. C.J. and Gajdusek, D.C. (1981). 
Archives of Virology 68., 129.
Sakano, H., Maki-, R., Kurosawa, Y., Roeder, W. and Tonegawa, R. (1980). 
Nature 286. 676.
Sigurdsson, B. (1954). British Veterinary Journal 110. 341.
Shirahama, T. and Cohen, A.S. (1975) American Journal of Pathology 81.
101.
Speigelberg, H.L. (1974). Advances in Immunology. Volume 19. p259. F.J.
Dixon and H.G. Kunkel, Eds., Academic Press, N.Y.
Stamp, J.T., Brotherston, J.G., Zlotmik, I., Mackay, J.M.K. and Smith, W.
(1959). Journal of Comparative Pathology 69., 268.
Stobo, J.D. and Paul, W.E. (1973). Journal of Immunology 110. 362.
Swinscow, T.D.V. (1978). 'Statistics at Square One'. Macmillan Press.
Tagliabue, A. Ruco, L., McCoy, J.L., Meltzer, M.S. and Herberman, R.B.
(1978) In 'Origin's of Inbred Mice* p461. H.C. Morse III Ed., 
Academic Press. N.Y.
Valdimarsson, H. and Santos, T.Q. (1983). B.S.I. Spring Meeting, London.
Vaz, N.A., Phillips—Quagliata, J.M., Levine. B.E. and Vaz, E.M. (1971). 
Journal of Experimental Medicine 134. 1335.
Vettermann, W., Werner, H.J., Schmeiber, S. and Koch, M.A. (1981). Medical 
Microbiology and Immunology 169. 75.
Wilson, D.R., Anderson, R.D. and Smith, W. (1950). Journal of Comparative 
Pathology 60, 267.
Wisniewski, H.M., Moretz, R.C. and Lossinsky, A.S. (1981). Annals of 
Neurology 10: 517.
Worthington, M. (1972). Infection and Immunity 6., 643.
Worthington, M. and Clark, R. (1971). Journal of General Virology 13. 
349.
Zlotnik, I. and Rennie, J.C. (1965). Journal of Comparative Pathology 75,
/
147.
Additional References'
Ey, P.L., Prowse, S.J. and Jenkin. C.R. (1978). Immunochemistry 15. 429.
Gronowicz, E. and Coutinho, A. (1976). Scandinavian Journal of Immunology
5., 55.
Hudson, L. and Hay, F.C. (1980). 'Practical Immunology'. Blackwell 
Scientific Publications, Oxford, U.K.
Tagliabue, A., Ruco, L.,M;CCoy, J.L., Meltzel, M.s. and Herberraan, R.B.
(1978). In 'Origins of Inbred Mice', p461. H.C.Morse III, Ed. 
Academic Press, N.Y.
J . C o m p . P a t h . 1979. V o l . 89. 389
I M M U N O G L O B U L I N  G C O N C E N T R A T I O N S  IN T H E
S E R A  OF H E R D W I C K  S H E E P  W I T H
N A T U R A L  S C R A P I E
By ;
S. C . C o l l i s , R . H . K i m b e r l i n  a n d  G . C . M i l l s o n
Agricultural Research Council, Institute fo r Research on Animal Diseases,
Compton, Nr. Newbury, Berkshire RG 16 ONN, U .K.
IN TRO DUCTION
Scrapie is a well known disease of sheep of considerable economic im portance 
in  the U nited K ingdom  and in  other countries. T he disease affects the central 
nervous system and can only be diagnosed by clinical signs (including pruritis 
and  incoordinated gait; see Dickinson, 1976) and histological lesions in  the 
brain  (e.g. vacuolated neurons; see Fraser, 1976). Scrapie is caused by a trans­
missible, filterable replicating agent bu t genetic factors in  both agent and host 
have a considerable influence on the appearance of clinical disease. T he causal 
agent is m ainly transm itted from m other to offspring although contact spread 
of infection from sheep to sheep also occurs to an  appreciable extent (see 
Dickinson, 1976). Control of the disease depends upon selective culling of 
infected m aternal lines and measures to reduce the opportunities for contagion. 
In  practice, these procedures can be successful b u t their effectiveness is generally 
reduced by the long incubation period o f scrapie and by the curren t inability  
to identify infected animals before they develop clinical disease (see K im berlin, 
1979).
Breeding experim ents w ith both Cheviot (Dickinson, Stam p, Renwick and 
Rennie, 1968) and H erdwick sheep (Nussbaum, Henderson, Pattison, Elcock 
and Davies, 1975) have shown th a t it is possible to produce divergent flocks 
which differ by nearly 100 per cent in their response to experim ental infection 
with a standard  source of scrapie agent. These studies have shown th a t sus­
ceptibility to experim ental infection is m ainly controlled by a single gene with 
the dom inant allele conferring susceptibility. Resistance to experim entally 
induced scrapie is currently regarded in  terms of long incubation  period ra ther 
th an  simply resistance to infection (K im berlin, 1979).
T he availability of susceptible and resistant flocks of H erdwick sheep a t 
C om pton has stim ulated the search for genetically controlled differences in 
blood constituents. So far, 20 biochemical param eters have been investigated 
(Collis and Millson, 1975; Collis, M illson and K im berlin, 1977; Collis u n p u b ­
lished) . In  the course of this work an  increased serum concentration of IgG  was 
observed among uninjected sheep of the susceptible flock which had  apparently  
developed the na tu ra l disease. T he first 2 cases were described by Pattison in 
1974. Since then  a large scale outbreak has occurred involving over 100 cases,
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mostly from  the susceptible flock (see K im berlin, 1979). This paper reports 
the results of an extensive survey of IgG  concentrations in  sera from nearly 70 
o f these cases of natu ra l scrapie in  H erdw ick sheep.
M A T E R I A L S  A N D  M E T H O D S
Sera. Sheep were bled from the jugular vein with disposable needles and syringes. 
The blood was allowed to clot at room temperature, centrifuged and the serum 
filtered and stored at —20 °C. Routine bleeding of the susceptible flock of Herdwicks 
was started in July 1975, with the lambs born that year and in March/April 1974 (H), 
and has been continued at intervals of 4 to 6 months. In  this way 4 or 5 sera were 
collected from each sheep in the 1975 (J) and 1976 (K) lamb crops before natural 
scrapie developed. Blood samples were obtained from clinical cases at slaughter.
Preparation o f antiserum to Herdwick IgG. Sera were collected from 6 Herdwick sheep 
of varying ages but all at the clinical stage of natural scrapie. The sera were dialysed 
against sterile distilled water for 48 h at 4 °G to precipitate the euglobulin fraction, 
which was separated by centrifugation at 500 g for 10 min. Saturated ammonium 
sulphate was added to the supernate to give a concentration of 33 per cent. The 
precipitate was collected by centrifugation (500 g, 10 min), dissolved in 0-1 m  
Tris-HCl, pH  8-3 containing 0-05 m  NaGl and dialysed against the same buffer for 
24 h at 4 °G. The solution was then run onto a column of DEAE Sephadex A-50 
(Pharmacia) and purified IgG2 and IgG l fractions were collected as described by 
Butler and Maxwell (1972). The fractions were dialysed, lyophilized and stored at 
4 °G. A pool of IgG l and IgG2 fractions from all 6 Herdwick sheep was prepared 
and dissolved in saline at a concentration of 1 mg per ml. Aliquots of 1 ml were 
emulsified with 1 ml of Freund’s complete adjuvant and 0-2 to TO ml was injected 
intramuscularly into New Zealand white rabbits at 4 day intervals. Twenty days 
after the 5th injection the rabbits were exsanguinated and filtered serum was stored 
at —20 °G as separate aliquots.
Estimation o f IgG concentration in serum was by a single radial diffusion assay which 
involved the diffusion of antigen through a 7 per cent agarose medium containing 
3 per cent of rabbit antiserum. Serum samples were diluted 1 in 100 before assay and 
standard solutions of purified sheep IgG were run on the same agarose plate. The 
plates were held at room temperature for 16 h. The diameter of the precipitation zone 
around the sample wells was measured and compared with the values obtained with 
standard IgG samples to give the concentration of IgG in serum.
RESULTS
T here were 41 sheep available for this study from  the 1974 (H) lam b crop, 
and of these 33 developed natu ra l scrapie between 21 and 28 m onths of age 
and 8 have rem ained norm al. Table 1 shows th a t the serum  concentration of 
IgG  in  the norm al anim als stayed fairly constant between 16 and 52 months 
of age although the values obtained from the 46 and  52 m onth  samples appear 
to be rising. In  contrast, the average IgG  levels in  clinically-affected sheep 
were considerably higher th an  those found in  either norm al sheep or in scrapie 
sheep before clinical signs developed.
This p a tte rn  was confirmed by the results obtained w ith the 1975 and  1976 
lam b crops w hich were bled m ore frequently. T he values for norm al sheep were 
variable (possibly because some were destined to develop the na tu ra l disease) 
bu t the average concentration of IgG  was consistently elevated in  both lam b 
crops w hen clinical signs o f scrapie developed (Table 1).
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TA BLE 1
SERUM Ig G  CONCENTRATION IN  H E RD W ICK  SH EEP A T D IFFE REN T AGES AND W H E N  SHOW ING 
CLINICAL SIGNS OF SCRAPIE
Serum IgG (mgper 100 ml: mean +  S.D . o f (n) sheep)
Age in 1974 crop (H ) 1975 crop (J ) 1976 crop (K )
months Normal Scrapie Normal Scrapie Normal Scrapie
(#) (33) (11) (17) (29) (17)
2 1725 +  384 1589 +  345 1960 +  250 2082 +  536
8 1850 +  327 2029 +  752 2112 +  314 2277 +  365
14 2159 ± 4 4 7 2387 ± 7 2 6 2 0 1 5 ± 2 6 7 2429 ± 3 8 1
16 1888 ± 2 5 3 1839 ± 2 8 0
20 , 1925 ± 2 9 0 2389 ± 7 8 2 2170 ± 3 1 8 2641 ± 4 4 8
22 1868 ± 2 4 6 1960 ± 4 9 1
24 2 0 1 0 ± 3 2 8
26 2347 ± 4 4 4 2500
28 1875 ±  261 (2 sheep only)
30 1677 ± 2 4 8
34 1888 ±  275
36 2650 ± 4 0 9
40 18864-261
46 19564-524
52 23634-498
Clinical 3068 ± 1 8 2 2 30 6 8 + 1 4 7 5 3821 ± 1 0 5 0
(21-28)
However, the patterns of increased IgG  in sheep incubating  scrapie were 
very variable when individual anim als were studied (Fig. 1). A few, for example 
J126, showed a progressive increase in  IgG  concentration throughout the 
incubation  period (assuming infection before or a t the tim e of b ir th ) . O thers 
such as J90  showed a dram atic rise early in life w ith a decrease a t the clinical 
stage of scrapie. Most showed either a dram atic increase when clinical signs 
developed ( J 129) or showed no significant increase (J159).
J126o  6 0
4 0
J90
J159
20 25
Months of age
Fig. 1. Examples o f  the variable patterns o f  serum IgG  concentration seen in sheep that develop natural 
scrapie.
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T he possibility th a t an  increase in  serum  IgG  concentration in, a t least some, 
clinically affected sheep m ight be of diagnostic value led us to consider ways 
to identify these individuals. Because of the large variation in  IgG  values found 
in  these studies we assessed the increase in IgG  in  each clinically-affected sheep 
in  terms of the num ber of standard  deviations above several possible “norm al” 
values. Table 2 shows the results obtained w ith the 1974 lam b crop. In  (A), 
individual values were tested against the m ean of all preclinical values of all 
sheep th a t developed scrapie. T en  scrapie sheep (30 per cent) had  clinical-IgG  
values greater than  the m ean plus 3 standard  deviations. In  (B), individual 
values were tested against the m ean of all serum samples from  all 8 norm al 
sheep. T he 10 sheep identified by test A were also identified by test B.
TA BLE 2
IDEN TIFICATION OF INDIVIDUAL SH EEP W IT H  INCREASED CONCENTRATION OF Ig G  IN  T H E  
CLINICAL STAGE OF SCRAPIE
Sheep with IgG values greater than the mean plus 3  S .D . of:
(C) As A but (D) Preclinical 
{A) A ll preclinical only preclinical values up to
values o f  all (B ) A ll values o f values up to 18 months for
scrapie cases all normal sheep 18-months-old each sheep
1974 (H) lam b crop (33 sheep) 
Num ber 10 10 14
Per cent 30 30 42 —
1975 (J) lam b crop (17 sheep) 
Num ber 4 4 4 7
Per cent 24 24 24 41
1976 (K) lam b crop (17 sheep) 
Num ber 9 13 13 15
Per cent 53 76 76 88
Total o f  H , J  and K  lam b crops 
Num ber 23 27 31 22
Per cent 34 40 46 65
A possible objection to test A is th a t it is too stringent because of the large 
variation found in  the preclinical IgG  levels in  sheep incubating  scrapie (see 
Fig. 1). A similar problem  exists w ith test B in  th a t some of the norm al animals 
m ay yet develop natu ra l scrapie and consequently the variation in  m ean B 
m ay be exaggerated. W e have observed th a t na tu ra l scrapie rarely develops 
before 18 months of age in H erdwick sheep a t Com pton. T he d a ta  in Table 1 
show th a t there is not a pronounced age effect on IgG  levels in  norm al sheep 
up to 4 years of age. Therefore in  test G (Table 2), clinical IgG  values were 
assessed against all preclinical values before 18 months of age in  all the sheep 
incubating scrapie. T he 10 sheep identified by tests A and  B were also identified 
by test C as having an  IgG  concentration greater th an  m ean C plus 3 standard  
deviations. In  addition 4 other sheep were identified by test G m aking a total 
of 14, or 42 per cent of na tu ra l cases.
Theoretically, the variation in  the preclinical IgG  values used to test the 
significance of clinical levels would be less if each sheep could be used as its 
own control. I t  was possible to examine this w ith the 1975 and  1976 lam b crops
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because 3 blood samples were collected before the animals reached 18 months 
of age. In  test D, the clinical IgG  values for each sheep were com pared with 
the m ean plus 3 standard  deviations of the 3 values found in  the same anim al 
before.18 months of age. Tests A, B and  G identified 4 sheep in the 1975 lam b 
crop w ith significantly increased concentrations o f IgG . Test D identified the 
same 4 sheep and 3 others, m aking a to tal of 7 (41 per cent) (Table 2). In  the 
1976 lam b crop (Table 2), test A identified 53 per cent of sheep, tests B and G 
identified 76 per cent bu t test D increased this figure to 88 per cent.
TA BLE 3
SUMMARY OF Ig G  VALUES IN  NORM AL AND SCRAPIE AFFECTED SH EEP
Serum IgG {mg per 100 ml)
{mean +  S .D . o f  (n) sheep)
1975 (J )  lamb crop 1976  (K ) lamb crop
Norm al sheep
2-18  months old§[ 1912+  361 (11) 2 0 5 0 +  182 (29)
21-27  months old§ 2 0 1 0 ±  328 (11) 2347 ±  444 (29)J
Scrapie sheep
1983+  509 (17)2—18 months oldff 2261 ±  380 (17)
21-27 months old (Clinical) §
(a) A ll 30 6 8 + 1 4 7 5  (17)* 3821 +  1050 (17)**
(b) < m e a n + 3  s.D .f 2 6 4 5 + 1 2 5 0  (10) 2 6 0 0 +  141 (2)
(c) > m e a n + 3  s.D .f 3671 +  1653 (7)** 3 9 2 7 +  919 (15)**
IgG  value for each sheep was the average from 1 (§) or 3 (fj) sera collected at different ages w ithin  
the range shown.
|  Scrapie sheep were separated into 2 groups having IgG  concentrations greater or less than the 
m ean plus 3 s .d . o f  preclinical values up to 18 months o f  age (Test D  in  Tables 3 and 4).
* Significantly different from IgG  concentrations in scrapie sheep at 2 -1 8  months o f  age, P < 0 - 0 1 : 
**P < 0 -0 0 1 .
J O ne sheep in this group had an IgG  value >  m ean plus 3 s .d . o f the 2 -1 8  m onth-old normals; 
see results.
Table 3 summarizes the results obtained w ith the 1975 and  1976 lam b crop. 
T he IgG  concentrations in both  norm al and  scrapie groups of sheep were 
sim ilar a t 2 to 18 'months of age. T here was a slight increase in serum  IgG  in 
norm al sheep of 21 to 27 m onths of age, when natu ra l scrapie appears in  this 
flock of Herdwicks, bu t w ith a single exception, none o f the older anim als had  
an IgG  value greater than  the m ean plus 3 s .d . a t 2 to 18 months o f age. T he 
exception was a sheep born in  1976 which had  an  IgG  value of 3850 m g per 
100 ml of serum. In  view of its age (28 months) it is quite possible th a t this 
anim al m ay be incubating scrapie and the very high value seen preclinically 
could be explained by the kind of pattern  seen w ith J 1 26 in  Fig. 1. However 
this exception represents only 2-5 per cent of the norm al anim als in  T ab le 3.
In  contrast, a total of 22 out of 34 scrapie sheep (65 per cent) had  IgG  values 
in  the clinical stage of scrapie th a t exceeded the m ean value plus 3 s .d . found 
in  the same animals a t 2 to 18 months of age (Table 3). I t  is interesting to note 
th a t the proportion in the 1975 lam b crop (41 per cent) was considerably less 
th an  th a t found in the 1976 crop (88 per cent). However in both  lam b crops, 
the average increase in  the serum  concentration of IgG  was similar, 85 per 
cent and 74 per cent, respectively (Table 3).
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DISCUSSION
This paper shows th a t large increases in the concentration o f serum IgG  
occur in the clinical stage of na tu ra l scrapie in  H erdwick sheep. However it is 
emphasized th a t these changes only occur in  a proportion o f clinical cases. 
T here are indications th a t serum  IgG  concentrations m ay be increased pre- 
clinically b u t the variable am ounts o f IgG  seen in norm al sheep and in  
individual animals a t different ages m ake it difficult to evaluate this statistically.
T he significance of these changes in scrapie is unknown. I t  is unlikely th a t 
they are due to environm ental factors, such as unrelated  infections, because 
the norm al sheep were fed and  housed w ith the sheep th a t were destined to 
develop natu ra l scrapie. T here is a possibility th a t the changes arose from 
secondary infections associated w ith clinical scrapie, particularly  in those cases 
w ith extensive skin dam age caused by rubbing  or nibbling. However we have 
observed no correlation between animals showing intense pruritis and those 
w ith high concentrations of IgG . Also, we have m ade prelim inary studies of 
sheep w ith scrapie after experim ental infection and in m any of these animals, 
pruritis is absent bu t increased concentrations of IgG  still occur in  some cases.
T he present studihs were carried out w ith antiserum  prepared against a 
pool of purified IgG  from 6 natu ra l cases in Herdwicks. This was done because 
prelim inary studies w ith com m ercial antisera gave ra ther low and variable 
results and we suspected th a t breed differences m ight be im portant. We now 
have prelim inary evidence th a t IgG2 m ay be the m ain im m unoglobulin 
present in the serum of clinically-affected H erdwick sheep whereas norm al 
Herdwicks and sheep of other breeds (C urtain, 1975; H alliday, 1978; Collis, 
unpublished) have Ig G l as the m ain com ponent. W e are currently examining 
the possibility of a relatively specific increase in  some im munoglobulins in 
scrapie.
O ne of the central dogmas of scrapie research is th a t there is no specific 
antibody response to infection. This is based largely on studies of experim ental 
scrapie in mice (Porter, Porter and Cox, 1973; C unnington, K im berlin, H un ter 
and Newsome, 1976) and little work has been done on the natu ra l disease in 
sheep. However, there is increasing evidence from studies of scrapie in  mice 
th a t the lym phoreticular system is involved in  the developm ent of disease. For 
example, it is known th a t scrapie agent replicates in  lym phoid tissues such as 
spleen (Dickinson and Fraser, 1977) and  th a t the incubation  period of scrapie 
in  mice can be reduced by injecting phytohaem agglutinin (Dickinson, Fraser, 
M cConnell and O utram , 1978) or m ethanol extraction residue of BCG vaccine 
(K im berlin and C unnington, 1978) a t the tim e of infection.
An im portan t series of studies by Bruce and co-workers has shown th a t some 
com binations of agent strain and mouse genotype are associated w ith the 
deposition of amyloid in  the brain. T he chemical nature of this amyloid is not 
known b u t it could be the result of an  im m unological process (Bruce and 
Fraser, 1975; Wisniewski, Bruce and Fraser, 1975; Bruce, Dickinson and 
Fraser, 1976). I t  is significant th a t the deposition of cerebral amyloid in 
scrapie mouse brain  is associated more commonly w ith some strains of agent 
than  w ith others. Since there have been prelim inary reports of amyloid deposits
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in  scrapie sheep bra in  (see Fraser, 1976), this leads us to suggest th a t the 
increased concentrations of serum  IgG  in natu ra l scrapie m ay be related to the 
form ation of cerebral amyloid. This suggestion is attractive because it is known 
th a t natu ra l scrapie infections often involve more than  one strain of agent 
(Dickinson, 1976). I f  the same is true for the curren t outbreak of scrapie in 
Herdw ick sheep a t Com pton, then it could explain why only a proportion of 
sheep have an  increased concentration of IgG  in  serum. I t  could also explain 
why the proportion was greater for the 1976 lam b crop than  for the 1974 or 
1975 lam b crops, if  we assume th a t the population of agent strains is changing . 
T he phenom enon of strain  selection has been shown to occur on experim ental 
passage of scrapie in hamsters (K im berlin and  W alker, 1978).
W e are currently examining brains from natu ra l cases of scrapie to see if  
there is any correlation between cerebral amyloid and high levels of serum  IgG. 
In  other studies, we are m easuring the concentration of IgG  in the sera of mice 
infected w ith strains of agent th a t produce large or very small am ounts of 
cerebral amyloid.
S U M M A R Y
Studies have been m ade of a flock of H erdw ick sheep, genetically selected 
for susceptibility to experim ental infection w ith scrapie, in which an  extensive 
outbreak of the natu ra l disease has occurred. O ne hundred  and fifteen sheep 
in 3 lam b crops (1974, 1975 and 1976) were bled a t approxim ately 6 m onthly 
intervals and measurem ents m ade of the concentration of IgG  in serum. Sixty- 
seven of these sheep developed natu ra l scrapie a t 21 to 28 m onths of age. 
Between 41 and 88 per cent of the scrapie cases (depending on the lam b crop) 
had  greatly increased concentrations of IgG  in the clinical stage of the disease. 
O n average, the increases were about 70 to 90 per cent above the concen­
trations of IgG  found in norm al and scrapie sheep of 2 to 18 m onths of age. T he 
significance of these changes is not known bu t it is suggested th a t they m ay be 
associated with the deposition of cerebral amyloid which is known to be a 
feature of some experim ental models of scrapie in  mice.
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IN TRO DUCTION
T he diagnosis o f scrapie, a natu ra lly  occurring disease o f sheep and, to a 
lesser extent, of goats, is m ade initially  on clinical signs (Stam p, 1962), b u t 
can only be confirmed by histopathological exam ination of b ra in  (Fraser, 
1976). T he causal agent has yet to be purified and  characterized and, a t 
resent, there is no im m unological test to identify infected anim als preclinically 
r  clinically. E arly  attem pts to identify scrapie-specific antibodies in  blood, 
erebrospinal fluid (CSF) and  various tissues o f sheep and  goats yielded nega- 
ive results (C handler, 1959; Pattison, M illson and  Smith, 1964; C lark an d  
aig, 1966). W ith the successful transmission o f scrapie from  experim entally- 
nfected goats to mice (C handler, 1961, 1963), arid la ter d irect transm ission 
rom  sheep to mice (Zlotnik and  R ennie, 1962; Dickinson an d  Sm ith, 1966) 
esearch has moved aw ay from the im m unological aspects o f the n a tu ra l an d  
he experim ental disease in  sheep and  goats towards studies in  mice because 
hese provide a  m ore homogeneous genetic background and  m ore convenient 
xperim ental models o f scrapie.
In  a recent paper (Collis, K im berlin  and  M illson, 1979) we reported  th a t  
ith in  a num ber of lam b crops w hich developed n a tu ra l scrapie it  was possible 
o identify a large proportion  o f anim als w ith significantly increased concentra- 
‘ons o f serum  im m unoglobulin G (IgG) a t the clinical stage. In  the present 
aper we describe sim ilar findings in  sheep infected experim entally w ith the  
SBP/1 (Scrapie Sheep Brain Pool, num ber 1) source of scrapie agent w hich 
ontains a m ixture o f strains (Dickinson, 1976). W e also describe fu rther work 
n  sheep w ith na tu ra l scrapie to investigate the percentage d istribution o f  
gG  isotypes in the sera and  CSF of affected anim als and  to test for local 
ynthesis o f im m unoglobulin in  the CNS.
m a t e r i a l s  a n d  m e t h o d s
nimals Used
All experiments were carried out with a flock of Herdwick sheep bred for sus- 
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ceptibility to subcutaneous infection with the SSBP/1 source of sheep passaged 
scrapie agent (Nussbaum, Henderson, Pattison, Elcock and Davies, 1975), a flock in 
which there has also been an outbreak of natural scrapie (Kimberlin, 1979). Sera 
were collected as described by Collis et al. (1979) from 3 groups of animals; (a) sheep 
at the clinical stage of natural scrapie; (b) clinically normal flockmates in the same 
age range as (a), and (c) sheep subcutaneously infected with the SSBP/1 source of 
agent (5 ml of a 10 per cent brain suspension). In  the last group, serum samples were 
collected shortly before infection from lambs aged 11 months (1973 crop), 5 months 
(1974 crop) and 8 months (1977. crop), and from the same animals at the clinical 
stage of scrapie which developed 4 to 10, 5 to 12, and 10 to 15 months later, rer 
spectively. Cerebral spinal fluid samples were also collected directly from the brains 
of sheep with clinical signs of natural scrapie. Fresh samples were centrifuged at 
1000 Xg  for 15 min, filtered through 450 nm filters and stored at —20°C.
Analytical Methods
The concentration of IgG and albumin in sera and CSF samples was measured by 
a single radial diffusion assay (SRD) as described previously (Collis et al., 1979). 
Rabbit antiserum to sheep IgG was obtained from Miles Research Laboratories, or 
was prepared as described by Collis et al. (1979). In  the latter case, antisera were 
prepared to a pool of purified IgG from either normal Herdwick sheep or from 
Herdwick sheep with clinical signs of natural scrapie. Rabbit antisera to purified 
sheep albumin (Sigma Chemical Co.) were also prepared. In  some experiments 
serum IgG was separated into IgG l and IgG2 isotypes as described by Collis et al. 
(1979) and protein concentrations were measured by the method of Lowry, Rose- 
brough, Farr and Randal (1951). Immunoelectrophoresis of non-haemolysed CSF 
and sera from individual sheep was carried out by the method of Ouchterlony and 
Nilsson (1978). Statistical significance between mean values was calculated by the 
“ Student /-test” . Regression lines for the correlation of IgG or albumin concentra­
tions in animal-matched CSF and serum samples were calculated, and the ratio of 
the slopes for the 2 regression lines (i.e. IgG CSF:Serum and Albumin CSF:Serum) 
for animals affected with scrapie was used to test for antibody synthesis within the 
central nervous system (CNS).
RESULTS
Three groups of lambs had been experimentally infected with scrapie at 5 to 
11 months of age. W hen clinical disease developed 4 to 15 months later (see 
Materials and Methods) the concentrations of IgG in sera were measured. 
Since previous studies o f this flock have shown that the serum concentration of 
IgG does not vary with age in uninfected sheep of up to 3 years old (Collis, et 
al., 1979) the values obtained for the scrapie-affected sheep were compared 
with those obtained from the same sheep before infection and from some of 
their flockmates bled at the same time. Table l shows that IgG values were 
increased by an average o f 39 to 66 per cent in sheep with scrapie. However, 
it was possible to demonstrate 2 populations within each lamb crop; those 
which showed little or no change in serum IgG, and those with highly signifi­
cant increase (P < 0 0 0 1 ) of 40 to 89 per cent. The proportion o f animals with 
large increases in serum IgG concentrations varied from group to group, being 
73 per cent in the 1973 lamb crop, and 79 and 97 per cent, respectively, in the 
1974 and 1977 lamb crops. -
These and previously published results (Collis et al., 1979) were obtained 
using a standard antiserum prepared against a pool of purified IgG from
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TA BLE 1
SERUM IgG  CONCENTRATIO N IN  SH EEP B EFO R E EX PER IM EN T A L INFECTION W IT H  SCRAPIE AND 
W H E N  SHOW ING CLIN ICAL SIGNS O F SCRAPIE
Serum IgG (mg per 100 ml) 
(mean-f.s .d . o f  (n) sheep)
1973 1974 1977
Lamb crop Lamb crop Lamb crop
Before infection 2080 ± 1 5 9 2071 ± 1 1 8 2945 ± 6 1
Scrapie cases
(22) (36) . (64)
(a) A ll 3450 ± 4 6 0 * 3 2 0 5 ± 2 5 1 * 4086 ± 1 0 5 *
(11) (19) (38)
(b) < M e a n ± 3  s .d . J 2183 ± 153 2 2 3 8 ± 1 4 4 3000
(3) (4) (1)
(c) > M e a n ± 3  s .d . J 39 2 5 ± 1 3 3 0 * * 3 4 2 3 ± 1 0 1 0 * * 4 1 1 5 ± 6 3 0 * *
(8) (15) ' (37)
IgG  values w ere m easured w ith rabbit aiitisera to IgG  prepared from natural cases in  
Herdwicks.
X Scrapie sheep w ere separated into 2 groups having IgG  concentrations greater or less 
than the m ean plus 3 s .d . o f values before infection. Significant differences from IgG  values 
before infection (* P < 0 -0 1 ;  ** P < (H )0 1 ).
natural cases o f scrapie in Herdwicks. Table 2 shows that the estimated con­
centrations o f serum IgG varied with the source of antiserum used in the assay. 
Both commercially available antiserum and that prepared against normal 
Herdwick IgG (see Materials and Methods) gave very similar results for 
clinically-normal sheep and age-matched flock mates with natural scrapie, in  
which the average increase in IgG concentration was 39 per cent,' using either 
antiserum. However, the standard antiserum prepared against purified IgG  
from natural scrapie cases gave slightly higher IgG values for control sheep, 
compared to values obtained with the 2 other sources of antiserum, but in the 
scrapie-affected sheep the average increase in serum IgG concentration was 
greater (55 instead of 39 per cent) and more highly significant (P <0*001 
instead o f P<0*01). Hence it may be speculated that the serum IgG fraction 
isolated from naturally-affected sheep differs from an identically isolated 
fraction from control sheep.
This observation led to studies of the relative proportions o f IgG l and IgG2
TA BLE 2
EFFECT OF D IFFE R EN T AN TISERA ON T H E  A P P A R E N T  SERUM IgG  CO NCENTRATIO N 
IN  CONTROLS AND IN  N A TU RA L CASES OF SCRAPIE
Serum IgG (mg per 100 ml) 
(meanf:s . d . (n) sheep)
• Change 
in IgG  
(per cent)
Source o f  
antiserum
Control sheep 
(17)
Scrapie sheep 
(12)
Values
o fP
Commercial 2 1 3 5 ± 5 8 0 2967 ± 6 8 4 ± 3 9 < 0-01
N orm al Herdwick 2206 ± 6 0 3 3 0 7 5 ± 6 8 4 ± 3 9 <0-01
Scrapie Herdwick 2485 ± 6 4 4 3842 ± 1 0 1 1 ± 5 5 < 0-001
Serum samples were obtained from  natural scrapie cases and clinically norm al 
sheep from the 1975 lam b crop.
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isotypes in the sera o f 3 control sheep and of 8 sheep affected with natural 
scrapie in which the increase in total IgG was exceptionally large. As shown in 
Table 3, the concentrations of IgG l increased by about 50 per cent above that 
o f controls in the animals with natural scrapie, but the concentrations o f IgG2 
increased dramatically from an average of 622 mg per 100 ml serum to 3347 
mg per 100 ml serum, an increase of about 5-fold. There is thus a shift from 
IgG l as the predominant isotype in control sheep sera (71 per cent of the total 
IgG) to IgG2 in the sera from scrapie sheep.
Immunoelectrophoresis o f animal-matched CSF and serum samples was
TA BLE 3
CO NCENTRATIO N OF IgG  SUBCLASSES IN  SERA OF CONTROLS AND NA TU RA L CASES
Group
Age
{months)
IgG (mg per 100 ml) IgG (per cent o f total) *
IgG l IgG2 IgG l IgG 2
Control 37 . 779 811 65 35
Control 80 1999 631 76 24
Control 91 1984 423 71 29
M ean values 1587 622 71 29
Scrapie 23 1176 1624 42 58
Scrapie 29 3888 3312 54 46
Scrapie 31 1680 2520 40 60
Scrapie 35 1395 1705 45 55
Scrapie 53 2176 4624 32 68
Scrapie 90 3710 3290 53 47
Scrapie 96 3700 6300 37 63
Scrapie 101 1196 3404 26 : 74 . .
M ean values 2365 3347 41 59
* Total is the sum o f values for Ig G l and IgG 2.
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Fig. 1. R elationships betw een protein concentration (album in or IgG ) in  CSF and serum o f sheep  
affected w ith  natural scrapie. Solid circles ( • )  represent IgG  values in  sheep w ith  detectable (by  
im muno-electrophoresis) IgG 2 in CSF. O pen circles (O) represent IgG  values in  sheep w ith no  
detectable IgG 2 in  CSF. Solid line is the calculated regression line for IgG  (slope=0*0040; 
correlation coefficient r= 0*821; significance, P < 0-01). D otted line is the calculated regression 
line (data not shown) for album in (slope=0*0037; correlation coefficient r=0*543; significance, 
P<0*01).
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carried out with antiserum prepared against IgG from natural scrapie cases. 
.The relative proportion of IgG l and IgG2 was determined semi-quantitatively 
by visual inspection of coded samples. IgG2 was the major IgG component in 
90 per cent of the 20 sera from sheep affected with natural scrapie but in all of 
the 26 control sera tested IgG2 .was the minor, component. In corresponding 
CSF samples, IgG2 was detected in 75 per cent o f those from scrapie cases but 
in  none of the controls.
It has been shown in man that synthesis of albumin does not occur within the 
CNS, and that the concentration o f albumin in CSF is proportional to that in 
serum (Cutler, Denel and Barlow, 1967). Figure 1 shows that a similar situation 
probably occurs in scrapie sheep because there was a clear correlation (r =  
0-543; P < 0-01) between albumin concentration in CSF and serum. There was 
also a highly significant correlation (r=0-821; P < 0-01) between CSF and 
serum concentrations o f IgG in scrapie sheep, and the slope o f the regression 
line for IgG (0-0040) was very similar to that for albumin (0-0037), which 
suggests that both albumin and IgG in CSF probably arise by passive filtration. 
This interpretation is supported by the additional observation that there were 
5 sheep with undetectable levels o f IgG2 in CSF (Fig. 1, open circles) because 
the same animals had relatively low concentrations o f IgG2 in serum.
DISCUSSION
There are 3 main findings from our present studies. First, 73 to 97 per cent 
o f Herdwick sheep from different lamb crops had an increased serum IgG  
concentration at the clinical stage of scrapie induced by injection o f the SSBP/1 
■ source o f agent. The average increase varied between 40 and 89 per cent of 
control values (Table 1). These results are similar to our published findings on 
natural scrapie in Herdwicks of which 41 to 88 per cent showed increases 
ranging from 74 to 85 per cent (Collis et al., 1979). The similarities in serum 
IgG are interesting in view of some differences between the sheep with experi­
mental and natural scrapie. Comparison of the strains o f agent isolated from 
experimental scrapie by serial passage in mice with some of the isolates from 
natural cases suggests that they differ (Kimberlin, unpublished). There were 
also striking differences in clinical signs. Pruritus was a very common feature o f  
the natural disease but was rare in experimental scrapie. This difference could 
be due to variation in strains o f agent or in routes o f infection but, whatever the 
explanation, it appears that similar increases in serum IgG are associated with 
different clinical signs o f scrapie in our Herdwick sheep. Studies o f scrapie in  
other Herdwick flocks and in other breeds of sheep are now needed to assess the 
diagnostic value of an increased IgG concentration in serum.
There are 2 main mechanisms whereby the concentration of IgG in the CSF 
can be increased; either passive filtration from serum containing increased 
IgG, or local synthesis within the CNS, as. is known to occur in several chronic 
CNS diseases caused by conventional viruses, for example visna (Griffin, 
Narayan, Bukowski, Adams and Cohen, 1978), Borna disease (Ludwig, Becht 
and Groh, 1973) and subac'ute sclerosing panencephalitis (Vandvik and Norby, 
1973). However, our second finding was that, in scrapie, IgG is probably not
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synthesized within the CNS, but reaches there by passive filtration from the 
serum. This view is supported by the fact that cellular infiltration o f brain is a 
major pathological feature of the above mentioned diseases whereas in scrapie 
its occurrence is rare (Museteanu and Diringer, 1981) and its significance 
questionable (Zlotnik and Rennie, 1957). Hence the inference from Fig. 1 is 
that the increased concentrations o f IgG in scrapie serum and CSF are due to 
synthesis in systemic B lymphocytes. This seems reasonable since the scrapie 
agent replicates for many months in lymphoid organs of naturally (Hadlow, 
Race, Kennedy and Eklund, 1979) and experimentally infected animals 
(Outram, 1976).
The third main finding was qualitative as well as quantitative differences in  
the serum IgG of scrapie cases compared to clinically normal flock mates 
(Tables 2 and 3). The increased proportion of IgG2 relative to IgG l argues 
against defective catabolism of IgG and suggests an increased synthesis by cer­
tain subclasses o f B lymphocytes. However, too little is known of IgG sub­
classes in sheep diseases to interpret the scrapie data satisfactorily. There is 
evidence that specific antibodies to visna infection in sheep occur only in the 
IgG l subfraction (Mehta and Thormar, 1974) whereas in sheep with foot-rot 
the situation is more complex and specific antibodies to the protease o f Bac- 
teroides nodosus occur initially in the IgG2 fraction, followed later by their 
appearance in the IgG l (Merritt and Egerton, 1978).
At present we have no immunological data on the significance of the in­
creases in serum IgG in sheep scrapie but there are several possibilities. The in­
crease may represent a specific immune response either to antigens associated 
with scrapie agent (assuming there are any) or to host antigens that may be 
released following agent-induced tissue damage (e.g. in brain). The failure o f  < 
others to detect any scrapie-specific response in sheep, goats (see. Introduction) 
or laboratory rodents (see Kimberlin, 1981) argues against the increased IgG  
in scrapie sera being a specific antibody to the infectious agent and no one has 
so far reported any evidence to support an autoimmune process in scrapie.
An alternative explanation is that replication o f scrapie agent in lymphoid 
organs (though not apparently in circulating lymphocytes) may lead t o . a 
non-specific overproduction o f IgG. A general hypergammaglobulinaemia ac­
companies specific antibody production to chronic infection with some con­
ventional viruses; for example, in Aleutian disease o f mink (Henson, Gorham, 
McGuire and Crawford, 1976) and ovine progressive pneumonia (Molitor, 
Light and Schipper, 1979). In the latter example, the increase in serum IgG  
was quantitatively similar to that seen in scrapie. However, histological studies 
of Aleutian disease and ovine progressive pneumonia reveal an underlying 
lymphoid hyperplasia which has not been seen in scrapie. .H ence the IgG  
changes in scrapie may be due to a more subtle disruption in the normal func­
tion o f certain lymphoid cells which, over a long period, leads to an accumula­
tion o f IgG in serum. This concept is consistent with recent studies o f mouse 
scrapie showing disturbances in the capping process o f some splenic lympho­
cytes (Vettermann, Werner, Schmeisser and Koch, 1981).
Our studies of IgG changes have been carried out on lines o f Herdwick 
sheep selectively bred for susceptibility to SSBP/1 scrapie. Even so, the varia­
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tion in normal IgG concentrations between sheep was considerable (Collis et 
al., 1979). Future work on the nature o f the IgG changes in scrapie would be 
easier if  the uncontrolled biological variation could be reduced further by using 
inbred mouse strains, which have the added advantage of being better under­
stood immunologically than sheep. In this connection we have recently found 
that increases in serum IgG occur in some experimental models of mouse 
scrapie.
S U M M A R Y
Previous studies showed that the concentration o f IgG in serum was in­
creased in a high proportion o f Herdwick sheep in the clinical stage of natural 
scrapie. The present paper reports similar findings in Herdwicks with experi­
mental scrapie in which the clinical signs were different. Further studies o f the 
natural disease showed increased concentrations o f IgG in CSF due to passive 
filtration from serum and not to local antibody production in the CNS. Quali­
tative differences in serum IgG have also been found in natural scrapie, in­
volving a shift in the major IgG isotype from IgG l to IgG2. The significance of 
these changes is not known but the limited evidence available may indicate a 
progressive dysfunction in certain sub-populations o f lymphocytes in sheep 
scrapie.
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